U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

McDonagh M, Skelly AC, Hermesch A, et al. Cervical Ripening in the Outpatient Setting [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. (Comparative Effectiveness Review, No. 238.)

Cover of Cervical Ripening in the Outpatient Setting

Cervical Ripening in the Outpatient Setting [Internet].

Show details

Appendix IExcluded Studies List

Table I-1Key to exclusion codes

Exclusion CodeExclusion Reason
1Ineligible population
2Ineligible intervention (include ineligible comparator)
3Ineligible outcome
4Ineligible setting
5Ineligible study design
6Ineligible publication type
7Foreign language
8Study not obtainable
9Outdated or ineligible systematic review
1.
Abaza R, Prall D. Drain placement can be safely omitted after the majority of robotic partial nephrectomies. J Urol. 2013 Mar;189(3):823–7. doi: 10.1016/j.juro.2012.08.236. PMID: 23009869. Exclusion: 1. [PubMed: 23009869] [CrossRef]
2.
Abdelaziz A, Mahmoud AA, Ellaithy MI, et al. Pre-induction cervical ripening using two different dinoprostone vaginal preparations: a randomized clinical trial of tablets and slow release retrievable insert. Taiwan J Obstet Gynecol. 2018 Aug;57(4):560–6. doi: 10.1016/j.tjog.2018.06.016. PMID: 30122579. Exclusion: 4. [PubMed: 30122579] [CrossRef]
3.
Abdellah MS, Hussien M, Aboalhassan A. Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial. Arch Gynecol Obstet. 2011 Jul;284(1):25–30. doi: 10.1007/s00404-010-1572-4. PMID: 20582425. Exclusion: 2. [PubMed: 20582425] [CrossRef]
4.
Abdul MA, Ibrahim UN, Yusuf MD, et al. Efficacy and safety of misoprostol in induction of labour in a Nigerian tertiary hospital. West Afr J Med. 2007 Jul–Sep;26(3):213–6. doi: 10.4314/wajm.v26i3.28312. PMID: 18399337. Exclusion: 4. [PubMed: 18399337] [CrossRef]
5.
Acharya N, Gadge A, Agrawal M, et al. Mechanical cervical ripening with foley catheter balloon: rekindling a forgotten art. Journal of SAFOG. 2018;10(1):1–4. doi: 10.5005/jp-journals-10006-1548. Exclusion: 4. [CrossRef]
6.
Adair CD, Weeks JW, Barrilleaux S, et al. Oral or vaginal misoprostol administration for induction of labor: a randomized, double-blind trial. Obstet Gynecol. 1998 Nov;92(5):810–3. doi: 10.1016/s0029-7844(98)00278-6. PMID: 9794674. Exclusion: 2. [PubMed: 9794674] [CrossRef]
7.
Adelson PL, Wedlock GR, Wilkinson CS, et al. A cost analysis of inpatient compared with outpatient prostaglandin E2 cervical priming for induction of labour: results from the OPRA trial. Aust Health Rev. 2013 Sep;37(4):467–73. doi: 10.1071/AH13081. PMID: 24018055. Exclusion: 3. [PubMed: 24018055] [CrossRef]
8.
Adeniji AO, Akinola SE. A comparison of orally administered misoprostol and membrane sweeping for labour induction in uncomplicated singleton post-term pregnancies. S Afr J Obstet Gynaecol. 2013;19(1):4–7. doi: 10.7196/SAJOG.584. PMID: 00912287. Exclusion: 2. [CrossRef]
9.
Adeniji OA, Oladokun A, Olayemi O, et al. Pre-induction cervical ripening: transcervical foley catheter versus intravaginal misoprostol. J Obstet Gynaecol. 2005 Feb;25(2):134–9. doi: 10.1080/01443610500040737. PMID: 15814391. Exclusion: 4. [PubMed: 15814391] [CrossRef]
10.
Afolabi BB, Oyeneyin OL, Ogedengbe OK. Intravaginal misoprostol versus foley catheter for cervical ripening and induction of labor. Int J Gynaecol Obstet. 2005 Jun;89(3):263–7. doi: 10.1016/j.ijgo.2005.02.010. PMID: 15919393. Exclusion: 4. [PubMed: 15919393] [CrossRef]
11.
Aftab S, Noorani KJ. Comparison of efficacy of vaginal misoprostol and prostaglandin E2 for induction of labour in primigravidae title page. Medical Channel. 2011;17(1):39–43. Exclusion: 4.
12.
Agarwal K, Batra A, Batra A, et al. Randomized comparison of isosorbide mononitrate and PGE2 gel for cervical ripening at term including high risk pregnancy. International Journal of Reproductive Medicine Print. 2014;2014:147274. doi: 10.1155/2014/147274. PMID: 25763391. Exclusion: 2. [PMC free article: PMC4334047] [PubMed: 25763391] [CrossRef]
13.
Agarwal N, Gupta A, Kriplani A, et al. Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction. J Obstet Gynaecol Res. 2003 Jun;29(3):147–51. doi: 10.1046/j.1341-8076.2003.00091.x. PMID: 12841697. Exclusion: 4. [PubMed: 12841697] [CrossRef]
14.
Aghideh FK, Mullin PM, Ingles S, et al. A comparison of obstetrical outcomes with labor induction agents used at term. J Matern Fetal Neonatal Med. 2014 Apr;27(6):592–6. doi: 10.3109/14767058.2013.831066. PMID: 23919802. Exclusion: 4. [PubMed: 23919802] [CrossRef]
15.
Akhtar A, Talib W, Shami N, et al. Induction of labour - a comparison between misoprostol and dinoprostone. Pakistan Journal of Medical and Health Sciences. 2011 Oct;5(4):617–9. PMID: 00902431. Exclusion: 4.
16.
Al-Assadi AF, Al-Waeely FA, Ahmed H, et al. Extraamniotic versus vaginal misoprostol for ripening the unfavorable cervix. J Bahrain Med Soc. 2009;21(1):207–11. Exclusion: 4.
17.
Al-Assadi AF, Al-Waeely FA, Kadhim SS. The use of extraamniotic dexamethasone for ripening the unfavourable cervix. J Bahrain Med Soc. 2007 Oct;19(4):148–53. doi: 10.1093/ajcn/31.10.S125. PMID: 00707362. Exclusion: 4. [CrossRef]
18.
Al-Ibraheemi Z, Brustman L, Bimson BE, et al. Misoprostol with foley bulb compared with misoprostol alone for cervical ripening: a randomized controlled trial. Obstet Gynecol. 2018 Jan;131(1):23–9. doi: 10.1097/AOG.0000000000002403. PMID: 29215514. Exclusion: 4. [PubMed: 29215514] [CrossRef]
19.
Al-Taani MI. Intravaginal prostaglandin-E2 for cervical priming and induction of labour. East Mediterr Health J. 2007 Jul–Aug;13(4):855–61. PMID: 17955768. Exclusion: 4. [PubMed: 17955768]
20.
Allameh Z, Rouholamin S, Hekmat R. Comparison of vaginal misoprostol tablet with oxytocin infusion for induction of labor in term pregnancy. J Res Med Sci. 2012;17(1 SPL.1):S134–S9. Exclusion: 2.
21.
Amon E, Fossick K, Sibai B. Serial changes in the biophysical profile in patients undergoing cervical ripening with a controlled release PGE2 vaginal pessary. J Matern Fetal Med. 1999 Jan–Feb;8(1):8–11. doi: 10.1002/(SICI)1520-6661(199901/02)8:1<8::AID-MFM2>3.0.CO;2-0. PMID: 10052838. Exclusion: 4. [PubMed: 10052838] [CrossRef]
22.
Anabusi S, Mei-Dan E, Hallak M, et al. Mechanical labor induction in the obese population: a secondary analysis of a prospective randomized trial. Arch Gynecol Obstet. 2016 Jan;293(1):75–80. doi: 10.1007/s00404-015-3765-3. PMID: 26054823. Exclusion: 5. [PubMed: 26054823] [CrossRef]
23.
Anand AK, Mir S. A randomized comparison between intravaginal misoprostol and intracervical dinoprostone for cervical ripening and labour induction in participants with unfavourable cervices. JK Science. 2012;14(3):115–9. Exclusion: 4.
24.
Ande AB, Ezeanochie CM, Olagbuji NB. Induction of labor in prolonged pregnancy with unfavorable cervix: comparison of sequential intracervical Foley catheter-intravaginal misoprostol and intravaginal misoprostol alone. Arch Gynecol Obstet. 2012 Apr;285(4):967–71. doi: 10.1007/s00404-011-2094-4. PMID: 22012248. Exclusion: 4. [PubMed: 22012248] [CrossRef]
25.
Andreasson B, Bock JE, Larsen J. Induction of labor. A double-blind randomized controlled study of prostaglandin E2 vaginal suppositories compared with intranasal oxytocin and with sequential treatment. Acta Obstet Gynecol Scand. 1985;64(2):157–61. doi: 10.3109/00016348509154710. PMID: 3885670. Exclusion: 2. [PubMed: 3885670] [CrossRef]
26.
Anjum S, Sharma R. Oral misoprostol vs intravenous oxytocin infusion for induction of labor in prelabor rupture of membranes. Journal of SAFOG. 2016;8(1):4–7. doi: 10.5005/jp-journals-10006-1375. Exclusion: 4. [CrossRef]
27.
Anonymous. A clinical trial of induction of labor versus expectant management in postterm pregnancy. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1994 Mar;170(3):716–23. PMID: 7710467. Exclusion: 4. [PubMed: 7710467]
28.
Arif A, Khan NR, Zeb L. Mode of delivery and fetal outcome in patients with prolonged pregnancy undergoing elective induction at 41 & 41+ weeks. Journal of Postgraduate Medical Institute. 2015;29(4):227–30. Exclusion: 4.
29.
Arulkumaran S, Adaikan PG, Anandakumar C, et al. Comparative study of a two dose schedule of PGE2 3 mg pessary and 1700 micrograms film for induction of labour in nulliparae with poor cervical score. Prostaglandins Leukot Essent Fatty Acids. 1989 Oct;38(1):37–41. doi: 10.1016/0952-3278(89)90145-2. PMID: 2608700. Exclusion: 4. [PubMed: 2608700] [CrossRef]
30.
Arulkumaran S, Gibb DM, Heng SH, et al. Perinatal outcome of induced labour. Asia Oceania J Obstet Gynaecol. 1985 Mar;11(1):33–7. doi: 10.1111/j.1447-0756.1985.tb00044.x. PMID: 4040358. Exclusion: 2. [PubMed: 4040358] [CrossRef]
31.
Asher GN, Coeytaux RR, Chen W, et al. Acupuncture to initiate labor (Acumoms 2): a randomized, sham-controlled clinical trial. J Matern Fetal Neonatal Med. 2009 Oct;22(10):843–8. doi: 10.1080/14767050902906386. PMID: 19526433. Exclusion: 2. [PMC free article: PMC2919333] [PubMed: 19526433] [CrossRef]
32.
Ashrafunnessa, Khatun SS, Chowdhury SA, et al. Induction of labor by intracervical prostaglandin gel and oxytocin infusion in primigravid women with unfavorable cervix. Bangladesh Med Res Counc Bull. 1997 Dec;23(3):66–71. PMID: 9621474. Exclusion: 8. [PubMed: 9621474]
33.
Atad J, Hallak M, Auslender R, et al. A randomized comparison of prostaglandin E2, oxytocin, and the double-balloon device in inducing labor. Obstet Gynecol. 1996 Feb;87(2):223–7. doi: 10.1016/0029-7844(95)00389-4. PMID: 8559528. Exclusion: 4. [PubMed: 8559528] [CrossRef]
34.
Attanasio LB, Kozhimannil KB, Kjerulff KH. Factors influencing women’s perceptions of shared decision making during labor and delivery: results from a large-scale cohort study of first childbirth. Patient Educ Couns. 2018 Jun;101(6):1130–6. doi: 10.1016/j.pec.2018.01.002. PMID: 29339041. Exclusion: 3. [PMC free article: PMC5977392] [PubMed: 29339041] [CrossRef]
35.
Attanayake K, Goonewardene M. Cervical ripening with self administered iso sorbide mononitrate vaginally, in uncomplicated singleton pregnancies at 39 weeks gestation: a double blind randomised controlled trial. Ceylon Med J. 2016 Dec 30;61(4):142–8. doi: 10.4038/cmj.v61i4.8378. PMID: 28076940. Exclusion: 2. [PubMed: 28076940] [CrossRef]
36.
Austin D, Benn C. Induction of labour: the influences on decision making. J N Z Coll Midwives. 2006(34):6–11. PMID: 106351886. Exclusion: 1.
37.
Austin K, Chambers GM, de Abreu Lourenco R, et al. Cost-effectiveness of term induction of labour using inpatient prostaglandin gel versus outpatient Foley catheter. Aust N Z J Obstet Gynaecol. 2015 Oct;55(5):440–5. doi: 10.1111/ajo.12348. PMID: 26173911. Exclusion: 3. [PubMed: 26173911] [CrossRef]
38.
Austin SC, Sanchez-Ramos L, Adair CD. Labor induction with intravaginal misoprostol compared with the dinoprostone vaginal insert: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010 Jun;202(6):624.e1–9. doi: 10.1016/j.ajog.2010.03.014. PMID: 20430362. Exclusion: 9. [PubMed: 20430362] [CrossRef]
39.
Avdiyovski H, Haith-Cooper M, Scally A. Membrane sweeping at term to promote spontaneous labour and reduce the likelihood of a formal induction of labour for postmaturity: a systematic review and meta-analysis. J Obstet Gynaecol. 2019 Jan;39(1):54–62. doi: 10.1080/01443615.2018.1467388. PMID: 30284490. Exclusion: 2. [PubMed: 30284490] [CrossRef]
40.
Ayachi A, Bouchahda R, Derouich S, et al. Labor induction: why complicate things when they can be simple? A randomized controlled clinical trial. Gazz Med Ital. 2017;176(7–8):419–23. doi: 10.23736/S0393-3660.16.03399-4. PMID: 01396788. Exclusion: 4. [CrossRef]
41.
Ayaz H, Black M, Madhuvrata P, et al. Maternal and neonatal outcomes following additional doses of vaginal prostaglandin E2 for induction of labour: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):364–7. doi: 10.1016/j.ejogrb.2013.07.021. PMID: 23932182. Exclusion: 4. [PubMed: 23932182] [CrossRef]
42.
Badejoko OO, Ijarotimi AO, Awowole IO, et al. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial. J Obstet Gynaecol Res. 2012 Nov;38(11):1294–301. doi: 10.1111/j.1447-0756.2012.01869.x. PMID: 22612662. Exclusion: 2. [PubMed: 22612662] [CrossRef]
43.
Bagratee JS, Moodley J. Synthetic laminaria tent for cervical ripening. Samj, S. 1990 Dec 15;78(12):738–41. PMID: 2251632. Exclusion: 4. [PubMed: 2251632]
44.
Bahar AM, Archibong EI, Zaki ZM, et al. Induction of labour using low and high dose regimens of prostaglandin E2 vaginal tablets. East Afr Med J. 2003 Jan;80(1):51–5. doi: 10.4314/eamj.v80i1.8666. PMID: 12755242. Exclusion: 4. [PubMed: 12755242] [CrossRef]
45.
Bai DL, Wu KM, Tarrant M. Association between intrapartum interventions and breastfeeding duration. J Midwifery Womens Health. 2013 Jan–Feb;58(1):25–32. doi: 10.1111/j.1542-2011.2012.00254.x. PMID: 23317341. Exclusion: 1. [PubMed: 23317341] [CrossRef]
46.
Bailit JL, Grobman W, Zhao Y, et al. Nonmedically indicated induction vs expectant treatment in term nulliparous women. Am J Obstet Gynecol. 2015 Jan;212(1):103.e1–7. doi: 10.1016/j.ajog.2014.06.054. PMID: 24983681. Exclusion: 4. [PMC free article: PMC4275393] [PubMed: 24983681] [CrossRef]
47.
Bakker JJ, Verhoeven CJ, Janssen PF, et al. Outcomes after internal versus external tocodynamometry for monitoring labor. N Engl J Med. 2010 Jan 28;362(4):306–13. doi: 10.1056/NEJMoa0902748. PMID: 20107216. Exclusion: 1. [PubMed: 20107216] [CrossRef]
48.
Barda G, Ganer Herman H, Sagiv R, et al. Foley catheter versus intravaginal prostaglandins E2 for cervical ripening in women at term with an unfavorable cervix: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018 Oct;31(20):2777–81. doi: 10.1080/14767058.2017.1355906. PMID: 28764579. Exclusion: 4. [PubMed: 28764579] [CrossRef]
49.
Barnfield L, Neale E, Reynolds S. Outpatient cervical ripening in a district general hospital: a five-year retrospective cohort study. J Obstet Gynaecol. 2018 Apr;38(3):301–4. doi: 10.1080/01443615.2017.1346594. PMID: 28920504. Exclusion: 5. [PubMed: 28920504] [CrossRef]
50.
Barrilleaux PS, Bofill JA, Terrone DA, et al. Cervical ripening and induction of labor with misoprostol, dinoprostone gel, and a foley catheter: a randomized trial of 3 techniques. Am J Obstet Gynecol. 2002 Jun;186(6):1124–9. doi: 10.1067/mob.2002.123821. PMID: 12066084. Exclusion: 4. [PubMed: 12066084] [CrossRef]
51.
Bartha JL, Comino-Delgado R, Garcia-Benasach F, et al. Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: a randomized comparison. Obstet Gynecol. 2000 Sep;96(3):465–9. doi: 10.1016/s0029-7844(00)00954-6. PMID: 10960643. Exclusion: 4. [PubMed: 10960643] [CrossRef]
52.
Bartnicki J, Tzanow G, Friedmann W, et al. Computer analysis of fetal heart rate during induction of labor with oxytocin. Gynecol Obstet Invest. 1995;40(3):168–73. doi: 10.1159/000292329. PMID: 8529949. Exclusion: 2. [PubMed: 8529949] [CrossRef]
53.
Battarbee AN, Palatnik A, Peress DA, et al. Association of early amniotomy after foley balloon catheter ripening and duration of nulliparous labor induction. Obstet Gynecol. 2016 Sep;128(3):592–7. doi: 10.1097/AOG.0000000000001563. PMID: 27500341. Exclusion: 4. [PubMed: 27500341] [CrossRef]
54.
Battarbee AN, Palatnik A, Peress DA, et al. The association between cervical exam after ripening with foley balloon catheter and outcomes of nulliparous labor induction. Am J Perinatol. 2018 Aug;35(10):1001–5. doi: 10.1055/s-0038-1635091. PMID: 130908973. Exclusion: 4. [PubMed: 29490397] [CrossRef]
55.
Battista L, Chung JH, Lagrew DC, et al. Complications of labor induction among multiparous women in a community-based hospital system. Am J Obstet Gynecol. 2007 Sep;197(3):241.e1–7; discussion 322–3, e1–4. doi: 10.1016/j.ajog.2006.12.027. PMID: 17826404. Exclusion: 2. [PubMed: 17826404] [CrossRef]
56.
Baud D, Rouiller S, Hohlfeld P, et al. Adverse obstetrical and neonatal outcomes in elective and medically indicated inductions of labor at term. J Matern Fetal Neonatal Med. 2013 Nov;26(16):1595–601. doi: 10.3109/14767058.2013.795533. PMID: 23581489. Exclusion: 2. [PubMed: 23581489] [CrossRef]
57.
Beckmann M, Acreman M, Schmidt E, et al. Women’s experience of induction of labor using PGE2 as an inpatient versus balloon catheter as an outpatient. Eur J Obstet Gynecol Reprod Biol. 2020 Jun;249:1–6. doi: 10.1016/j.ejogrb.2020.03.031. PMID: 32311627. Exclusion: 3. [PubMed: 32311627] [CrossRef]
58.
Beckmann M, Paterson E, Smith A. Redesigning induction of labour processes. Aust N Z J Obstet Gynaecol. 2018 Jun;58(3):315–20. doi: 10.1111/ajo.12734. PMID: 29067683. Exclusion: 4. [PubMed: 29067683] [CrossRef]
59.
Beckmann M, Thompson R, Miller Y, et al. Measuring women’s experience of induction of labor using prostaglandin vaginal gel. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:189–95. doi: 10.1016/j.ejogrb.2016.12.032. PMID: 28056435. Exclusion: 1. [PubMed: 28056435] [CrossRef]
60.
Beigi A, Kabiri M, Zarrinkoub F. Cervical ripening with oral misoprostol at term. Int J Gynaecol Obstet. 2003 Dec;83(3):251–5. doi: 10.1016/s0020-7292(03)00275-3. PMID: 14643034. Exclusion: 4. [PubMed: 14643034] [CrossRef]
61.
Beigi A, Kazemipour SM, Tabarestani H. Induction of labor in term pregnancy: sublingual versus vaginal misoprostol. Tehran University Medical Journal. 2010 Jul;68(3):175–81. PMID: 01786665 Exclusion: 7.
62.
Ben-Aroya Z, Hallak M, Segal D, et al. Ripening of the uterine cervix in a post-cesarean parturient: prostaglandin E2 versus foley catheter. J Matern Fetal Neonatal Med. 2002 Jul;12(1):42–5. doi: 10.1080/jmf.12.1.42.45. PMID: 12422908. Exclusion: 2. [PubMed: 12422908] [CrossRef]
63.
Benalcazar-Parra C, Monfort-Orti R, Ye-Lin Y, et al. Comparison of labour induction with misoprostol and dinoprostone and characterization of uterine response based on electrohysterogram. J Matern Fetal Neonatal Med. 2019 May;32(10):1586–94. doi: 10.1080/14767058.2017.1410791. PMID: 29251182. Exclusion: 4. [PubMed: 29251182] [CrossRef]
64.
Bendix JM, Friis Petersen J, Andersen BR, et al. Induction of labor with high- or low-dosage oral misoprostol-a Danish descriptive retrospective cohort study 2015–16. Acta Obstet Gynecol Scand. 2020 Feb;99:222–30. doi: 10.1111/aogs.13739. PMID: 31557305. Exclusion: 4. [PubMed: 31557305] [CrossRef]
65.
Bennett KA, Butt K, Crane JM, et al. A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction. Obstet Gynecol. 1998 Oct;92(4 Pt 1):481–6. doi: 10.1016/s0029-7844(98)00226-9. PMID: 9764615. Exclusion: 4. [PubMed: 9764615] [CrossRef]
66.
Bergholt T, Skjeldestad FE, Pyykonen A, et al. Maternal age and risk of cesarean section in women with induced labor at term-A Nordic register-based study. Acta Obstet Gynecol Scand. 2020 02;99(2):283–9. doi: 10.1111/aogs.13743. PMID: 31583694. Exclusion: 1. [PubMed: 31583694] [CrossRef]
67.
Berkane N, Verstraete L, Uzan S, et al. Use of mifepristone to ripen the cervix and induce labor in term pregnancies. Am J Obstet Gynecol. 2005 Jan;192(1):114–20. doi: 10.1016/j.ajog.2004.05.084. PMID: 15672012. Exclusion: 2. [PubMed: 15672012] [CrossRef]
68.
Bernstein P, Leyland N, Gurland P, et al. Cervical ripening and labor induction with prostaglandin E2 gel: a placebo-controlled study. Am J Obstet Gynecol. 1987 Feb;156(2):336–40. doi: 10.1016/0002-9378(87)90279-1. PMID: 3548368. Exclusion: 4. [PubMed: 3548368] [CrossRef]
69.
Berzosa J, Martinez-Guisasola J, Guerrero M, et al. Application of prostaglandin E2 gel in post-term pregnancy (> 287 days). Clin Invest Ginecol Obstet. 1996;23(3):101–5. Exclusion: 7.
70.
Bharathi A, Ashok Kumar K, Pavana Ganga A. A comparative study of 25 mcg vs 50 mcg of vaginal misoprostol for induction of labor. Journal of SAFOG. 2013;5(3):111–5. doi: 10.5005/jp-journals-10006-1240. Exclusion: 4. [CrossRef]
71.
Bhatia M, Mitsi V, Court L, et al. The outcomes of pregnancies with reduced fetal movements: a retrospective cohort study. Acta Obstet Gynecol Scand. 2019 Nov;98(11):1450–4. doi: 10.1111/aogs.13671. PMID: 31148156. Exclusion: 1. [PubMed: 31148156] [CrossRef]
72.
Bhatti K, Hafeez R, Shaikh F. Role of foleys catheter for pre-induction ripening of cervix. Medical Forum Monthly. 2013;24(2):39–41. Exclusion: 8.
73.
Bhatti K, Mahar T, Hafeez R. Comparison of efficacy of cervical foleys catheter and prostaglandin E2 for induction of labour. Medical Forum Monthly. 2013;24(7):31–4. Exclusion: 8.
74.
Bleicher I, Dikopoltsev E, Kadour-Ferro E, et al. Double-balloon device for 6 compared with 12 hours for cervical ripening: A randomized controlled trial. Obstet Gynecol. 2020 May;135(5):1153–60. doi: 10.1097/AOG.0000000000003804. PMID: 32282603. Exclusion: 1. [PubMed: 32282603] [CrossRef]
75.
Bolla D, Weissleder SV, Radan AP, et al. Misoprostol vaginal insert versus misoprostol vaginal tablets for the induction of labour: a cohort study. BMC Pregnancy Childbirth. 2018 May 10;18(1):149. doi: 10.1186/s12884-018-1788-z. PMID: 29747591. Exclusion: 4. [PMC free article: PMC5946434] [PubMed: 29747591] [CrossRef]
76.
Bollapragada S, Mackenzie F, Norrie J, et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy Childbirth. 2006;6 doi: 10.1186/1471-2393-6-25. Exclusion: 2. [PMC free article: PMC1569865] [PubMed: 16869966] [CrossRef]
77.
Bollapragada SS, MacKenzie F, Norrie JD, et al. Randomised placebo-controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour--clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG. 2009 Aug;116(9):1185–95. doi: 10.1111/j.1471-0528.2009.02216.x. PMID: 19624440. Exclusion: 2. [PubMed: 19624440] [CrossRef]
78.
Bolnick JM, Velazquez MD, Gonzalez JL, et al. Randomized trial between two active labor management protocols in the presence of an unfavorable cervix. Am J Obstet Gynecol. 2004 Jan;190(1):124–8. doi: 10.1016/s0002-9378(03)00952-9. PMID: 14749647. Exclusion: 2. [PubMed: 14749647] [CrossRef]
79.
Boulvain M, Marcoux S, Bureau M, et al. Risks of induction of labour in uncomplicated term pregnancies. Paediatr Perinat Epidemiol. 2001 Apr;15(2):131–8. doi: 10.1046/j.1365-3016.2001.00337.x. PMID: 11383577. Exclusion: 4. [PubMed: 11383577] [CrossRef]
80.
Boulvain M, Stan CM, Irion O. Membrane sweeping for induction of labour. Cochrane Database Syst Rev. 2009(4):CD000451. doi: 10.1002/14651858.CD000451. PMID: 11405964. Exclusion: 9. [PubMed: 11405964] [CrossRef]
81.
Brandstetter A, Döbert M, Schwaerzler P, et al. Standard and adjusted criteria for the use of the misoprostol vaginal insert for labor induction: a comparative cohort study. J Perinat Med. 2019 Sep 25;47(7):750–6. doi: 10.1515/jpm-2019-0153. PMID: 31373898. Exclusion: 4. [PubMed: 31373898] [CrossRef]
82.
Brandstetter A, Dobert M, Schwaerzler P, et al. Safety of misoprostol vaginal insert for labor induction using standard vs. adjusted retrieval criteria: a comparative cohort study. J Perinat Med. 2020 Jun 25;48(5):488–94. doi: 10.1515/jpm-2020-0071. PMID: 32304314. Exclusion: 1. [PubMed: 32304314] [CrossRef]
83.
Brasil R, Lutescia Coelho H, D’Avanzo B, et al. Misoprostol and congenital anomalies. Pharmacoepidemiol Drug Saf. 2000 Sep;9(5):401–3. doi: 10.1002/1099-1557(200009/10)9:5<401::AID-PDS527>3.0.CO;2-1. PMID: 19025846. Exclusion: 4. [PubMed: 19025846] [CrossRef]
84.
Breart G, Goupil F, Legrand H, et al. Antepartum fetal heart rate monitoring. A semi-quantitative evaluation of the ‘non-stressed’ fetal heart rate. Eur J Obstet Gynecol Reprod Biol. 1981 Feb;11(4):227–37. doi: 10.1016/0028-2243(81)90003-4. PMID: 7194814. Exclusion: 1. [PubMed: 7194814] [CrossRef]
85.
Bregand-White JM, Kominiarek MA, Hibbard JU. Hypertension and patterns of induced labor at term. Pregnancy Hypertens. 2017 Oct;10:57–63. doi: 10.1016/j.preghy.2017.06.003. PMID: 29153691. Exclusion: 4. [PMC free article: PMC5777229] [PubMed: 29153691] [CrossRef]
86.
Bremme K, Bygdeman M. A comparative study of uterine activity and fetal heart rate pattern in labor induced with oral prostaglandin E2 or oxytocin. Acta Obstet Gynecol Scand Suppl. 1980 Mar 10;92(5):23–9. PMID: 00024055. Exclusion: 2. [PubMed: 7004051]
87.
Brennand JE, Calder AA, Leitch CR, et al. Recombinant human relaxin as a cervical ripening agent. Br J Obstet Gynaecol. 1997 Jul;104(7):775–80. doi: 10.1111/j.1471-0528.1997.tb12019.x. PMID: 9236640. Exclusion: 2. [PubMed: 9236640] [CrossRef]
88.
Bricker L, Peden H, Tomlinson AJ, et al. Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial. BJOG. 2008 Nov;115(12):1503–11. doi: 10.1111/j.1471-0528.2008.01890.x. PMID: 18752586. Exclusion: 4. [PubMed: 18752586] [CrossRef]
89.
Brown J, Beckmann M. Induction of labour using balloon catheter and prostaglandin gel. Aust N Z J Obstet Gynaecol. 2017 Feb;57(1):68–73. doi: 10.1111/ajo.12577. PMID: 28251639. Exclusion: 4. [PubMed: 28251639] [CrossRef]
90.
Brun R, Spoerri E, Schaffer L, et al. Induction of labor and postpartum blood loss. BMC Pregnancy Childbirth. 2019 Jul 25;19(1):265. doi: 10.1186/s12884-019-2410-8. PMID: 31345178. Exclusion: 1. [PMC free article: PMC6659310] [PubMed: 31345178] [CrossRef]
91.
Buccellato CA, Stika CS, Frederiksen MC. A randomized trial of misoprostol versus extra-amniotic sodium chloride infusion with oxytocin for induction of labor. Am J Obstet Gynecol. 2000 May;182(5):1039–44. doi: 10.1067/mob.2000.106052. PMID: 10819821. Exclusion: 2. [PubMed: 10819821] [CrossRef]
92.
Buchanan D, Macer J, Yonekura ML. Cervical ripening with prostaglandin E2 vaginal suppositories. Obstet Gynecol. 1984 May;63(5):659–63. PMID: 6585733. Exclusion: 2. [PubMed: 6585733]
93.
Buhimschi CS, Buhimschi IA, Patel S, et al. Rupture of the uterine scar during term labour: contractility or biochemistry? BJOG. 2005 Jan;112(1):38–42. doi: 10.1111/j.1471-0528.2004.00300.x. PMID: 15663395. Exclusion: 1. [PubMed: 15663395] [CrossRef]
94.
Bujold E, Blackwell SC, Gauthier RJ. Cervical ripening with transcervical foley catheter and the risk of uterine rupture. Obstet Gynecol. 2004 Jan;103(1):18–23. doi: 10.1097/01.AOG.0000109148.23082.C1. PMID: 14704239. Exclusion: 4. [PubMed: 14704239] [CrossRef]
95.
Caliskan E, Cakiroglu Y, Corakci A, et al. Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. J Matern Fetal Neonatal Med. 2009 Sep;22(5):445–51. doi: 10.1093/oxfordjournals.jbchem.a132159. PMID: 00721793. Exclusion: 2. [PubMed: 19530004] [CrossRef]
96.
Carlan SJ, Blust D, O’Brien WF. Buccal versus intravaginal misoprostol administration for cervical ripening. Am J Obstet Gynecol. 2002 Feb;186(2):229–33. doi: 10.1067/mob.2002.119630. PMID: 11854640. Exclusion: 4. [PubMed: 11854640] [CrossRef]
97.
Carlan SJ, O’Brien WF, Logan S. Serial intravaginal prostaglandin E2 gel cervical ripening in preterm pregnancies. Prostaglandins. 1996 Sep;52(3):237–46. doi: 10.1016/s0090-6980(96)00086-x. PMID: 8908623. Exclusion: 1. [PubMed: 8908623] [CrossRef]
98.
Carlomagno G, Bacci A. Vaginal administration of PgE1 analogue misoprostol for induction of labor. Preliminary report. J Foetal Med. 1993;13(1–4):5–7. Exclusion: 4.
99.
Carr CJ, Patton R. A comparison of varying doses of vaginal prostaglandin E2 for induction of labour. Ir Med J. 1984 Mar;77(3):70–2. PMID: 6706529. Exclusion: 4. [PubMed: 6706529]
100.
Caruso A, De Santis L, Carducci B, et al. The use of prostaglandin E2 for cervical ripening in patients requiring induction of labour. J Int Med Res. 1997 May–Jun;25(3):159–66. doi: 10.1177/030006059702500306. PMID: 9178148. Exclusion: 4. [PubMed: 9178148] [CrossRef]
101.
Chai Y, Qu M, Jin M. Application effect of single balloon catheters in labor induction of pregnant women in late-term pregnancy and their influences on stress and inflammatory responses. Experimental Ther. 2018 Apr;15(4):3352–6. doi: 10.3892/etm.2018.5767. PMID: 29545854. Exclusion: 3. [PMC free article: PMC5841050] [PubMed: 29545854] [CrossRef]
102.
Chan LY, Fu L, Leung TN, et al. Obstetric outcomes after cervical ripening by multiple doses of vaginal prostaglandin E2. Acta Obstet Gynecol Scand. 2004 Jan;83(1):70–4. PMID: 14678088. Exclusion: 2. [PubMed: 14678088]
103.
Chandran JR, Sumangala Devi D. Analysis of induction of labor by foley extra-amniotic saline concurrent with misoprostol (PGE1) versus foley extra-amniotic saline alone. Journal of SAFOG. 2018;10(4):375–6. doi: 10.5005/jp-journals-10006-1628. Exclusion: 1. [CrossRef]
104.
Chang YK, Chen WH, Yu MH, et al. Intracervical misoprostol and prostaglandin E2 for labor induction. Int J Gynaecol Obstet. 2003 Jan;80(1):23–8. doi: 10.1016/s0020-7292(02)00333-8. PMID: 12527456. Exclusion: 4. [PubMed: 12527456] [CrossRef]
105.
Chanrachakul B, Herabutya Y, Punyavachira P. Randomized comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstet Gynecol. 2000 Oct;96(4):549–53. doi: 10.1016/s0029-7844(00)00990-x. PMID: 11004357. Exclusion: 2. [PubMed: 11004357] [CrossRef]
106.
Chanrachakul B, Herabutya Y, Punyavachira P. Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. Int J Gynaecol Obstet. 2002 Aug;78(2):139–45. doi: 10.1016/s0020-7292(02)00128-5. PMID: 12175715. Exclusion: 2. [PubMed: 12175715] [CrossRef]
107.
Charoenkul S, Sripramote M. A randomized comparison of one single dose of vaginal 50 microg misoprostol with 3 mg dinoprostone in pre-induction cervical ripening. J Med Assoc Thai. 2000 Sep;83(9):1026–34. PMID: 11075969. Exclusion: 4. [PubMed: 11075969]
108.
Chatterjee MS, Ramchandran K, Ferlita J, et al. Prostaglandin E2 (PGE2) vaginal gel for cervical ripening. Eur J Obstet Gynecol Reprod Biol. 1991 Feb 25;38(3):197–202. doi: 10.1016/0028-2243(91)90291-r. PMID: 2007444. Exclusion: 4. [PubMed: 2007444] [CrossRef]
109.
Chavakula PR, Benjamin SJ, Abraham A, et al. Misoprostol versus Foley catheter insertion for induction of labor in pregnancies affected by fetal growth restriction. Int J Gynaecol Obstet. 2015 May;129(2):152–5. doi: 10.1016/j.ijgo.2014.11.018. PMID: 25661322. Exclusion: 4. [PubMed: 25661322] [CrossRef]
110.
Cheng YW, Snowden JM, King TL, et al. Selected perinatal outcomes associated with planned home births in the United States. Am J Obstet Gynecol. 2013 Oct;209(4):325.e1–8. doi: 10.1016/j.ajog.2013.06.022. PMID: 23791564. Exclusion: 1. [PubMed: 23791564] [CrossRef]
111.
Cheuk QK, Lo TK, Lee CP, et al. Double balloon catheter for induction of labour in Chinese women with previous caesarean section: one-year experience and literature review. Hong Kong Med. 2015 Jun;21(3):243–50. doi: 10.12809/hkmj144404. PMID: 25999032. Exclusion: 4. [PubMed: 25999032] [CrossRef]
112.
Chigbu CO, Ezeome IV, Okezie AO, et al. Induction of labor on request in a resource-poor setting. Int J Gynaecol Obstet. 2007 Sep;98(3):208–11. doi: 10.1016/j.ijgo.2007.03.022. PMID: 17445817. Exclusion: 1. [PubMed: 17445817] [CrossRef]
113.
Chowdhary A, Bagga R, Jasvinder K, et al. Comparison of intracervical Foley catheter used alone or combined with a single dose of dinoprostone gel for cervical ripening: a randomised study. J Obstet Gynaecol. 2019 May;39(4):461–7. doi: 10.1080/01443615.2018.1534090. PMID: 30747025. Exclusion: 4. [PubMed: 30747025] [CrossRef]
114.
Chua S, Arulkumaran S, Kurup A, et al. Does prostaglandin confer significant advantage over oxytocin infusion for nulliparas with pre-labor rupture of membranes at term? Obstet Gynecol. 1991 May;77(5):664–7. PMID: 2014076. Exclusion: 2. [PubMed: 2014076]
115.
Chua S, Arulkumaran S, Kurup A, et al. Oxytocin titration for induction of labour: a prospective randomized study of 15 versus 30 minute dose increment schedules. Aust N Z J Obstet Gynaecol. 1991 May;31(2):134–7. doi: 10.1111/j.1479-828x.1991.tb01801.x. PMID: 1930035. Exclusion: 2. [PubMed: 1930035] [CrossRef]
116.
Chua S, Arulkumaran S, Vanaja K, et al. Preinduction cervical ripening: prostaglandin E2 gel vs hygroscopic mechanical dilator. J Obstet Gynaecol Res. 1997 Apr;23(2):171–7. doi: 10.1111/j.1447-0756.1997.tb00828.x. PMID: 9158305. Exclusion: 4. [PubMed: 9158305] [CrossRef]
117.
Chua S, Arulkumaran S, Yap C, et al. Premature rupture of membranes in nulliparas at term with unfavorable cervices: a double-blind randomized trial of prostaglandin and placebo. Obstet Gynecol. 1995 Oct;86(4 Pt 1):550–4. doi: 10.1016/0029-7844(95)00214-c. PMID: 7675378. Exclusion: 4. [PubMed: 7675378] [CrossRef]
118.
Chung JH, Huang WH, Rumney PJ, et al. A prospective randomized controlled trial that compared misoprostol, foley catheter, and combination misoprostol-foley catheter for labor induction. Am J Obstet Gynecol. 2003 Oct;189(4):1031–5. doi: 10.1067/s0002-9378(03)00842-1. PMID: 14586350. Exclusion: 4. [PubMed: 14586350] [CrossRef]
119.
Chyu JK, Strassner HT. Prostaglandin E2 for cervical ripening: a randomized comparison of cervidil versus prepidil. Am J Obstet Gynecol. 1997 Sep;177(3):606–11. doi: 10.1016/s0002-9378(97)70153-4. PMID: 9322631. Exclusion: 4. [PubMed: 9322631] [CrossRef]
120.
Clark SL, Meyers JA, Frye DK, et al. Recognition and response to electronic fetal heart rate patterns: impact on newborn outcomes and primary cesarean delivery rate in women undergoing induction of labor. Am J Obstet Gynecol. 2015 Apr;212(4):494.e1–6. doi: 10.1016/j.ajog.2014.11.019. PMID: 25460835. Exclusion: 1. [PubMed: 25460835] [CrossRef]
121.
Coates D, Goodfellow A, Sinclair L. Induction of labour: Experiences of care and decision-making of women and clinicians. Women Birth. 2020 Feb;33(1):e1–e14. doi: 10.1016/j.wombi.2019.06.002. PMID: 31208865. Exclusion: 1. [PubMed: 31208865] [CrossRef]
122.
Collingham JP, Fuh KC, Caughey AB, et al. Oral misoprostol and vaginal isosorbide mononitrate for labor induction: a randomized controlled trial. Obstet Gynecol. 2010 Jul;116(1):121–6. doi: 10.1097/AOG.0b013e3181e408f2. PMID: 20567177. Exclusion: 2. [PubMed: 20567177] [CrossRef]
123.
Colon I, Clawson K, Hunter K, et al. Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. Am J Obstet Gynecol. 2005 Mar;192(3):747–52. doi: 10.1016/j.ajog.2004.12.051. PMID: 15746667. Exclusion: 4. [PubMed: 15746667] [CrossRef]
124.
Cooper JM, Carignan CS, Cher D, et al. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol. 2003 Jul;102(1):59–67. doi: 10.1016/s0029-7844(03)00373-9. PMID: 12850608. Exclusion: 1. [PubMed: 12850608] [CrossRef]
125.
Crane JM, Young DC. Induction of labour with a favourable cervix and/or pre-labour rupture of membranes. Best Pract Res Clin Obstet Gynaecol. 2003 Oct;17(5):795–809. doi: 10.1016/s1521-6934(03)00067-1. PMID: 12972015. Exclusion: 6. [PubMed: 12972015] [CrossRef]
126.
Cromi A, Ghezzi F, Agosti M, et al. Is transcervical Foley catheter actually slower than prostaglandins in ripening the cervix? A randomized study. Am J Obstet Gynecol. 2011 Apr;204(4):338.e1–7. doi: 10.1016/j.ajog.2010.11.029. PMID: 21272849. Exclusion: 4. [PubMed: 21272849] [CrossRef]
127.
Cromi A, Ghezzi F, Tomera S, et al. Cervical ripening with the foley catheter. Int J Gynaecol Obstet. 2007 May;97(2):105–9. doi: 10.1016/j.ijgo.2006.10.014. PMID: 17316649. Exclusion: 4. [PubMed: 17316649] [CrossRef]
128.
Cromi A, Ghezzi F, Uccella S, et al. A randomized trial of preinduction cervical ripening: dinoprostone vaginal insert versus double-balloon catheter. Am J Obstet Gynecol. 2012 Aug;207(2):125.e1–7. doi: 10.1016/j.ajog.2012.05.020. PMID: 22704766. Exclusion: 4. [PubMed: 22704766] [CrossRef]
129.
Cross WG, Pitkin RM. Laminaria as an adjunct in induction of labor. Obstet Gynecol. 1978 May;51(5):606–8. doi: 10.1097/00006250-197805000-00021. PMID: 652210. Exclusion: 2. [PubMed: 652210] [CrossRef]
130.
Culver J, Strauss RA, Brody S, et al. A randomized trial comparing vaginal misoprostol versus foley catheter with concurrent oxytocin for labor induction in nulliparous women. Am J Perinatol. 2004 Apr;21(3):139–46. doi: 10.1055/s-2004-823777. PMID: 15085496. Exclusion: 2. [PubMed: 15085496] [CrossRef]
131.
Cunningham FG, Cox K, Hauth JC, et al. Oral prostaglandin E2 for labor induction in high-risk pregnancy. Am J Obstet Gynecol. 1976 Aug 01;125(7):881–8. doi: 10.1016/0002-9378(76)90483-x. PMID: 941942. Exclusion: 2. [PubMed: 941942] [CrossRef]
132.
Curtin SC, Park MM. Trends in the attendant, place, and timing of births, and in the use of obstetric interventions: United States, 1989–97. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 1999 Dec 02;47(27):1–12. PMID: 10598437. Exclusion: 5. [PubMed: 10598437]
133.
D’Agostino J. Sending the patient home with an indwelling foley catheter. Urol Nurs. 1990 Jun;10(2):23. PMID: 2363053. Exclusion: 1. [PubMed: 2363053]
134.
D’Aniello G, Bocchi C, Florio P, et al. Cervical ripening and induction of labor by prostaglandin E2: a comparison between intracervical gel and vaginal pessary. J Matern Fetal Neonatal Med. 2003 Sep;14(3):158–62. doi: 10.1080/jmf.14.3.158.162. PMID: 14694970. Exclusion: 4. [PubMed: 14694970] [CrossRef]
135.
Dalui R, Suri V, Ray P, et al. Comparison of extraamniotic foley catheter and intracervical prostaglandin E gel for preinduction cervical ripening. Acta Obstet Gynecol Scand. 2005 Apr;84(4):362–7. doi: 10.1111/j.0001-6349.2005.00662.x. PMID: 15762966. Exclusion: 4. [PubMed: 15762966] [CrossRef]
136.
Danielsson KG, Marions L, Rodriguez A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 1999 Feb;93(2):275–80. doi: 10.1016/s0029-7844(98)00436-0. PMID: 9932569. Exclusion: 1. [PubMed: 9932569] [CrossRef]
137.
Danish N, Fawad A, Abbasi N. Assessment of pregnancy outcome in primigravida: comparison between booked and un-booked patients. J Ayub Med Coll Abbottabad. 2010 Apr–Jun;22(2):23–5. PMID: 21702258. Exclusion: 1. [PubMed: 21702258]
138.
Danon D, Ben-Haroush A, Yogev Y, et al. Prostaglandin E2 induction of labor for isolated oligohydramnios in women with unfavorable cervix at term. Fetal Diagn Ther. 2007;22(1):75–9. doi: 10.1159/000095848. PMID: 17003561. Exclusion: 4. [PubMed: 17003561] [CrossRef]
139.
Darling EK, Bennett N, Burton N, et al. Outcomes of uninsured midwifery clients in Ontario, Canada: a retrospective cohort study. Midwifery. 2019 Oct;77:24–31. doi: 10.1016/j.midw.2019.06.009. PMID: 31247482. Exclusion: 1. [PubMed: 31247482] [CrossRef]
140.
Darroca RJ, Buttino L, Jr., Miller J, et al. Prostaglandin E2 gel for cervical ripening in patients with an indication for delivery. Obstet Gynecol. 1996 Feb;87(2):228–30. doi: 10.1016/0029-7844(95)00409-2. PMID: 8559529. Exclusion: 2. [PubMed: 8559529] [CrossRef]
141.
Davey DA, Dommisse J, MacNab M. Intravaginal prostaglandin E2 for cervical ripening and induction of labour. A comparison of gel and tablets. S Afr Med J. 1980 Sep 27;58(13):516–8. PMID: 7423283. Exclusion: 4. [PubMed: 7423283]
142.
De Bonrostro Torralba C, Tejero Cabrejas EL, Envid Lazaro BM, et al. Low-dose vaginal misoprostol vs vaginal dinoprostone insert for induction of labor beyond 41st week: a randomized trial. Acta Obstet Gynecol Scand. 2019 Jul;98(7):913–9. doi: 10.1111/aogs.13556. PMID: 30723912. Exclusion: 4. [PubMed: 30723912] [CrossRef]
143.
de Vries BS, Barratt A, McGeechan K, et al. Outcomes of induction of labour in nulliparous women at 38 to 39 weeks pregnancy by clinical indication: an observational study. Aust N Z J Obstet Gynaecol. 2019 Aug;59(4):484–92. doi: 10.1111/ajo.12930. PMID: 30588611. Exclusion: 4. [PubMed: 30588611] [CrossRef]
144.
Dede FS, Haberal A, Dede H, et al. Misoprostol for cervical ripening and labor induction in pregnancies with oligohydramnios. Gynecol Obstet Invest. 2004;57(3):139–43. PMID: 14707473. Exclusion: 4. [PubMed: 14707473]
145.
Del Valle GO, Adair CD, Sanchez-Ramos L, et al. Cervical ripening in women with previous cesarean deliveries. Int J Gynaecol Obstet. 1994 Oct;47(1):17–21. doi: 10.1016/0020-7292(94)90455-3. PMID: 7813746. Exclusion: 4. [PubMed: 7813746] [CrossRef]
146.
Delporte V, Grabarz A, Ramdane N, et al. Cesarean during labor: Is induction a risk factor for complications? J Gynecol Obstet Hum Reprod. 2019 Nov;48(9):757–61. doi: 10.1016/j.jogoh.2019.08.008. PMID: 31479772. Exclusion: 1. [PubMed: 31479772] [CrossRef]
147.
Deshmukh VL, Yelikar KA, Waso V. Comparative study of efficacy and safety of oral versus vaginal misoprostol for induction or labour. J Obstet Gynaecol India. 2013;63(5):321–4. doi: 10.1007/s13224-012-0337-3. Exclusion: 4. [PMC free article: PMC3798443] [PubMed: 24431667] [CrossRef]
148.
Diederen M, Gommers J, Wilkinson C, et al. Safety of the balloon catheter for cervical ripening in outpatient care: complications during the period from insertion to expulsion of a balloon catheter in the process of labour induction: a systematic review. BJOG. 2018 Aug;125(9):1086–95. doi: 10.1111/1471-0528.15047. PMID: 29211328. Exclusion: 9. [PubMed: 29211328] [CrossRef]
149.
Diguisto C, Le Gouge A, Giraudeau B, et al. Mechanical cervicAl ripeninG for women with PrOlongedPregnancies (MAGPOP): protocol for a randomised controlled trial of a silicone double balloon catheter versus the propess system for the slow release of dinoprostone for cervical ripening of prolonged pregnancies. BMJ Open. 2017 Sep 14;7(9):e016069. doi: 10.1136/bmjopen-2017-016069. PMID: 28912192. Exclusion: 4. [PMC free article: PMC5640144] [PubMed: 28912192] [CrossRef]
150.
Dixi MS, Somalwar SA, Tathe GR. Effectiveness of isosorbide mononitrate vs prostaglandin E2 gel for cervical ripening: A study. Journal of SAFOG. 2019;11(5):288–91. doi: 10.5005/jp-journals-10006-1712. Exclusion: 2. [CrossRef]
151.
Dobert M, Brandstetter A, Henrich W, et al. The misoprostol vaginal insert compared with oral misoprostol for labor induction in term pregnancies: a pair-matched case-control study. J Perinat Med. 2018 Apr 25;46(3):309–16. doi: 10.1515/jpm-2017-0049. PMID: 28672758. Exclusion: 4. [PubMed: 28672758] [CrossRef]
152.
Dommisse J, Davey DA, Allerton G. The induction of labour with prostaglandin E2 tablets administered intravaginally. S Afr Med J. 1980 Sep 27;58(13):518–9. PMID: 7423284. Exclusion: 4. [PubMed: 7423284]
153.
Dongol AS, Shakya S, Chawla CD. Safety and efficacy of misoprostol for induction of labour. J Nepal Health Res Counc 2010 Apr;8(1):27–30. PMID: 21879010. Exclusion: 4. [PubMed: 21879010]
154.
Dowswell T, Kelly AJ, Livio S, et al. Different methods for the induction of labour in outpatient settings. Cochrane Database Syst Rev. 2010 Aug 04(8):CD007701. doi: 10.1002/14651858.CD007701.pub2. PMID: 20687092. Exclusion: 9. [PMC free article: PMC4241469] [PubMed: 20687092] [CrossRef]
155.
Du C, Liu Y, Liu Y, et al. Double-balloon catheter vs. dinoprostone vaginal insert for induction of labor with an unfavorable cervix. Arch Gynecol Obstet. 2015 Jun;291(6):1221–7. doi: 10.1007/s00404-014-3547-3. PMID: 25408273. Exclusion: 4. [PubMed: 25408273] [CrossRef]
156.
Duenhoelter JH, Whalley PJ, MacDonald PC. An analysis of the utility of plasma immunoreactive estrogen measurements in determining delivery time of gravidas with a fetus considered at high risk. Am J Obstet Gynecol. 1976 Aug 01;125(7):889–98. doi: 10.1016/0002-9378(76)90484-1. PMID: 941943. Exclusion: 2. [PubMed: 941943] [CrossRef]
157.
Duff C, Sinclair M. Exploring the risks associated with induction of labour: a retrospective study using the NIMATS database. Northern Ireland Maternity System. J Adv Nurs. 2000 Feb;31(2):410–7. doi: 10.1046/j.1365-2648.2000.01335.x. PMID: 10672100. Exclusion: 4. [PubMed: 10672100] [CrossRef]
158.
Duro Gómez J, Garrido Oyarzún MF, Rodríguez Marín AB, et al. Vaginal misoprostol and cervical ripening balloon for induction of labor in late-term pregnancies. J Obstet Gynaecol Res. 2017 Jan;43(1):87–91. doi: 10.1111/jog.13193. PMID: 27928864. Exclusion: 4. [PubMed: 27928864] [CrossRef]
159.
Dyson DC, Miller PD, Armstrong MA. Management of prolonged pregnancy: induction of labor versus antepartum fetal testing. Am J Obstet Gynecol. 1987 Apr;156(4):928–34. doi: 10.1016/0002-9378(87)90359-0. PMID: 3472467. Exclusion: 4. [PubMed: 3472467] [CrossRef]
160.
Eddama O, Petrou S, Schroeder L, et al. The cost-effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG. 2009 Aug;116(9):1196–203. doi: 10.1111/j.1471-0528.2009.02236.x. PMID: 19485990. Exclusion: 2. [PubMed: 19485990] [CrossRef]
161.
Eden RD, Evans MI, Evans SM, et al. The “fetal reserve index”: re-engineering the interpretation and responses to fetal heart rate patterns. Fetal Diagn Ther. 2018;43(2):90–104. doi: 10.1159/000475927. PMID: 28591756. Exclusion: 1. [PubMed: 28591756] [CrossRef]
162.
Edwards C, Witter FR. Preeclampsia, labor duration and mode of delivery. Int J Gynaecol Obstet. 1997 Apr;57(1):39–42. doi: 10.1016/s0020-7292(97)02854-3. PMID: 9175668. Exclusion: 1. [PubMed: 9175668] [CrossRef]
163.
Edwards RK, Szychowski JM, Berger JL, et al. Foley catheter compared with the controlled-release dinoprostone insert: a randomized controlled trial. Obstet Gynecol. 2014 Jun;123(6):1280–7. doi: 10.1097/AOG.0000000000000238. PMID: 24807327. Exclusion: 4. [PubMed: 24807327] [CrossRef]
164.
Eik-Nes SH, Salvesen KA, Okland O, et al. Routine ultrasound fetal examination in pregnancy: the ‘Alesund’ randomized controlled trial. Ultrasound Obstet Gynecol. 2000 Jun;15(6):473–8. doi: 10.1046/j.1469-0705.2000.00147.x. PMID: 11005114. Exclusion: 2. [PubMed: 11005114] [CrossRef]
165.
Einerson BD. Are there any good data to support outpatient cervical ripening? BJOG. 2020 Jan 30;30:30. doi: 10.1111/1471-0528.16074. PMID: 32003097. Exclusion: 6. [PubMed: 32003097] [CrossRef]
166.
Ekerhovd E, Bullarbo M, Andersch B, et al. Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study. Am J Obstet Gynecol. 2003 Dec;189(6):1692–7. doi: 10.1016/s0002-9378(03)00865-2. PMID: 14710100. Exclusion: 2. [PubMed: 14710100] [CrossRef]
167.
el-Mardi AA, el-Qarmalawi MA, Siddik M, et al. A comparison of single prostaglandin E2 vaginal tablet with prostaglandin E2 vaginal pessaries for induction of labor at term. Int J Gynaecol Obstet. 1991 Jul;35(3):221–4. doi: 10.1016/0020-7292(91)90289-h. PMID: 1677625. Exclusion: 2. [PubMed: 1677625] [CrossRef]
168.
El-Refaey H, Nooh R, O’Brien P, et al. The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. BJOG. 2000 Sep;107(9):1104–10. doi: 10.1111/j.1471-0528.2000.tb11108.x. PMID: 11002953. Exclusion: 2. [PubMed: 11002953] [CrossRef]
169.
El-Shawarby SA, Connell RJ. Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of prostin vs propess. J Obstet Gynaecol. 2006 Oct;26(7):627–30. doi: 10.1080/01443610600903362. PMID: 17071427. Exclusion: 4. [PubMed: 17071427] [CrossRef]
170.
El-Sherbiny MT, El-Gharieb IH, Gewely HA. Vaginal misoprostol for induction of labor: 25 vs. 50 microg dose regimen. Int J Gynaecol Obstet. 2001 Jan;72(1):25–30. doi: 10.1016/s0020-7292(00)00308-8. PMID: 11146073. Exclusion: 2. [PubMed: 11146073] [CrossRef]
171.
Elden H, Hagberg H, Wessberg A, et al. Study protocol of SWEPIS a Swedish multicentre register based randomised controlled trial to compare induction of labour at 41 completed gestational weeks versus expectant management and induction at 42 completed gestational weeks. BMC Pregnancy Childbirth. 2016 Mar 07;16:49. doi: 10.1186/s12884-016-0836-9. PMID: 26951777. Exclusion: 2. [PMC free article: PMC4782290] [PubMed: 26951777] [CrossRef]
172.
Elliott JP, Clewell WH, Radin TG. Intracervical prostaglandin E2 gel. Safety for outpatient cervical ripening before induction of labor. J Reprod Med. 1992 Aug;37(8):713–6. PMID: 1432988. Exclusion: 2. [PubMed: 1432988]
173.
Ennen CS, Bofill JA, Magann EF, et al. Risk factors for cesarean delivery in preterm, term and post-term patients undergoing induction of labor with an unfavorable cervix. Gynecol Obstet Invest. 2009;67(2):113–7. doi: 10.1159/000166307. PMID: 18971583. Exclusion: 5. [PubMed: 18971583] [CrossRef]
174.
Epplin KA, Tuuli MG, Odibo AO, et al. Effect of growth restriction on fetal heart rate patterns in the second stage of labor. Am J Perinatol. 2015 Jul;32(9):873–8. doi: 10.1055/s-0034-1543954. PMID: 25607225. Exclusion: 1. [PubMed: 25607225] [CrossRef]
175.
Evans MI, Dougan MB, Moawad AH, et al. Ripening of the human cervix with porcine ovarian relaxin. Am J Obstet Gynecol. 1983 Oct 15;147(4):410–4. doi: 10.1016/s0002-9378(16)32236-0. PMID: 6353927. Exclusion: 2. [PubMed: 6353927] [CrossRef]
176.
Ewert K, Powers B, Robertson S, et al. Controlled-release misoprostol vaginal insert in parous women for labor induction: a randomized controlled trial. Obstet Gynecol. 2006 Nov;108(5):1130–7. doi: 10.1097/01.AOG.0000239100.16166.5a. PMID: 17077234. Exclusion: 4. [PubMed: 17077234] [CrossRef]
177.
Ezechi OC, Kalu BK, Njokanma FO, et al. Vaginal misoprostol induction of labour: a Nigerian hospital experience. J Obstet Gynaecol. 2004 Apr;24(3):239–42. doi: 10.1080/01443610410001660698. PMID: 15203615. Exclusion: 4. [PubMed: 15203615] [CrossRef]
178.
Ezechukwu PC, Ugwu EO, Obi SN, et al. Oral versus vaginal misoprostol for induction of labor in Enugu, Nigeria: a randomized controlled trial. Arch Gynecol Obstet. 2015 Mar;291(3):537–44. doi: 10.1007/s00404-014-3429-8. PMID: 25138128. Exclusion: 4. [PubMed: 25138128] [CrossRef]
179.
Ezimokhai M, Nwabineli JN. The use of foley’s catheter in ripening the unfavourable cervix prior to induction of labour. Br J Obstet Gynaecol. 1980 Apr;87(4):281–6. doi: 10.1111/j.1471-0528.1980.tb04540.x. PMID: 7426497. Exclusion: 4. [PubMed: 7426497] [CrossRef]
180.
Facchinetti F, Neri I, Genazzani AR. Factors predicting labour onset in patients treated with prostaglandin E2 for cervical ripening. Eur J Obstet Gynecol Reprod Biol. 1995 Jun;60(2):129–32. doi: 10.1016/0028-2243(95)02090-f. PMID: 7641963. Exclusion: 4. [PubMed: 7641963] [CrossRef]
181.
Facchinetti F, Venturini P, Fazzio M, et al. Elective cervical ripening in women beyond the 290th day of pregnancy: a randomized trial comparing 2 dinoprostone preparations. J Reprod Med. 2007 Oct;52(10):945–9. PMID: 17977171. Exclusion: 4. [PubMed: 17977171]
182.
Fadel HE, Hammond SD. Diabetes mellitus and pregnancy: management and results. J Reprod Med. 1982 Feb;27(2):56–66. PMID: 7097664. Exclusion: 1. [PubMed: 7097664]
183.
Farrukh R, Zill EH, Qayyum S. Misoprostol vaginal pessary versus dinoproston vaginal gel in induction of labour. Pakistan Journal of Medical and Health Sciences. 2014;8(2):347–51. Exclusion: 4.
184.
Fayaz M, Tabassum H, Zia S. Comparison of efficacy of misoprostol and dinoprostone in inducing labour at term cases. Pakistan Journal of Medical and Health Sciences. 2017;11(1):463–5. Exclusion: 4.
185.
Feitosa FE, Sampaio ZS, Alencar CA, Jr., et al. Sublingual vs. vaginal misoprostol for induction of labor. Int J Gynaecol Obstet. 2006 Aug;94(2):91–5. doi: 10.1016/j.ijgo.2006.04.031. PMID: 16828095. Exclusion: 4. [PubMed: 16828095] [CrossRef]
186.
Filosomi F, Torricelli M, Voltolini C, et al. Efficacy and safety of slow release dinoprostone insert for induction of labor: correlation with parity. Journal of Chinese Clinical Medicine. 2010;5(1):1–6. Exclusion: 4.
187.
Fisher SA, Mackenzie VP, Davies GA. Oral versus vaginal misoprostol for induction of labor: a double-blind randomized controlled trial. Am J Obstet Gynecol. 2001 Oct;185(4):906–10. doi: 10.1067/mob.2001.117303. PMID: 11641676. Exclusion: 4. [PubMed: 11641676] [CrossRef]
188.
Flamm BL, Anton D, Goings JR, et al. Prostaglandin E2 for cervical ripening: a multicenter study of patients with prior cesarean delivery. Am J Perinatol. 1997 Mar;14(3):157–60. PMID: 9259919. Exclusion: 4. [PubMed: 9259919]
189.
Fletcher H, Hutchinson S. A retrospective review of pregnancy outcome after misoprostol (prostaglandin E1) induction of labour. West Indian Med J. 2001 Mar;50(1):47–9. PMID: 11398287. Exclusion: 4. [PubMed: 11398287]
190.
Fletcher H, Mitchell S, Frederick J, et al. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol. 1994 Feb;83(2):244–7. PMID: 8290188. Exclusion: 4. [PubMed: 8290188]
191.
Fletcher HM, Mitchell S, Simeon D, et al. Intravaginal misoprostol as a cervical ripening agent. Br J Obstet Gynaecol. 1993 Jul;100(7):641–4. doi: 10.1111/j.1471-0528.1993.tb14230.x. PMID: 8369246. Exclusion: 2. [PubMed: 8369246] [CrossRef]
192.
Foeller ME, Cruz MO, Kominiarek MA, et al. Does induction with misoprostol impact the small for gestational age neonate? Am J Perinatol. 2015 Dec;32(14):1311–7. doi: 10.1055/s-0035-1563718. PMID: 26352682. Exclusion: 4. [PubMed: 26352682] [CrossRef]
193.
Fok WY, Leung TY, Tsui MH, et al. Effect of prostaglandin E2 for cervical priming on fetal hemodynamics. J Reprod Med. 2005 Sep;50(9):697–700. PMID: 16363758. Exclusion: 4. [PubMed: 16363758]
194.
Fonseca L, Wood HC, Lucas MJ, et al. Randomized trial of preinduction cervical ripening: misoprostol vs oxytocin. Am J Obstet Gynecol. 2008 Sep;199(3):305.e1–5. doi: 10.1016/j.ajog.2008.07.014. PMID: 18771993. Exclusion: 2. [PubMed: 18771993] [CrossRef]
195.
Fontenot MT, Lewis DF, Barton CB, et al. Abruptio placentae associated with misoprostol use in women with preeclampsia. J Reprod Med. 2005 Sep;50(9):653–8. PMID: 16363752. Exclusion: 4. [PubMed: 16363752]
196.
Fox CE, Tirlapur SA, Gulmezoglu AM, et al. Assimilating evidence quality at a glance using graphic display: research synthesis on labor induction. Acta Obstet Gynecol Scand. 2012 Aug;91(8):885–92. doi: 10.1111/j.1600-0412.2012.01459.x. PMID: 22583063. Exclusion: 9. [PubMed: 22583063] [CrossRef]
197.
Frass KA, Shuaib AA, Al-Harazi AH. Misoprostol for induction of labor in women with severe preeclampsia at or near term. Saudi Med J. 2011 Jul;32(7):679–84. PMID: 21748203. Exclusion: 1. [PubMed: 21748203]
198.
Frick A, Kostiv V, Vojtassakova D, et al. Comparison of different methods of measuring angle of progression in the prediction of labor outcome. Ultrasound Obstet Gynecol; 2019. p. 06. Exclusion: 2. [PubMed: 31692170]
199.
Fuchs AR, Goeschen K, Rasmussen AB, et al. Cervical ripening and plasma prostaglandin levels. Comparison of endocervical and extra-amniotic PGE2. Prostaglandins. 1984 Aug;28(2):217–27. doi: 10.1016/0090-6980(84)90058-3. PMID: 6594722. Exclusion: 4. [PubMed: 6594722] [CrossRef]
200.
Garba I, Muhammed AS, Muhammad Z, et al. Induction to delivery interval using transcervical Foley catheter plus oxytocin and vaginal misoprostol: a comparative study at Aminu Kano Teaching Hospital, Kano, Nigeria. Ann Afr Med. 2016 Jul–Sep;15(3):114–9. doi: 10.4103/1596-3519.188890. PMID: 27549415. Exclusion: 2. [PMC free article: PMC5402811] [PubMed: 27549415] [CrossRef]
201.
Garcia B, Llurba E, Valle L, et al. Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial. Ultrasound Obstet Gynecol. 2016 Jun;47(6):680–9. doi: 10.1002/uog.15873. PMID: 26823208. Exclusion: 1. [PubMed: 26823208] [CrossRef]
202.
Garry D, Figueroa R, Kalish RB, et al. Randomized controlled trial of vaginal misoprostol versus dinoprostone vaginal insert for labor induction. J Matern Fetal Neonatal Med. 2003 Apr;13(4):254–9. doi: 10.1080/jmf.13.4.254.259. PMID: 12854927. Exclusion: 4. [PubMed: 12854927] [CrossRef]
203.
Gattas D, da Silva Junior JR, Souza ASR, et al. Misoprostol administered sublingually at a dose of 12.5 mug versus vaginally at a dose of 25 mug for the induction of full-term labor: a randomized controlled trial protocol. Reprod Health. 2018 Apr 18;15(1):65. doi: 10.1186/s12978-018-0508-5. PMID: 29669596. Exclusion: 4. [PMC free article: PMC5907413] [PubMed: 29669596] [CrossRef]
204.
Gattás DSMB, de Amorim MMR, Feitosa FEL, et al. Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial. Reprod Health. 2020;17(1):1–9. doi: 10.1186/s12978-020-0901-8. PMID: 29669596 Exclusion: 1. [PMC free article: PMC7147027] [PubMed: 32272959] [CrossRef]
205.
Gatward H, Simpson M, Woodhart L, et al. Women’s experiences of being induced for post-date pregnancy. Women Birth. 2010 Mar;23(1):3–9. doi: 10.1016/j.wombi.2009.06.002. PMID: 19647506. Exclusion: 5. [PubMed: 19647506] [CrossRef]
206.
Gelisen O, Caliskan E, Dilbaz S, et al. Induction of labor with three different techniques at 41 weeks of gestation or spontaneous follow-up until 42 weeks in women with definitely unfavorable cervical scores. Eur J Obstet Gynecol Reprod Biol. 2005 Jun 01;120(2):164–9. doi: 10.1016/j.ejogrb.2004.08.013. PMID: 15925045. Exclusion: 4. [PubMed: 15925045] [CrossRef]
207.
Georgieva A, Payne SJ, Moulden M, et al. Computerized intrapartum electronic fetal monitoring: analysis of the decision to deliver for fetal distress. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:5888–91. doi: 10.1109/IEMBS.2011.6091456. PMID: 22255679. Exclusion: 1. [PubMed: 22255679] [CrossRef]
208.
Ghanaei MM, Sharami H, Asgari A. Labor induction in nulliparous women: a randomized controlled trial of foley catheter with extra-amniotic saline infusion. J Turk Ger Gynecol Assoc. 2009;10(2):71–5. Exclusion: 4.
209.
Gherman RB, Browning J, O’Boyle A, et al. Oral misoprostol vs. intravaginal prostaglandin E2 for preinduction cervical ripening. A randomized trial. J Reprod Med. 2001 Jul;46(7):641–6. PMID: 11499184. Exclusion: 4. [PubMed: 11499184]
210.
Ghezzi F, Massimo F, Raio L, et al. Extra-amniotic foley catheter and prostaglandin E(2) gel for cervical ripening at term gestation. Eur J Obstet Gynecol Reprod Biol. 2001 Aug;97(2):183–7. doi: 10.1016/s0301-2115(00)00544-3. PMID: 11451546. Exclusion: 4. [PubMed: 11451546] [CrossRef]
211.
Gidaszewski B, Khajehei M, McGee T. Outpatient cervical ripening: discomfort/pain during speculum and foley catheter insertion. Midwifery. 2018 Dec;67:57–63. doi: 10.1016/j.midw.2018.09.012. PMID: 30248552. Exclusion: 5. [PubMed: 30248552] [CrossRef]
212.
Gilad R, Hochner H, Savitsky B, et al. Castor oil for induction of labor in post-date pregnancies: a randomized controlled trial. Women Birth. 2018 Feb;31(1):e26–e31. doi: 10.1016/j.wombi.2017.06.010. PMID: 28750937. Exclusion: 2. [PubMed: 28750937] [CrossRef]
213.
Gill SV, May-Benson TA, Teasdale A, et al. Birth and developmental correlates of birth weight in a sample of children with potential sensory processing disorder. BMC Pediatr. 2013 Feb 25;13:29. doi: 10.1186/1471-2431-13-29. PMID: 23442948. Exclusion: 1. [PMC free article: PMC3598529] [PubMed: 23442948] [CrossRef]
214.
Gilson GJ, Russell DJ, Izquierdo LA, et al. A prospective randomized evaluation of a hygroscopic cervical dilator, Dilapan, in the preinduction ripening of patients undergoing induction of labor. Am J Obstet Gynecol. 1996 Jul;175(1):145–9. doi: 10.1016/s0002-9378(96)70264-8. PMID: 8694040. Exclusion: 4. [PubMed: 8694040] [CrossRef]
215.
Girija S, Manjunath AP. Comparison of two dosing regimens of vaginal misoprostol for labour induction: a randomised controlled trial. J Turk Ger Gynecol Assoc. 2009;10(4):220–5. PMID: 24591876. Exclusion: 4. [PMC free article: PMC3939169] [PubMed: 24591876]
216.
Glantz JC. Elective Induction at 39 Weeks of Gestation and the Implications of a Large, Multicenter, Randomized Controlled Trial. Obstet Gynecol. 2019 07;134(1):178–9. doi: 10.1097/AOG.0000000000003342. PMID: 31241585. Exclusion: 1. [PubMed: 31241585] [CrossRef]
217.
Goeschen K. Premature rupture of membranes near term: induction of labor with endocervical prostaglandin E2 gel or intravenous oxytocin. Am J Perinatol. 1989 Apr;6(2):181–4. doi: 10.1055/s-2007-999572. PMID: 2712914. Exclusion: 4. [PubMed: 2712914] [CrossRef]
218.
Golbus MS, Creasy RK. Uterine priming with oral prostaglandin E2 prior to elective induction with oxytocin. Prostaglandins. 1977 Sep;14(3):577–81. doi: 10.1016/0090-6980(77)90272-6. PMID: 333516. Exclusion: 4. [PubMed: 333516] [CrossRef]
219.
Goldberger SB, Rosen DJ, Michaeli G, et al. The use of PGE2 for induction of labor in parturients with a previous cesarean section scar. Acta Obstet Gynecol Scand. 1989;68(6):523–6. PMID: 2520807. Exclusion: 4. [PubMed: 2520807]
220.
Goldkrand JW, Litvack BL. Demonstration of fetal habituation and patterns of fetal heart rate response to vibroacoustic stimulation in normal and high-risk pregnancies. J Perinatol. 1991 Mar;11(1):25–9. PMID: 2037884. Exclusion: 2. [PubMed: 2037884]
221.
Goldman GA, Kaplan B, Rabinerson D, et al. Vaginal delivery following caesarean section - the use of oxytocin and prostaglandins. J Obstet Gynaecol. 1998;18(4):328–30. Exclusion: 2. [PubMed: 15512101]
222.
Goldman JB, Wigton TR. A randomized comparison of extra-amniotic saline infusion and intracervical dinoprostone gel for cervical ripening. Obstet Gynecol. 1999 Feb;93(2):271–4. doi: 10.1016/s0029-7844(98)00359-7. PMID: 9932568. Exclusion: 4. [PubMed: 9932568] [CrossRef]
223.
Gomez LR, Burgos J, Cobos P, et al. Oxytocin versus dinoprostone vaginal insert for induction of labor after previous cesarean section: a retrospective comparative study. J Perinat Med. 2011 Jul;39(4):397–402. doi: 10.1515/JPM.2011.030. PMID: 21604996. Exclusion: 2. [PubMed: 21604996] [CrossRef]
224.
Goodlin RC, Reschl L, Clewell WH. Absence of maternal side effects from prostaglandins used for cervical ripening. J Reprod Med. 1986 Dec;31(12):1095–7. PMID: 3467066. Exclusion: 4. [PubMed: 3467066]
225.
Goonewardene M. Cervical ripening and induction of labour: Inpatient or outpatient, oral misoprostol or foley catheter? Ceylon Med J. 2017 Sep 30;62(3):117–20. doi: 10.4038/cmj.v62i3.8512. PMID: 29072048. Exclusion: 9. [PubMed: 29072048] [CrossRef]
226.
Gornisiewicz T, Jaworowski A, Zembala-Szczerba M, et al. Analysis of intravaginal misoprostol 0.2 mg versus intracervical dinoprostone 0.5 mg doses for labor induction at term pregnancies. Ginekol Pol. 2017;88(6):320–4. doi: 10.5603/GP.a2017.0060. PMID: 28727132. Exclusion: 4. [PubMed: 28727132] [CrossRef]
227.
Gower RH, Toraya J, Miller JM, Jr. Laminaria for preinduction cervical ripening. Obstet Gynecol. 1982 Nov;60(5):617–9. PMID: 6755325. Exclusion: 4. [PubMed: 6755325]
228.
Graves GR, Baskett TF, Gray JH, et al. The effect of vaginal administration of various doses of prostaglandin E2 gel on cervical ripening and induction of labor. Am J Obstet Gynecol. 1985 Jan 15;151(2):178–81. doi: 10.1016/0002-9378(85)90007-9. PMID: 3855601. Exclusion: 4. [PubMed: 3855601] [CrossRef]
229.
Gribel GP, Coca-Velarde LG, Moreira de Sa RA. Electroacupuncture for cervical ripening prior to labor induction: a randomized clinical trial. Arch Gynecol Obstet. 2011 Jun;283(6):1233–8. doi: 10.1007/s00404-010-1526-x. PMID: 20532541. Exclusion: 4. [PubMed: 20532541] [CrossRef]
230.
Grivell RM, Reilly AJ, Oakey H, et al. Maternal and neonatal outcomes following induction of labor: a cohort study. Acta Obstet Gynecol Scand. 2012 Feb;91(2):198–203. doi: 10.1111/j.1600-0412.2011.01298.x. PMID: 21995778. Exclusion: 4. [PubMed: 21995778] [CrossRef]
231.
Grobman WA, Rice MM, Reddy UM, et al. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med. 2018 Aug 09;379(6):513–23. doi: 10.1056/NEJMoa1800566. PMID: 30089070. Exclusion: 4. [PMC free article: PMC6186292] [PubMed: 30089070] [CrossRef]
232.
Gudex G. Induction of labour with prostaglandin E2; a prospective audit. N Z Med J. 1993 Mar 10;106(951):78–80. PMID: 8474705. Exclusion: 4. [PubMed: 8474705]
233.
Guha K, Fatema A, Biswas PK, et al. Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Med J. 2015 Apr;24(2):346–51. PMID: 26007264. Exclusion: 2. [PubMed: 26007264]
234.
Gulersen M, DiSturco M, Krantz DA, et al. Comparison of two management options for labor induction following unsuccessful prostaglandin E2 ripening. J Matern Fetal Neonatal Med. 2020 May 24:1–5. doi: 10.1080/14767058.2020.1769594. PMID: 32449419. Exclusion: 1. [PubMed: 32449419] [CrossRef]
235.
Gungorduk K, Yildirim G, Gungorduk O, et al. Sustained-release dinoprostone vaginal pessary with concurrent high-dose oxytocin infusion compared to sustained-release dinoprostone vaginal pessary followed 6 h later by high-dose oxytocin infusion for labor induction in women at term with unfavorable cervix: a randomized controlled trial. Gynecol Obstet Invest. 2011;71(1):32–40. doi: 10.1159/000320725. PMID: 21160192. Exclusion: 4. [PubMed: 21160192] [CrossRef]
236.
Gupta S, Hak J, Kumar D. Comparative study of efficacy of misoprostol vs dinoprostone gel for induction of labour. JK Science. 2015;17(3):118–22. Exclusion: 4.
237.
Gupta S, Hak J, Kumar D. Comparative study of efficacy of misoprostol vs dinoprostone gel for induction of labour. JK Science. 2016;18(3):166–71. Exclusion: 4.
238.
Habib SM, Emam SS, Saber AS. Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. Int J Gynaecol Obstet. 2008 Apr;101(1):57–61. doi: 10.1016/j.ijgo.2007.09.027. PMID: 18222450. Exclusion: 2. [PubMed: 18222450] [CrossRef]
239.
Haghighi L, Homam H, Raoofi Z, et al. Intravaginal isosorbide dinitrate or misoprostol for cervical ripening prior to induction of labour: a randomised controlled trial. J Obstet Gynaecol. 2013 Apr;33(3):272–6. doi: 10.3109/01443615.2012.753422. PMID: 23550856. Exclusion: 2. [PubMed: 23550856] [CrossRef]
240.
Haghighi L, Moukhah S, Goshtasbi A. Comparing the effect of oral and vaginal isosorbide dinitrate in pre-induction cervical ripening in term pregnancy: a controlled clinical trial. Adv. 2015;4:129. doi: 10.4103/2277-9175.158259. PMID: 26284225. Exclusion: 2. [PMC free article: PMC4534518] [PubMed: 26284225] [CrossRef]
241.
Hannah ME, Hannah WJ, Hellmann J, et al. Induction of labor as compared with serial antenatal monitoring in post-term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial Group. N Engl J Med. 1992 Jun 11;326(24):1587–92. doi: 10.1056/NEJM199206113262402. PMID: 1584259. Exclusion: 2. [PubMed: 1584259] [CrossRef]
242.
Haq AN, Ahsan S, Sher Z. Induction of labour in postdates pregnant women. J Coll Physicians Surg Pak. 2012 Oct;22(10):644–7. doi: 10.2012/JCPSP.644647. PMID: 23058148. Exclusion: 1. [PubMed: 23058148] [CrossRef]
243.
Harper TC, Coeytaux RR, Chen W, et al. A randomized controlled trial of acupuncture for initiation of labor in nulliparous women. J Matern Fetal Neonatal Med. 2006 Aug;19(8):465–70. doi: 10.1080/14767050600730740. PMID: 16966110. Exclusion: 2. [PubMed: 16966110] [CrossRef]
244.
Hasegawa J, Sekizawa A, Ikeda T, et al. The use of balloons for uterine cervical ripening is associated with an increased risk of umbilical cord prolapse: population based questionnaire survey in Japan. BMC Pregnancy Childbirth. 2015 Jan 22;15:4. doi: 10.1186/s12884-015-0432-4. PMID: 25927949. Exclusion: 4. [PMC free article: PMC4310172] [PubMed: 25927949] [CrossRef]
245.
Heazell AE, Bernatavicius G, Roberts SA, et al. A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation--a feasibility study. BMC Pregnancy Childbirth. 2013 Apr 16;13:95. doi: 10.1186/1471-2393-13-95. PMID: 23590451. Exclusion: 1. [PMC free article: PMC3640967] [PubMed: 23590451] [CrossRef]
246.
Helmig RB, Hvidman LE. An audit of oral administration of Angusta R (misoprostol) 25 micro g for induction of labor in 976 consecutive women with a singleton pregnancy in a university hospital in Denmark. Acta Obstet Gynecol Scand. 2020 Apr 20;20:20. doi: 10.1111/aogs.13876. PMID: 32311758. Exclusion: 1. [PubMed: 32311758] [CrossRef]
247.
Herabutya Y, P OP. Ripening of the unfavorable cervix with prostaglandin E2: intracervical versus intravaginal route. J Med Assoc Thai. 1993 Jan;76 Suppl 1:63–8. PMID: 8113660. Exclusion: 4. [PubMed: 8113660]
248.
Herabutya Y, P OP, Pokpirom J. A comparison of intravaginal misoprostol and intracervical prostaglandin E2 gel for ripening of unfavorable cervix and labor induction. J Obstet Gynaecol Res. 1997 Aug;23(4):369–74. doi: 10.1111/j.1447-0756.1997.tb00860.x. PMID: 9311179. Exclusion: 2. [PubMed: 9311179] [CrossRef]
249.
Herabutya Y, Prasertsawat PO, Tongyai T, et al. Prolonged pregnancy: the management dilemma. Int J Gynaecol Obstet. 1992 Apr;37(4):253–8. doi: 10.1016/0020-7292(92)90325-d. PMID: 1350540. Exclusion: 4. [PubMed: 1350540] [CrossRef]
250.
Hildingsson I, Karlstrom A, Nystedt A. Women’s experiences of induction of labour--findings from a Swedish regional study. Aust N Z J Obstet Gynaecol. 2011 Apr;51(2):151–7. doi: 10.1111/j.1479-828X.2010.01262.x. PMID: 21466518. Exclusion: 2. [PubMed: 21466518] [CrossRef]
251.
Hill MG, Gonzalez MG, Lo-Ciganic WH, et al. Misoprostol in addition to a double-balloon catheter for induction: a double-blind randomized controlled trial. Am J Perinatol. 2018 Feb;35(3):225–32. doi: 10.1055/s-0037-1606606. PMID: 28910848. Exclusion: 4. [PubMed: 28910848] [CrossRef]
252.
Hillier TA, Vesco KK, Whitlock EP, et al. Screening for gestational diabetes mellitus. AHRQ WebM&M. 2008 May:05. PMID: 20722157. Exclusion: 2.
253.
Hobday K, Hulme J, Belton S, et al. Community-based misoprostol for the prevention of post-partum haemorrhage: a narrative review of the evidence base, challenges and scale-up. Glob Public Health. 2018 Aug;13(8):1081–97. doi: 10.1080/17441692.2017.1303743. PMID: 28357885. Exclusion: 9. [PubMed: 28357885] [CrossRef]
254.
Hoffman MK, Sciscione A, Srinivasana M, et al. Uterine rupture in patients with a prior cesarean delivery: the impact of cervical ripening. Am J Perinatol. 2004 May;21(4):217–22. doi: 10.1055/s-2004-828608. PMID: 15168320. Exclusion: 2. [PubMed: 15168320] [CrossRef]
255.
Hokkila E, Kruit H, Rahkonen L, et al. The efficacy of misoprostol vaginal insert compared with oral misoprostol in the induction of labor of nulliparous women: A randomized national multicenter trial. Acta Obstet Gynecol Scand. 2019 08;98(8):1032–9. doi: 10.1111/aogs.13580. PMID: 30771243. Exclusion: 1. [PubMed: 30771243] [CrossRef]
256.
Hopkins MK, Hamm RF, Srinivas SK, et al. Labor and delivery outcomes with the sequential use of misoprostol followed by cervical foley catheter. Am J Perinatol. 2020 Jun 28;28:28. doi: 10.1055/s-0040-1713818. PMID: 32594510. Exclusion: 1. [PMC free article: PMC9152634] [PubMed: 32594510] [CrossRef]
257.
Hoppe KK, Schiff MA, Peterson SE, et al. 30 mL single- versus 80 mL double-balloon catheter for pre-induction cervical ripening: a randomized controlled trial. J Matern Fetal Neonatal Med. 2016;29(12):1919–25. doi: 10.3109/14767058.2015.1067297. PMID: 26302817. Exclusion: 4. [PubMed: 26302817] [CrossRef]
258.
Hösli I, Zanetti-Daellenbach R, Gairing A, et al. Selection of appropriate prostaglandin for the induction of labor at term is more predictive for the achievement of delivery within 24 hours than pre-assessed cervical parameters - a prospective, randomized trial. Geburtshilfe Frauenheilkd. 2008;68(2):147–51. doi: 10.1055/s-2007-989479. Exclusion: 4. [CrossRef]
259.
How HY, Leaseburge L, Khoury JC, et al. A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. Am J Obstet Gynecol. 2001 Oct;185(4):911–5. doi: 10.1067/mob.2001.117358. PMID: 11641677. Exclusion: 4. [PubMed: 11641677] [CrossRef]
260.
Howarth GR, Funk M, Steytler P, et al. A randomised controlled trial comparing vaginally administered misoprostol to vaginal dinoprostone gel in labour induction. J Obstet Gynaecol. 1996;16(6):474–8. doi: 10.3109/01443619609030076. Exclusion: 4. [CrossRef]
261.
Howe KA. Home births in south-west Australia. Med J Aust. 1988 Sep 19;149(6):296–7, 300, 2. PMID: 3419375. Exclusion: 1. [PubMed: 3419375]
262.
Huang YC, Ho DR, Wu CF, et al. Modified bowel preparation to reduce infection after prostate biopsy. Chang Gung Med J. 2006 Jul–Aug;29(4):395–400. PMID: 17051837. Exclusion: 1. [PubMed: 17051837]
263.
Huisman CMA, Ten Eikelder MLG, Mast K, et al. Balloon catheter for induction of labor in women with one previous cesarean and an unfavorable cervix. Acta Obstet Gynecol Scand. 2019 07;98(7):920–8. doi: 10.1111/aogs.13558. PMID: 30723900. Exclusion: 1. [PMC free article: PMC6618009] [PubMed: 30723900] [CrossRef]
264.
Hutchon DJ, Geirsson R, Patel NB. A double-blind controlled trial of PGE2 gel in cervical ripening. Int J Gynaecol Obstet. 1980 May–Jun;17(6):604–7. doi: 10.1002/j.1879-3479.1980.tb00218.x. PMID: 6106583. Exclusion: 2. [PubMed: 6106583] [CrossRef]
265.
Idrisa A, Kyari O, Kawuwa MB, et al. Preparation for induction of labour with an unfavourable cervix using a foley’s catheter. J Obstet Gynaecol. 2007 Feb;27(2):157–8. doi: 10.1080/01443610601114001. PMID: 17454463. Exclusion: 4. [PubMed: 17454463] [CrossRef]
266.
Iqbal S. Management of prolonged pregnancy. J Coll Physicians Surg Pak. 2004 May;14(5):274–7. doi: 05.2004/JCPSP.274277. PMID: 15225454. Exclusion: 8. [PubMed: 15225454]
267.
Irion O, Pedrazzoli J, Mermillod B. A randomized trial comparing vaginal and cervical prostaglandin gel for cervical ripening and labor induction. Obstet Gynecol. 1998 Jan;91(1):65–71. doi: 10.1016/s0029-7844(97)00608-x. PMID: 9464723. Exclusion: 4. [PubMed: 9464723] [CrossRef]
268.
Ishikawa Y, Uneki K, Fukui H, et al. A technique for the induction of labor by the extraovular administration of prostaglandin F2alpha. Int J Gynaecol Obstet. 1976;14(5):439–44. doi: 10.1002/j.1879-3479.1976.tb00081.x. PMID: 15912. Exclusion: 2. [PubMed: 15912] [CrossRef]
269.
Jackson GM, Sharp HT, Varner MW. Cervical ripening before induction of labor: a randomized trial of prostaglandin E2 gel versus low-dose oxytocin. Am J Obstet Gynecol. 1994 Oct;171(4):1092–6. doi: 10.1016/0002-9378(94)90042-6. PMID: 7943077. Exclusion: 2. [PubMed: 7943077] [CrossRef]
270.
Jacquemyn Y, Martens E, Martens G. Foetal monitoring during labour: practice versus theory in a region-wide analysis. Clin Exp Obstet Gynecol. 2012;39(3):307–9. PMID: 23157030. Exclusion: 2. [PubMed: 23157030]
271.
Jakobsson M, Gissler M, Tapper AM. Risk factors for blood transfusion at delivery in Finland. Acta Obstet Gynecol Scand. 2013 Apr;92(4):414–20. doi: 10.1111/j.1600-0412.2012.01490.x. PMID: 22708585. Exclusion: 1. [PubMed: 22708585] [CrossRef]
272.
James C, George SS, Gaunekar N, et al. Management of prolonged pregnancy: a randomized trial of induction of labour and antepartum foetal monitoring. Natl Med J India. 2001 Sep–Oct;14(5):270–3. PMID: 11767219. Exclusion: 4. [PubMed: 11767219]
273.
Javernick JA, Dempsey A. Reducing the primary cesarean birth rate: a quality improvement project. J Midwifery Womens Health. 2017;62(4):477–83. doi: 10.1111/jmwh.12606. PMID: 124396602. Exclusion: 3. [PubMed: 28703927] [CrossRef]
274.
Jeeva MA, Dommisse J. Laminaria tents or vaginal prostaglandins for cervical ripening. A comparative trial. Samj, S. 1982 Mar 13;61(11):402–3. PMID: 7064013. Exclusion: 4. [PubMed: 7064013]
275.
Jozwiak M, ten Eikelder M, Oude Rengerink K, et al. Foley catheter versus vaginal misoprostol: randomized controlled trial (PROBAAT-M study) and systematic review and meta-analysis of literature. Am J Perinatol. 2014 Feb;31(2):145–56. doi: 10.1055/s-0033-1341573. PMID: 23564065. Exclusion: 4. [PubMed: 23564065] [CrossRef]
276.
Justus Hofmeyr G, Matonhodze BB, Alfirevic Z, et al. Titrated oral misoprostol, solution - a new method of labour induction. S Afr J Obstet Gynaecol 2001;7(3):90–1. Exclusion: 4.
277.
Kadanali S, Kucukozkan T, Zor N, et al. Comparison of labor induction with misoprostol vs. oxytocin/prostaglandin E2 in term pregnancy. Int J Gynaecol Obstet. 1996 Nov;55(2):99–104. doi: 10.1016/s0020-7292(96)02710-5. PMID: 8960988. Exclusion: 2. [PubMed: 8960988] [CrossRef]
278.
Kahila H, Stefanovic V, Loukovaara M, et al. Prenatal buprenorphine exposure: effects on biochemical markers of hypoxia and early neonatal outcome. Acta Obstet Gynecol Scand. 2008;87(11):1213–9. doi: 10.1080/00016340802460297. PMID: 18951215. Exclusion: 2. [PubMed: 18951215] [CrossRef]
279.
Kalia M, Atam K, Kochhar M. Comparative evaluation of oral prostaglandin E2 & intravenous oxytocin for induction of labour. Indian J Med Res. 1989 Dec;90:453–8. PMID: 2628313. Exclusion: 2. [PubMed: 2628313]
280.
Kandil M, Emarh M, Sayyed T, et al. Foley catheter versus intra-vaginal misoprostol for induction of labor in post-term gestations. Arch Gynecol Obstet. 2012 Aug;286(2):303–7. doi: 10.1007/s00404-012-2292-8. PMID: 22434058. Exclusion: 4. [PubMed: 22434058] [CrossRef]
281.
Kar MA, Jabeen F, Jamila B. A comparative study of prostaglandin E2 gel (intracervical) versus oxytocin drip in induction of labour. JK Pract. 2000;7(4):264–6. Exclusion: 2.
282.
Karcaaltincaba D, Akdag D, Kandemir O, et al. Is there any relation between development of persistent non-reassuring fetal heart rate pattern and acutely increased uterine artery vascular flow resistance during dinoprostone use in prolonged pregnancies? Acta Obstet Gynecol Scand. 2009 May;88(8):894–900. PMID: 00706791. Exclusion: 2. [PubMed: 19562559]
283.
Kashanian M, Bahasadri S, Nejat Dehkordy A, et al. A comparison between induction of labor with 3 methods of titrated oral misoprostol, constant dose of oral misoprostol and foley catheter with extra amniotic saline infusion (EASI), in women with unfavorable cervix. Med J Islam Repub Iran. 2019;33:115. doi: 10.34171/mjiri.33.115. PMID: 31934574. Exclusion: 4. [PMC free article: PMC6946922] [PubMed: 31934574] [CrossRef]
284.
Kashanian M, Fekrat M, Naghghash S, et al. Evaluation of the effect of extra-amniotic normal saline infusion alone or in combination with dexamethasone for the induction of labor. J Obstet Gynaecol Res. 2008 Feb;34(1):47–50. doi: 10.1111/j.1447-0756.2007.00703.x. PMID: 18226128. Exclusion: 2. [PubMed: 18226128] [CrossRef]
285.
Katz VL, Farmer RM, Dean CA, et al. Use of misoprostol for cervical ripening. South Med J. 2000 Sep;93(9):881–4. PMID: 11005347. Exclusion: 4. [PubMed: 11005347]
286.
Kazzi GM, Bottoms SF, Rosen MG. Efficacy and safety of laminaria digitata for preinduction ripening of the cervix. Obstet Gynecol. 1982 Oct;60(4):440–3. PMID: 7121931. Exclusion: 4. [PubMed: 7121931]
287.
Kehl S, Born T, Weiss C, et al. Induction of labour with sequential double-balloon catheter and oral misoprostol versus oral misoprostol alone in obese women. Eur J Obstet Gynecol Reprod Biol. 2019 Jul;3:100034. doi: 10.1016/j.eurox.2019.100034. PMID: 31403122. Exclusion: 4. [PMC free article: PMC6687443] [PubMed: 31403122] [CrossRef]
288.
Kehl S, Weiss C, Dammer U, et al. Induction of labour: change of method and its effects. Geburtshilfe Frauenheilkd. 2015 Mar;75(3):238–43. doi: 10.1055/s-0035-1545899. PMID: 25914416. Exclusion: 4. [PMC free article: PMC4397939] [PubMed: 25914416] [CrossRef]
289.
Kehl S, Welzel G, Ehard A, et al. Women’s acceptance of a double-balloon device as an additional method for inducing labour. Eur J Obstet Gynecol Reprod Biol. 2013 May;168(1):30–5. doi: 10.1016/j.ejogrb.2012.12.018. PMID: 23298898. Exclusion: 4. [PubMed: 23298898] [CrossRef]
290.
Kehl S, Ziegler J, Schleussner E, et al. Sequential use of double-balloon catheter and oral misoprostol versus oral misoprostol alone for induction of labour at term (CRBplus trial): a multicentre, open-label randomised controlled trial. BJOG. 2015 Jan;122(1):129–36. doi: 10.1111/1471-0528.13116. PMID: 25327872. Exclusion: 4. [PubMed: 25327872] [CrossRef]
291.
Kelly AJ, Alfirevic Z, Dowswell T. Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database Syst Rev. 2009 Apr 15(2):CD007372. doi: 10.1002/14651858.CD007372.pub2. PMID: 19370687. Exclusion: 9. [PMC free article: PMC4127418] [PubMed: 19370687] [CrossRef]
292.
Kelly AJ, Alfirevic Z, Ghosh A. Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database Syst Rev. 2013 Nov 12(11):CD007372. doi: 10.1002/14651858.CD007372.pub3. PMID: 24222365. Exclusion: 9. [PubMed: 24222365] [CrossRef]
293.
Kemp B, Winkler M, Rath W. Induction of labor by prostaglandin E(2) in relation to the Bishop score. Int J Gynaecol Obstet. 2000 Oct;71(1):13–7. doi: 10.1016/s0020-7292(00)00253-8. PMID: 11044536. Exclusion: 4. [PubMed: 11044536] [CrossRef]
294.
Kennare RM, Keirse MJ, Tucker GR, et al. Planned home and hospital births in South Australia, 1991–2006: differences in outcomes. Med J Aust. 2010 Jan 18;192(2):76–80. PMID: 20078406. Exclusion: 2. [PubMed: 20078406]
295.
Keskin HL, Kabacaoglu G, Secen EI, et al. Effects of intravaginally inserted controlled-release dinoprostone and oxytocin for labor induction on umbilical cord blood gas parameters. J Turk Ger Gynecol Assoc. 2012;13(4):257–60. doi: 10.5152/jtgga.2012.41. PMID: 24592052. Exclusion: 2. [PMC free article: PMC3881717] [PubMed: 24592052] [CrossRef]
296.
Khabbaz AY, Usta IM, El-Hajj MI, et al. Rupture of an unscarred uterus with misoprostol induction: case report and review of the literature. J Matern Fetal Med. 2001 Apr;10(2):141–5. doi: 10.1080/714904310. PMID: 11392596. Exclusion: 5. [PubMed: 11392596] [CrossRef]
297.
Khan OZ, Khan MH, Batool S, et al. Comparing the efficacy of sublingual misoprostol and vaginal misoprostol for induction of labor at term live pregnancy. Rawal Medical Journal. 2018 Aug 25;43(3):444–7. PMID: 01651933. Exclusion: 4.
298.
Khan RA, Khan ZE, Ashraf O. Concurrent versus sequential methods for labor induction at term. Int J Gynaecol Obstet. 2007 Feb;96(2):94–7. doi: 10.1016/j.ijgo.2006.10.002. PMID: 17239883. Exclusion: 2. [PubMed: 17239883] [CrossRef]
299.
Khireddine I, Le Ray C, Dupont C, et al. Induction of labor and risk of postpartum hemorrhage in low risk parturients. PLoS ONE. 2013;8(1):e54858. doi: 10.1371/journal.pone.0054858. PMID: 23382990. Exclusion: 2. [PMC free article: PMC3555986] [PubMed: 23382990] [CrossRef]
300.
Kho EM, Sadler L, McCowan L. Induction of labour: a comparison between controlled-release dinoprostone vaginal pessary (cervidil) and dinoprostone intravaginal gel (prostin E2). Aust N Z J Obstet Gynaecol. 2008 Oct;48(5):473–7. doi: 10.1111/j.1479-828X.2008.00901.x. PMID: 19032662. Exclusion: 4. [PubMed: 19032662] [CrossRef]
301.
Kjos SL, Henry OA, Montoro M, et al. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol. 1993 Sep;169(3):611–5. doi: 10.1016/0002-9378(93)90631-r. PMID: 8372870. Exclusion: 4. [PubMed: 8372870] [CrossRef]
302.
Klein MC, Sakala C, Simkin P, et al. Why do women go along with this stuff? Birth. 2006 Sep;33(3):245–50. doi: 10.1111/j.1523-536X.2006.00110.x. PMID: 16948725. Exclusion: 6. [PubMed: 16948725] [CrossRef]
303.
Knutzen VK, Tanneberger U, Davey DA. Complications and outcome of induced labour. S Afr Med J. 1977 Sep 10;52(12):482–5. PMID: 905910. Exclusion: 2. [PubMed: 905910]
304.
Koh LM, Percival B, Pauley T, et al. Complementary therapy and alternative medicine: effects on induction of labour and pregnancy outcome in low risk post-dates women. Heliyon. 2019 Nov;5(11):e02787. doi: 10.1016/j.heliyon.2019.e02787. PMID: 31799460. Exclusion: 2. [PMC free article: PMC6881689] [PubMed: 31799460] [CrossRef]
305.
Kolderup L, McLean L, Grullon K, et al. Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk? Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1543–50. doi: 10.1016/s0002-9378(99)70050-5. PMID: 10368502. Exclusion: 4. [PubMed: 10368502] [CrossRef]
306.
Komala K, Reddy M, Quadri IJ, et al. Comparative study of oral and vaginal misoprostol for induction of labour, maternal and foetal outcome. J Clin Diagn Res. 2013 Dec;7(12):2866–9. doi: 10.7860/JCDR/2013/5825.3779. PMID: 24551660. Exclusion: 4. [PMC free article: PMC3919353] [PubMed: 24551660] [CrossRef]
307.
Kosinska-Kaczynska K, Ciechanowicz P, Saletra A, et al. Two methods of cervix ripening: intracervical foley catether and dinoprostone - which one is actually more efficient? Neuro Endocrinol Lett. 2015;36(3):257–61. PMID: 26313393. Exclusion: 4. [PubMed: 26313393]
308.
Kozuki N, Katz J, Khatry SK, et al. Risk and burden of adverse intrapartum-related outcomes associated with non-cephalic and multiple birth in rural Nepal: a prospective cohort study. BMJ Open. 2017 Apr 20;7(4):e013099. doi: 10.1136/bmjopen-2016-013099. PMID: 28428183. Exclusion: 1. [PMC free article: PMC5663011] [PubMed: 28428183] [CrossRef]
309.
Krammer J, Williams MC, Sawai SK, et al. Pre-induction cervical ripening: a randomized comparison of two methods. Obstet Gynecol. 1995 Apr;85(4):614–8. doi: 10.1016/0029-7844(95)00013-H. PMID: 7898843. Exclusion: 2. [PubMed: 7898843] [CrossRef]
310.
Kreft M, Krahenmann F, Roos M, et al. Maternal and neonatal outcome of labour induction at term comparing two regimens of misoprostol. J Perinat Med. 2014 Sep;42(5):603–9. doi: 10.1515/jpm-2013-0215. PMID: 24633747. Exclusion: 4. [PubMed: 24633747] [CrossRef]
311.
Kruit H, Heikinheimo O, Ulander VM, et al. Management of foley catheter induction among nulliparous women: a retrospective study. BMC Pregnancy Childbirth. 2015 Oct 27;15:276. doi: 10.1186/s12884-015-0715-9. PMID: 26508361. Exclusion: 4. [PMC free article: PMC4624604] [PubMed: 26508361] [CrossRef]
312.
Kruit H, Tihtonen K, Raudaskoski T, et al. Foley catheter or oral misoprostol for induction of labor in women with term premature rupture of membranes: a randomized multicenter trial. Am J Perinatol. 2016 Jul;33(9):866–72. doi: 10.1055/s-0036-1580608. PMID: 27031055. Exclusion: 4. [PubMed: 27031055] [CrossRef]
313.
Kruit H, Wilkman H, Tekay A, et al. Induction of labor by foley catheter compared with spontaneous onset of labor after previous cesarean section: a cohort study. J Perinatol. 2017 Jul;37(7):787–92. doi: 10.1038/jp.2017.50. PMID: 28406484. Exclusion: 1. [PubMed: 28406484] [CrossRef]
314.
Kulshreshtha S, Sharma P, Mohan G, et al. Comparative study of misoprostol vs dinoprostone for induction of labour. Indian J Physiol Pharmacol. 2007 Jan–Mar;51(1):55–61. PMID: 17877293. Exclusion: 4. [PubMed: 17877293]
315.
Kundodyiwa TW, Majoko F, Rusakaniko S. Misoprostol versus oxytocin in the third stage of labor. Int J Gynaecol Obstet. 2001 Dec;75(3):235–41. doi: 10.1016/s0020-7292(01)00498-2. PMID: 11728483. Exclusion: 1. [PubMed: 11728483] [CrossRef]
316.
Lamvu GM, Thorp JM, Jr., Stuart N, et al. Impact of abnormal results of outpatient fetal heart rate monitoring on maternal intervention in labor. J Reprod Med. 2006 Sep;51(9):689–93. PMID: 17039696. Exclusion: 1. [PubMed: 17039696]
317.
Lange AP, Secher NJ, Westergaard JG, et al. Neonatal jaundice after labour induced or stimulated by prostaglandin E2 or oxytocin. Lancet. 1982 May 01;1(8279):991–4. doi: 10.1016/s0140-6736(82)91993-6. PMID: 6122848. Exclusion: 2. [PubMed: 6122848] [CrossRef]
318.
Lapaire O, Zanetti-Dallenbach R, Weber P, et al. Labor induction in preeclampsia: is misoprostol more effective than dinoprostone? J Perinat Med. 2007;35(3):195–9. doi: 10.1515/JPM.2007.028. PMID: 17378719. Exclusion: 4. [PubMed: 17378719] [CrossRef]
319.
Larranaga-Azcarate C, Campo-Molina G, Perez-Rodriguez AF, et al. Dinoprostone vaginal slow-release system (Propess) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes. Acta Obstet Gynecol Scand. 2008;87(2):195–200. doi: 10.1080/00016340701837421. PMID: 18231888. Exclusion: 4. [PubMed: 18231888] [CrossRef]
320.
Larson JD, Rayburn WF, Turnbull GL, et al. Effects of intracervical prostaglandin E2 on fetal heart rate and uterine activity patterns in the presence of oligohydramnios. Am J Obstet Gynecol. 1995 Oct;173(4):1166–70. doi: 10.1016/0002-9378(95)91346-7. PMID: 7485313. Exclusion: 4. [PubMed: 7485313] [CrossRef]
321.
Laube DW, Zlatnik FJ, Pitkin RM. Preinduction cervical ripening with prostaglandin E2 intracervical gel. Obstet Gynecol. 1986 Jul;68(1):54–7. PMID: 3523330. Exclusion: 4. [PubMed: 3523330]
322.
Laughon SK, Zhang J, Grewal J, et al. Induction of labor in a contemporary obstetric cohort. Am J Obstet Gynecol. 2012 Jun;206(6):486.e1–9. doi: 10.1016/j.ajog.2012.03.014. PMID: 22520652. Exclusion: 4. [PMC free article: PMC3361637] [PubMed: 22520652] [CrossRef]
323.
Lee HY. A randomised double-blind study of vaginal misoprostol vs dinoprostone for cervical ripening and labour induction in prolonged pregnancy. Singapore Med J. 1997 Jul;38(7):292–4. PMID: 9339095. Exclusion: 4. [PubMed: 9339095]
324.
Leftwich HK, Gao W, Hibbard JU. Do different modes of labor induction affect the overall success and risk of trial of labor after cesarean section? J Reprod Med. 2017 Jan–Feb;62(1–2):9–14. PMID: 29999274. Exclusion: 4. [PubMed: 29999274]
325.
Legarth J, Guldbaek E, Scher NJ. The efficiency of prostaglandin E2 vaginal suppositories versus intracervical prostaglandin gel for induction of labor in patients with unfavorable inducibility prospects. Eur J Obstet Gynecol Reprod Biol. 1988 Feb;27(2):93–8. doi: 10.1016/0028-2243(88)90001-9. PMID: 3277875. Exclusion: 4. [PubMed: 3277875] [CrossRef]
326.
Leiberman JR, Piura B, Chaim W, et al. The cervical balloon method for induction of labor. Acta Obstet Gynecol Scand. 1977;56(5):499–503. doi: 10.3109/00016347709155020. PMID: 602722. Exclusion: 2. [PubMed: 602722] [CrossRef]
327.
Lelaidier C, Baton C, Benifla JL, et al. Mifepristone for labour induction after previous caesarean section. Br J Obstet Gynaecol. 1994 Jun;101(6):501–3. doi: 10.1111/j.1471-0528.1994.tb13150.x. PMID: 8018638. Exclusion: 2. [PubMed: 8018638] [CrossRef]
328.
Leopold B, Sciscione A. Is there a place for outpatient preinduction cervical ripening? Obstet Gynecol Clin North Am. 2017 Dec;44(4):583–91. doi: 10.1016/j.ogc.2017.08.010. PMID: 29078940. Exclusion: 5. [PubMed: 29078940] [CrossRef]
329.
Leszczynska-Gorzelak B, Laskowska M, Oleszczuk J. Comparative analysis of the effectiveness of misoprostol and prostaglandin E(2) in the preinduction and induction of labor. Med Sci Monit. 2001 Sep–Oct;7(5):1023–8. PMID: 11535953. Exclusion: 2. [PubMed: 11535953]
330.
Leveno KJ, Cunningham FG, Nelson S, et al. A prospective comparison of selective and universal electronic fetal monitoring in 34,995 pregnancies. N Engl J Med. 1986 Sep 04;315(10):615–9. doi: 10.1056/NEJM198609043151004. PMID: 3736600. Exclusion: 1. [PubMed: 3736600] [CrossRef]
331.
Levey KA, Arslan AA, Funai EF. Extra-amniotic saline infusion increases cesarean risk versus other induction methods and spontaneous labor. Am J Perinatol. 2006 Oct;23(7):435–8. doi: 10.1055/s-2006-951303. PMID: 17001554. Exclusion: 4. [PubMed: 17001554] [CrossRef]
332.
Levine LD, Downes KL, Elovitz MA, et al. Mechanical and pharmacologic methods of labor induction: a randomized controlled trial. Obstet Gynecol. 2016 Dec;128(6):1357–64. doi: 10.1097/AOG.0000000000001778. PMID: 27824758. Exclusion: 4. [PMC free article: PMC5127406] [PubMed: 27824758] [CrossRef]
333.
Li ZX. Small balloon catheters in the induction of labour in mid-trimester pregnancy. Trop Doct. 1996 Oct;26(4):171–2. doi: 10.1177/004947559602600412. PMID: 8937234. Exclusion: 4. [PubMed: 8937234] [CrossRef]
334.
Lichtenegger W, Lahousen M, Kraemer H. Comparison of oral prostaglandin E2 and intravenous oxytocin for induction of labour. Gynecol Obstet Invest. 1981;12(4):197–202. doi: 10.1159/000299603. PMID: 7250782. Exclusion: 4. [PubMed: 7250782] [CrossRef]
335.
Liggins GC. Controlled trial of induction of labor by vaginal suppositories containing prostaglandin E2. Prostaglandins. 1979 Jul;18(1):167–72. doi: 10.1016/s0090-6980(79)80035-0. PMID: 392623. Exclusion: 2. [PubMed: 392623] [CrossRef]
336.
Lin MG, Reid KJ, Treaster MR, et al. Transcervical foley catheter with and without extraamniotic saline infusion for labor induction: a randomized controlled trial. Obstet Gynecol. 2007 Sep;110(3):558–65. doi: 10.1097/01.AOG.0000278077.30890.87. PMID: 17766600. Exclusion: 1. [PubMed: 17766600] [CrossRef]
337.
Lindblad A, Ekman G, Marsal K, et al. Fetal circulation 60 to 80 minutes after vaginal prostaglandin E2 in pregnant women at term. Arch Gynecol. 1985;237(1):31–6. doi: 10.1007/bf02133949. PMID: 3901936. Exclusion: 3. [PubMed: 3901936] [CrossRef]
338.
Liston R, Crane J, Hamilton E, et al. Fetal health surveillance in labour. J Obstet Gynaecol Can. 2002 Mar;24(3):250–76; quiz 77–80. PMID: 12196876. Exclusion: 9. [PubMed: 12196876]
339.
Little SE. Elective Induction of Labor: What is the Impact? Obstet Gynecol Clin North Am. 2017 Dec;44(4):601–14. doi: 10.1016/j.ogc.2017.08.005. PMID: 29078942. Exclusion: 6. [PubMed: 29078942] [CrossRef]
340.
Llanos-Chea F, Martinez D, Rosas A, et al. Characteristics of travel-related severe plasmodium vivax and plasmodium falciparum malaria in individuals hospitalized at a tertiary referral center in Lima, Peru. Am J Trop Med Hyg. 2015 Dec;93(6):1249–53. doi: 10.4269/ajtmh.14-0652. PMID: 26483126. Exclusion: 1. [PMC free article: PMC4674242] [PubMed: 26483126] [CrossRef]
341.
Lokkegaard E, Lundstrom M, Kjaer MM, et al. Prospective multi-centre randomised trial comparing induction of labour with a double-balloon catheter versus dinoprostone. J Obstet Gynaecol. 2015;35(8):797–802. doi: 10.3109/01443615.2015.1011101. PMID: 25692241. Exclusion: 4. [PubMed: 25692241] [CrossRef]
342.
Lokugamage AU, Forsyth SF, Sullivan KR, et al. Dinoprostone versus misoprostol: a randomized study of nulliparous women undergoing induction of labor. Acta Obstet Gynecol Scand. 2003 Feb;82(2):133–7. doi: 10.1034/j.1600-0412.2003.00066.x. PMID: 12648174. Exclusion: 4. [PubMed: 12648174] [CrossRef]
343.
Loto OM, Ikuomola AA, Ayuba, II, et al. Comparative study of the outcome of induction of labor using 25 micro g and 50 micro g of vaginal misoprostol. J Matern Fetal Neonatal Med. 2012 Nov;25(11):2359–62. doi: 10.3109/14767058.2012.696160. PMID: 22640229. Exclusion: 4. [PubMed: 22640229] [CrossRef]
344.
Lotshaw RR, Gordon HR. Optimal interval between prostaglandin E2 ripening of the cervix and oxytocin induction of labor: a prospective clinical trial. J Matern Fetal Med. 1994;3(4):153–6. Exclusion: 2.
345.
Lou S, Carstensen K, Hvidman L, et al. “I guess baby was just too comfy in there…”: A qualitative study of women’s experiences of elective late-term induction of labour. Women Birth. 2020 May 11;11:11. doi: 10.1016/j.wombi.2020.03.012. PMID: 32404274. Exclusion: 1. [PubMed: 32404274] [CrossRef]
346.
Lutgendorf MA, Johnson A, Terpstra ER, et al. Extra-amniotic balloon for preinduction cervical ripening: a randomized comparison of weighted traction versus unweighted. J Matern Fetal Neonatal Med. 2012 Jun;25(6):581–6. doi: 10.3109/14767058.2011.587063. PMID: 21728788. Exclusion: 4. [PubMed: 21728788] [CrossRef]
347.
Luther ER, Gray JH, Young D, et al. Comparison of natural and synthetic prostaglandin E2 tablets in labour induction. Can Med Assoc J. 1983 May 15;128(10):1189–91. PMID: 6340813. Exclusion: 4. [PMC free article: PMC1875306] [PubMed: 6340813]
348.
Luther ER, Roux J, Popat R, et al. The effect of estrogen priming on induction of labor with prostaglandins. Am J Obstet Gynecol. 1980 Jun 01;137(3):351–7. doi: 10.1016/0002-9378(80)90920-5. PMID: 7377255. Exclusion: 2. [PubMed: 7377255] [CrossRef]
349.
Lyndrup J, Nickelsen C, Weber T, et al. Induction of labour by balloon catheter with extra-amniotic saline infusion (BCEAS): a randomised comparison with PGE2 vaginal pessaries. Eur J Obstet Gynecol Reprod Biol. 1994 Mar 15;53(3):189–97. doi: 10.1016/0028-2243(94)90118-x. PMID: 8200466. Exclusion: 4. [PubMed: 8200466] [CrossRef]
350.
Machin D, Scamell A. Changing practice. Using ethnographic research to examine effects of ‘informed choice’. Br J Midwifery. 1998;6(5):304–9. PMID: 107285248. Exclusion: 3.
351.
MacKenzie IZ, Castle BM, Mountford L, et al. Prostaglandin release from preparations used vaginally for the induction of labour. Prostaglandins. 1987 Dec;34(6):939–46. doi: 10.1016/0090-6980(87)90073-6. PMID: 3482470. Exclusion: 1. [PubMed: 3482470] [CrossRef]
352.
Mackenzie IZ, Embrey MP. The influence of pre-induction vaginal prostaglandin E2 gel upon subsequent labour. Br J Obstet Gynaecol. 1978 Sep;85(9):657–61. PMID: 698144. Exclusion: 4. [PubMed: 698144]
353.
MacLennan AH, Chan FY, Eckert K. The safety of vaginal prostaglandin F2 alpha for the stimulation of labour. Aust N Z J Obstet Gynaecol. 1994 May;34(2):154–8. doi: 10.1111/j.1479-828x.1994.tb02679.x. PMID: 7980303. Exclusion: 4. [PubMed: 7980303] [CrossRef]
354.
MacLennan AH, Green RC, Bryant-Greenwood GD, et al. Cervical ripening with combinations of vaginal prostaglandin F2-alpha estradiol, and relaxin. Obstet Gynecol. 1981 Nov;58(5):601–4. PMID: 7029370. Exclusion: 4. [PubMed: 7029370]
355.
Madaan M, Agrawal S, Puri M, et al. Is low dose vaginal misoprostol better than dinoprostone gel for induction of labor: a randomized controlled trial. J Clin Diagn Res. 2014 Sep;8(9):OC31–4. doi: 10.7860/JCDR/2014/8101.4906. PMID: 25386492. Exclusion: 4. [PMC free article: PMC4225944] [PubMed: 25386492] [CrossRef]
356.
Magann EF, Perry KG, Jr., Dockery JR, Jr., et al. Cervical ripening before medical induction of labor: a comparison of prostaglandin E2, estradiol, and oxytocin. Am J Obstet Gynecol. 1995 Jun;172(6):1702–6; discussion 4–8. doi: 10.1016/0002-9378(95)91401-3. PMID: 7778622. Exclusion: 2. [PubMed: 7778622] [CrossRef]
357.
Maggi C, Mazzoni G, Gerosa V, et al. Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert. Acta Obstet Gynecol Scand. 2019 10;98(10):1268–73. doi: 10.1111/aogs.13667. PMID: 31140585. Exclusion: 1. [PubMed: 31140585] [CrossRef]
358.
Mahomed K, Wild K, Weekes CR. Prostaglandin gel versus oxytocin - prelabour rupture of membranes at term - a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2018 Dec;58(6):654–9. doi: 10.1111/ajo.12788. PMID: 29468633. Exclusion: 2. [PubMed: 29468633] [CrossRef]
359.
Maier JT, Metz M, Watermann N, et al. Induction of labor in patients with an unfavorable cervix after a cesarean using an osmotic dilator versus vaginal prostaglandin. J Perinat Med. 2018 Apr 25;46(3):299–307. doi: 10.1515/jpm-2017-0029. PMID: 28672756. Exclusion: 4. [PubMed: 28672756] [CrossRef]
360.
Manish P, Rathore S, Benjamin SJ, et al. A randomised controlled trial comparing 30 mL and 80 mL in foley catheter for induction of labour after previous caesarean section. Trop Doct. 2016 Oct;46(4):205–11. doi: 10.1177/0049475515626031. PMID: 26774112. Exclusion: 4. [PubMed: 26774112] [CrossRef]
361.
Marconi AM, Bozzetti P, Morabito A, et al. Comparing two dinoprostone agents for cervical ripening and induction of labor: a randomized trial. Eur J Obstet Gynecol Reprod Biol. 2008 Jun;138(2):135–40. doi: 10.1016/j.ejogrb.2007.08.009. PMID: 17889983. Exclusion: 4. [PubMed: 17889983] [CrossRef]
362.
Martinell J, Jodal U, Lidin-Janson G. Pregnancies in women with and without renal scarring after urinary infections in childhood. Bmj. 1990 Mar 31;300(6728):840–4. doi: 10.1136/bmj.300.6728.840. PMID: 2337697. Exclusion: 1. [PMC free article: PMC1662581] [PubMed: 2337697] [CrossRef]
363.
Marzouk AF. Oral and intravenous prostaglandin E2 in induction of labour. Br J Clin Pract. 1975 Mar;29(3):68–70. PMID: 1131330. Exclusion: 4. [PubMed: 1131330]
364.
Maslovitz S, Lessing JB, Many A. Complications of trans-cervical foley catheter for labor induction among 1,083 women. Arch Gynecol Obstet. 2010 Mar;281(3):473–7. doi: 10.1007/s00404-009-1136-7. PMID: 19488776. Exclusion: 4. [PubMed: 19488776] [CrossRef]
365.
Mati JK, Horrobin DF, Bramley PS. Induction of labour in sheep and in humans by single doses of corticosteroids. Br Med J. 1973 Apr 21;2(5859):149–51. doi: 10.1136/bmj.2.5859.149. PMID: 4699595. Exclusion: 1. [PMC free article: PMC1589263] [PubMed: 4699595] [CrossRef]
366.
Matonhodze BB, Hofmeyr GJ, Levin J. Labour induction at term--a randomised trial comparing foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. S Afr Med J. 2003 May;93(5):375–9. PMID: 12830603. Exclusion: 4. [PubMed: 12830603]
367.
Maul H, Mackay L, Garfield RE. Cervical ripening: biochemical, molecular, and clinical considerations. Clin Obstet Gynecol. 2006 Sep;49(3):551–63. doi: 10.1097/00003081-200609000-00015. PMID: 16885662. Exclusion: 1. [PubMed: 16885662] [CrossRef]
368.
Mayer RB, Oppelt P, Shebl O, et al. Initial clinical experience with a misoprostol vaginal insert in comparison with a dinoprostone insert for inducing labor. Eur J Obstet Gynecol Reprod Biol. 2016 May;200:89–93. doi: 10.1016/j.ejogrb.2016.03.008. PMID: 26995147. Exclusion: 4. [PubMed: 26995147] [CrossRef]
369.
Mbaluka CM, Kamau K, Karanja JG, et al. Effectiveness and safety of 2-hourly 20 mcg oral misoprostol solution compared to standard intravenous oxytocin in labour induction due to pre-labour rupture of membranes at term: a randomised clinical trial at Kenyatta National Hospital. East Afr Med J. 2014 Sep;91(9):303–10. PMID: 26866082. Exclusion: 2. [PubMed: 26866082]
370.
McGill J, Shetty A. Mifepristone and misoprostol in the induction of labor at term. Int J Gynaecol Obstet. 2007 Feb;96(2):80–4. doi: 10.1016/j.ijgo.2006.09.030. PMID: 17274998. Exclusion: 2. [PubMed: 17274998] [CrossRef]
371.
Mei-Dan E, Walfisch A, Suarez-Easton S, et al. Comparison of two mechanical devices for cervical ripening: a prospective quasi-randomized trial. J Matern Fetal Neonatal Med. 2012 Jun;25(6):723–7. doi: 10.3109/14767058.2011.591459. PMID: 21806490. Exclusion: 4. [PubMed: 21806490] [CrossRef]
372.
Mei-Dan E, Walfisch A, Valencia C, et al. Making cervical ripening EASI: a prospective controlled comparison of single versus double balloon catheters. J Matern Fetal Neonatal Med. 2014 Nov;27(17):1765–70. doi: 10.3109/14767058.2013.879704. PMID: 24397244. Exclusion: 4. [PubMed: 24397244] [CrossRef]
373.
Melamed N, Ben-Haroush A, Kremer S, et al. Failure of cervical ripening with prostaglandin-E2 can it be predicted? J Matern Fetal Neonatal Med. 2010 Jun;23(6):536–40. doi: 10.3109/14767050903197076. PMID: 19895355. Exclusion: 4. [PubMed: 19895355] [CrossRef]
374.
Metcalfe A, Mathai M, Liu S, et al. Proportion of neonatal readmission attributed to length of stay for childbirth: a population-based cohort study. BMJ Open. 2016 Sep 14;6(9):e012007. doi: 10.1136/bmjopen-2016-012007. PMID: 27630070. Exclusion: 1. [PMC free article: PMC5030571] [PubMed: 27630070] [CrossRef]
375.
Milchev N, Pehlivanov B, Paskaleva V, et al. Prostaglandin E2 in preinduction cervical ripening in postdate pregnancy. Folia Med (Plovdiv). 1999;41(3):81–5. PMID: 10658373. Exclusion: 4. [PubMed: 10658373]
376.
Milliez JM, Jannet D, Touboul C, et al. Two different regimens of preinduction ripening of the uterine cervix with prostaglandin E2: a randomized clinical study. Eur J Obstet Gynecol Reprod Biol. 1993 Aug;50(3):163–8. doi: 10.1016/0028-2243(93)90196-j. PMID: 8262291. Exclusion: 4. [PubMed: 8262291] [CrossRef]
377.
Minaretzis D, Tsionu C, Papageorgiou I, et al. Intracervical prostaglandin E2 gel for cervical ripening and labor induction: what is the appropriate dose? Gynecol Obstet Invest. 1993;35(1):34–7. doi: 10.1159/000292659. PMID: 8449431. Exclusion: 4. [PubMed: 8449431] [CrossRef]
378.
Mizrachi Y, Levy M, Bar J, et al. Induction of labor in nulliparous women with unfavorable cervix: a comparison of foley catheter and vaginal prostaglandin E2. Arch Gynecol Obstet. 2016 Oct;294(4):725–30. doi: 10.1007/s00404-016-4026-9. PMID: 26837386. Exclusion: 4. [PubMed: 26837386] [CrossRef]
379.
Mokgokong E. Induction of labour with oral prostaglandin E2. S Afr Med J. 1976 Apr 24;50(18):699–701. PMID: 1273734. Exclusion: 4. [PubMed: 1273734]
380.
Moodley J, Venkatachalam S, Songca P. Misoprostol for cervical ripening at and near term--a comparative study. S Afr Med J. 2003 May;93(5):371–4. PMID: 12830602. Exclusion: 4. [PubMed: 12830602]
381.
Moodley J, Venkatachalam S, Songca P. Misoprostol for cervical ripening at and near term - a comparative study. S Afr J Obstet Gynaecol. 2003 May;9(2):34–7. doi: 10.1111/j.1471-4159.1979.tb11080.x. PMID: 00438814. Exclusion: 4. [CrossRef]
382.
Moon KT. Internal vs. external monitoring of uterine contractions. Am Fam Physician. 2010 Jul;82(9):1142–3. doi: 10.4269/ajtmh.1977.26.650. PMID: 00889007. Exclusion: 6. [CrossRef]
383.
Moore KH, Sill R. Domiciliary fetal monitoring in a district maternity unit. Aust N Z J Obstet Gynaecol. 1990 Feb;30(1):36–40. doi: 10.1111/j.1479-828x.1990.tb03193.x. PMID: 2189393. Exclusion: 1. [PubMed: 2189393] [CrossRef]
384.
Moraes Filho OB, Albuquerque RM, Cecatti JG. A randomized controlled trial comparing vaginal misoprostol versus foley catheter plus oxytocin for labor induction. Acta Obstet Gynecol Scand. 2010 Aug;89(8):1045–52. doi: 10.3109/00016349.2010.499447. PMID: 20636243. Exclusion: 2. [PubMed: 20636243] [CrossRef]
385.
Mousa HA, Mahmood TA. Do practice guidelines guide practice? A prospective audit of induction of labor three years experience. Acta Obstet Gynecol Scand. 2000 Dec;79(12):1086–92. PMID: 11130093. Exclusion: 5. [PubMed: 11130093]
386.
Mukhopadhyay M, Lim KJ, Fairlie FM. Is propess a better method of induction of labour in nulliparous women. J Obstet Gynaecol. 2002 May;22(3):294–5. doi: 10.1080/01443610220130607. PMID: 12521503. Exclusion: 4. [PubMed: 12521503] [CrossRef]
387.
Mundle S, Bracken H, Khedikar V, et al. Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial. Lancet. 2017 Aug 12;390(10095):669–80. doi: 10.1016/S0140-6736(17)31367-3. PMID: 28668289. Exclusion: 4. [PubMed: 28668289] [CrossRef]
388.
Murphy AJ, Jalland M, Pepperell RJ, et al. Use of vaginal prostaglandin gel before induction of labour. Aust N Z J Obstet Gynaecol. 1980 May;20(2):84–6. doi: 10.1111/j.1479-828x.1980.tb00099.x. PMID: 6932208. Exclusion: 2. [PubMed: 6932208] [CrossRef]
389.
Murray HG, Buonocore A, Hawley J. A randomized trial of two preparations of vaginal prostaglandin for pre-induction cervical ripening. Obstet Gynecol. 1995 Dec;86(6):880–5. doi: 10.1016/0029-7844(95)00302-8. PMID: 7501332. Exclusion: 4. [PubMed: 7501332] [CrossRef]
390.
Muzonzini G, Hofmeyr JG. Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2009 Oct 18(4):CD004221. doi: 10.1002/14651858.CD004221.pub2. PMID: 15495088 Exclusion: 9. [PMC free article: PMC8768472] [PubMed: 15495088] [CrossRef]
391.
Mwau M, Bwana P, Kithinji L, et al. Mother-to-child transmission of HIV in Kenya: a cross-sectional analysis of the national database over nine years. PLoS ONE. 2017;12(8):e0183860. doi: 10.1371/journal.pone.0183860. PMID: 28850581. Exclusion: 1. [PMC free article: PMC5574578] [PubMed: 28850581] [CrossRef]
392.
Nadia Bennett K, Park H, Cioffi J, et al. A comparison of obstetrical outcomes and costs between misoprostol and dinoprostone for induction of labor. J Matern Fetal Neonatal Med. 2016 Nov;29(22):3732–6. doi: 10.3109/14767058.2016.1142965. PMID: 26782646. Exclusion: 4. [PubMed: 26782646] [CrossRef]
393.
Naeiji Z, Naghshvarian N, Mirzamoradi M, et al. Efficacy and safety of oral hyoscine used for outpatient cervical ripening among primiparous women with term pregnancy. Int J Gynaecol Obstet. 2019 Dec 17;17:17. doi: 10.1002/ijgo.13089. PMID: 31849035. Exclusion: 2. [PubMed: 31849035] [CrossRef]
394.
Nagdeve P, Shetty A. Review of use of mysodelle as a method of induction of labour. J Obstet Gynaecol. 2018 Jul;38(5):726. doi: 10.1080/01443615.2018.1444404. PMID: 29944050. Exclusion: 6. [PubMed: 29944050] [CrossRef]
395.
Nager CW, Key TC, Moore TR. Cervical ripening and labor outcome with preinduction intracervical prostaglandin E2 (Prepidil) gel. J Perinatol. 1987 Summer;7(3):189–93. PMID: 3504454. Exclusion: 4. [PubMed: 3504454]
396.
Nanda S, Singhal SR, Papneja A. Induction of labour with intravaginal misoprostol and prostaglandin E2 gel: a comparative study. Trop Doct. 2007 Jan;37(1):21–4. doi: 10.1258/004947507779952032. PMID: 17326881. Exclusion: 2. [PubMed: 17326881] [CrossRef]
397.
Nassar AH, Awwad J, Khalil AM, et al. A randomised comparison of patient satisfaction with vaginal and sublingual misoprostol for induction of labour at term. BJOG. 2007 Oct;114(10):1215–21. doi: 10.1111/j.1471-0528.2007.01492.x. PMID: 17877674. Exclusion: 4. [PubMed: 17877674] [CrossRef]
398.
Nayak S, Pati T, Sahu N, et al. Role of intracervical dinoprostone gel administration versus vaginal administration of oral prostaglandin E2 tablet for induction of labour. Int. J Pharm Sci Rev Res. 2015;30(1):279–84. Exclusion: 4.
399.
Nazneen S, Sultana F, Nahaer K. Intravaginal misoprostol versus transcervical foley catheter for pre-induction cervical ripening and their outcome - a comparative study. Bangladesh Journal of Obstetrics and Gynecology. 2012;27(2):72–8. Exclusion: 4.
400.
Neilson DR, Jr., Prins RP, Bolton RN, et al. A comparison of prostaglandin E2 gel and prostaglandin F2 alpha gel for preinduction cervical ripening. Am J Obstet Gynecol. 1983 Jul 01;146(5):526–32. doi: 10.1016/0002-9378(83)90795-0. PMID: 6344644. Exclusion: 4. [PubMed: 6344644] [CrossRef]
401.
Neri C, Familiari A, Preziosi F, et al. Oral misoprostol versus intravaginal dinoprostone for labor induction: a comparison study. Minerva Ginecol. 2018 Aug;70(4):378–84. doi: 10.23736/S0026-4784.18.04184-9. PMID: 29376620. Exclusion: 4. [PubMed: 29376620] [CrossRef]
402.
Neri I, Pignatti L, Fontanesi F, et al. Acupuncture in postdate pregnancy management. J Acupunct Meridian Stud. 2018 Oct;11(5):332–6. doi: 10.1016/j.jams.2018.06.001. PMID: 29890286. Exclusion: 2. [PubMed: 29890286] [CrossRef]
403.
Nigam A, Madan M, Puri M, et al. Labour induction with 25 micrograms versus 50 micrograms intravaginal misoprostol in full term pregnancies. Trop Doct. 2010 Jan;40(1):53–5. doi: 10.1258/td.2009.090203. PMID: 20008056. Exclusion: 4. [PubMed: 20008056] [CrossRef]
404.
Niromanesh S, Mosavi-Jarrahi A, Samkhaniani F. Intracervical foley catheter balloon vs. prostaglandin in preinduction cervical ripening. Int J Gynaecol Obstet. 2003 Apr;81(1):23–7. doi: 10.1016/s0020-7292(02)00392-2. PMID: 12676389. Exclusion: 4. [PubMed: 12676389] [CrossRef]
405.
Nisa MU, Anjum S. Elective induction versus expectant management of mild pre-eclampsia at term. J Coll Physicians Surg Pak. 2018 Sep;28(9):677–80. doi: 10.29271/jcpsp.2018.09.677. PMID: 30158032. Exclusion: 4. [PubMed: 30158032] [CrossRef]
406.
Noah ML, DeCoster JM, Fraser TJ, et al. Preinduction cervical softening with endocervical PGE2 gel. A multi-center trial. Acta Obstet Gynecol Scand. 1987;66(1):3–7. doi: 10.3109/00016348709092944. PMID: 3300135. Exclusion: 2. [PubMed: 3300135] [CrossRef]
407.
Nongkhlaw W, Singh CM, Phanbuh SS, et al. Randomized prospective trial to compare the efficacy and safety of intra-vaginal misoprostol with intra-cervical dinoprostone gel in induction of labor. JMS - Journal of Medical Society. 2014;28(2):73–6. doi: 10.4103/0972-4958.141079. Exclusion: 4. [CrossRef]
408.
Nopdonrattakoon L. A comparison between intravaginal and oral misoprostol for labor induction: a randomized controlled trial. J Obstet Gynaecol Res. 2003 Apr;29(2):87–91. doi: 10.1046/j.1341-8076.2003.00084.x. PMID: 12755528. Exclusion: 4. [PubMed: 12755528] [CrossRef]
409.
Noren H, Blad S, Carlsson A, et al. STAN in clinical practice--the outcome of 2 years of regular use in the city of Gothenburg. Am J Obstet Gynecol. 2006 Jul;195(1):7–15. doi: 10.1016/j.ajog.2006.01.108. PMID: 16643829. Exclusion: 1. [PubMed: 16643829] [CrossRef]
410.
Nunes FP, Campos AP, Pedroso SR, et al. Intravaginal glyceryl trinitrate and dinoprostone for cervical ripening and induction of labor. Am J Obstet Gynecol. 2006 Apr;194(4):1022–6. doi: 10.1016/j.ajog.2005.10.814. PMID: 16580291. Exclusion: 2. [PubMed: 16580291] [CrossRef]
411.
Nuthalapaty FS, Ramsey PS, Biggio JR, et al. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1065–70. doi: 10.1016/j.ajog.2005.05.087. PMID: 16157113. Exclusion: 1. [PMC free article: PMC3731987] [PubMed: 16157113] [CrossRef]
412.
Nuutila M, Cacciatore B, Ylikorkala O. Effect of local prostaglandin E2 on uterine and fetal doppler flow in pregnancy-induced hypertension. Hypertens Pregnancy. 1997;16(3):357–66. doi: 10.3109/10641959709031644. Exclusion: 3. [CrossRef]
413.
Nuutila M, Kajanoja P. Cervical ripening prior to labor induction with intracervical prostaglandin E2 gel in patients with preeclampsia - a placebo-controlled study. Hypertens. 1995;14(3):313–7. Exclusion: 4.
414.
O’Brien JM, Mercer BM, Cleary NT, et al. Efficacy of outpatient induction with low-dose intravaginal prostaglandin E2: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1995 Dec;173(6):1855–9. doi: 10.1016/0002-9378(95)90440-9. PMID: 8610775. Exclusion: 2. [PubMed: 8610775] [CrossRef]
415.
Odum CU, Isika AN, Lambo AO. Induction of labour with single insertion of vaginal tablet of prostagladin E2 (PGE2), amniotomy, and oxytocin infusion. West Afr J Med. 1993 Jul–Sep;12(3):153–7. PMID: 8312212. Exclusion: 8. [PubMed: 8312212]
416.
Omole-Ohonsi A, Ashimi A, Adeleke S. Spontaneous pre-labour rupture of membranes at term: immediate versus delayed induction of labour. West Afr J Med. 2009 May;28(3):156–60. doi: 10.4314/wajm.v28i3.48439. PMID: 20306730. Exclusion: 1. [PubMed: 20306730] [CrossRef]
417.
Ophir E, Haj N, Korenblum R, et al. Cervical ripening before induction of labor: comparison of an intracervical foley catheter and prostaglandin E2 vaginal tablets. International Journal of Feto-Maternal Medicine. 1992;5(2):101–6. Exclusion: 4.
418.
Osman I, MacKenzie F, Norrie J, et al. The “PRIM” study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol. 2006 Apr;194(4):1012–21. doi: 10.1016/j.ajog.2005.10.812. PMID: 16580290. Exclusion: 2. [PubMed: 16580290] [CrossRef]
419.
Osoti A, Kibii DK, Tong TMK, et al. Effect of extra-amniotic foley’s catheter and vaginal misoprostol versus vaginal misoprostol alone on cervical ripening and induction of labor in Kenya, a randomized controlled trial. BMC Pregnancy Childbirth. 2018 Jul 12;18(1):300. doi: 10.1186/s12884-018-1793-2. PMID: 30001195. Exclusion: 4. [PMC free article: PMC6044072] [PubMed: 30001195] [CrossRef]
420.
Ottinger WS, Menard MK, Brost BC. A randomized clinical trial of prostaglandin E2 intracervical gel and a slow release vaginal pessary for preinduction cervical ripening. Am J Obstet Gynecol. 1998 Aug;179(2):349–53. doi: 10.1016/s0002-9378(98)70363-1. PMID: 9731837. Exclusion: 4. [PubMed: 9731837] [CrossRef]
421.
Owen J, Winkler CL, Harris BA, Jr., et al. A randomized, double-blind trial of prostaglandin E2 gel for cervical ripening and meta-analysis. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):991–6. doi: 10.1016/0002-9378(91)90456-2. PMID: 1835301. Exclusion: 4. [PubMed: 1835301] [CrossRef]
422.
Ozden S, Delikara MN, Avci A, et al. Intravaginal misoprostol vs. expectant management in premature rupture of membranes with low Bishop scores at term. Int J Gynaecol Obstet. 2002 May;77(2):109–15. doi: 10.1016/s0020-7292(02)00030-9. PMID: 12031560. Exclusion: 4. [PubMed: 12031560] [CrossRef]
423.
Palatnik A, Kominiarek MA. Outcomes of elective induction of labor versus expectant management among obese women at ≥39 Weeks. Am J Perinatol. 2020;37(7):695–707. doi: 10.1055/s-0039-1688471. PMID: 31039597. Exclusion: 1. [PMC free article: PMC7191996] [PubMed: 31039597] [CrossRef]
424.
Parazzini F, Benedetto C, Danti L, et al. A randomized comparison of vaginal prostaglandin E2 with oxytocin plus amniotomy for induction of labour in women with intermediately ripe cervices. Eur J Obstet Gynecol Reprod Biol. 1998 Oct;81(1):15–20. doi: 10.1016/s0301-2115(98)00148-1. PMID: 9846707. Exclusion: 2. [PubMed: 9846707] [CrossRef]
425.
Parimkayala R, Shraddha Shetty K. Effectiveness of sublingual versus oral misoprostol for induction of labour at term. Indian Journal of Public Health Research and Development. 2019;10(12):160–4. doi: 10.37506/v10/i12/2019/ijphrd/192683. Exclusion: 1. [CrossRef]
426.
Parisaei M, Erskine KJ. Is expensive always better? Comparison of two induction agents for term rupture of membranes. J Obstet Gynaecol. 2008 Apr;28(3):290–3. doi: 10.1080/01443610802042951. PMID: 18569470. Exclusion: 4. [PubMed: 18569470] [CrossRef]
427.
Park H, Han JY, Ahn HK, et al. Unintentional uterine hyperactivity and perinatal outcomes following labor induction with intravaginal administration of sustained-release dinoprostone insert. Journal of Clinical Pharmacology and Pharmacoepidemiology. 2010;1(1):9–14. Exclusion: 4.
428.
Park KH, Kim SN, Lee SY, et al. Comparison between sonographic cervical length and Bishop score in preinduction cervical assessment: a randomized trial. Ultrasound Obstet Gynecol. 2011 Aug;38(2):198–204. doi: 10.1002/uog.9020. PMID: 21484904. Exclusion: 1. [PubMed: 21484904] [CrossRef]
429.
Parry E, Parry D, Pattison N. Induction of labour for post term pregnancy: an observational study. Aust N Z J Obstet Gynaecol. 1998 Aug;38(3):275–80. doi: 10.1111/j.1479-828x.1998.tb03065.x. PMID: 9761152. Exclusion: 4. [PubMed: 9761152] [CrossRef]
430.
Payne E, Reed MF, Cietak KA, et al. A comparison of prostaglandin E2 vaginal tablets with vaginal gel for ripening the unfavourable cervix and induction of labour. J Obstet Gynaecol. 1993;13(2):103–6. Exclusion: 4.
431.
Pearce DJ. Pre-induction priming of the uterine cervix with oral prostaglandin E2 and a placebo. Prostaglandins. 1977 Sep;14(3):571–6. doi: 10.1016/0090-6980(77)90271-4. PMID: 333515. Exclusion: 2. [PubMed: 333515] [CrossRef]
432.
Peedicayil A, Jasper P, Balasubramaniam N, et al. A randomized controlled trial of extra-amniotic ethinyloestradiol in ripening the cervix at term. Br J Obstet Gynaecol. 1989 Aug;96(8):973–7. doi: 10.1111/j.1471-0528.1989.tb03357.x. PMID: 2673340. Exclusion: 4. [PubMed: 2673340] [CrossRef]
433.
Peedicayil A, Jasper P, Balasubramaniam N, et al. A randomized controlled trial of extra-amniotic ethinyloestradiol for cervical ripening in multiparas. Aust N Z J Obstet Gynaecol. 1990 May;30(2):127–30. doi: 10.1111/j.1479-828x.1990.tb03241.x. PMID: 2205188. Exclusion: 2. [PubMed: 2205188] [CrossRef]
434.
Pekarev OG, Brega ES, Gus AI, et al. Sonoelastography for the comparative assessment of cervical maturation after different approaches to cervical preparation ahead of labor induction. J Matern Fetal Neonatal Med. 2020 May 27:1–7. doi: 10.1080/14767058.2020.1770220. PMID: 32460594. Exclusion: 1. [PubMed: 32460594] [CrossRef]
435.
Pennell CE, Henderson JJ, O’Neill MJ, et al. Induction of labour in nulliparous women with an unfavourable cervix: a randomised controlled trial comparing double and single balloon catheters and PGE2 gel. BJOG. 2009 Oct;116(11):1443–52. doi: 10.1111/j.1471-0528.2009.02279.x. PMID: 19656148. Exclusion: 4. [PubMed: 19656148] [CrossRef]
436.
Pereira Alves Filho E, Nogueira Arcanjo FC, Mesquita Rocha AR, et al. The efficacy and safety of intravaginal misoprostol for the induction of labor in patients with obstetrical or medical indication for labor induction. Clin Exp Obstet Gynecol. 2019 Jul 16–30;46(1):81–9. PMID: 01963682 Exclusion: 4.
437.
Petersen JF, Bergholt T, Lokkegaard EC. Safe induction of labour with low-dose misoprostol, but less effective than the conventional dinoprostone regimen. Dan Med J. 2013 Sep;60(9):A4706. PMID: 24001467. Exclusion: 4. [PubMed: 24001467]
438.
Petrini JR, Dias T, McCormick MC, et al. Increased risk of adverse neurological development for late preterm infants. J Pediatr. 2009 Feb;154(2):169–76. doi: 10.1016/j.jpeds.2008.08.020. PMID: 19081113. Exclusion: 2. [PubMed: 19081113] [CrossRef]
439.
Pettker CM, Pocock SB, Smok DP, et al. Transcervical foley catheter with and without oxytocin for cervical ripening: a randomized controlled trial. Obstet Gynecol. 2008 Jun;111(6):1320–6. doi: 10.1097/AOG.0b013e31817615a0. PMID: 18515515. Exclusion: 2. [PubMed: 18515515] [CrossRef]
440.
Pevzner L, Alfirevic Z, Powers BL, et al. Cardiotocographic abnormalities associated with misoprostol and dinoprostone cervical ripening and labor induction. Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):144–8. doi: 10.1016/j.ejogrb.2011.01.015. PMID: 21353372. Exclusion: 2. [PubMed: 21353372] [CrossRef]
441.
Pevzner L, Powers BL, Rayburn WF, et al. Effects of maternal obesity on duration and outcomes of prostaglandin cervical ripening and labor induction. Obstet Gynecol. 2009 Dec;114(6):1315–21. doi: 10.1097/AOG.0b013e3181bfb39f. PMID: 19935035. Exclusion: 4. [PubMed: 19935035] [CrossRef]
442.
Pfutzenreuter GR, Cavalieri JC, Fragoso APO, et al. Factors associated with intrapartum cesarean section in women submitted to labor induction. Rev. 2019 Jun;41(6):363–70. doi: 10.1055/s-0039-1688966. PMID: 31247664. Exclusion: 1. [PMC free article: PMC10316804] [PubMed: 31247664] [CrossRef]
443.
Politz LB, Chez RA, Parsons MT, et al. The effect of a pill inserter on vaginal misoprostol dosing. J Matern Fetal Med. 2001 Oct;10(5):332–4. PMID: 11730497. Exclusion: 4. [PubMed: 11730497]
444.
Poma S, Scudeller L, Gardella B, et al. Outcomes of induced versus spontaneous labor. J Matern Fetal Neonatal Med. 2017 May;30(10):1133–8. doi: 10.1080/14767058.2016.1205028. PMID: 27406914. Exclusion: 2. [PubMed: 27406914] [CrossRef]
445.
Poulsen HK, Moller LK, Westergaard JG, et al. Open randomized comparison of prostaglandin E2 given by intracervical gel or vagitory for preinduction cervical ripening and induction of labor. Acta Obstet Gynecol Scand. 1991;70(7–8):549–53. doi: 10.3109/00016349109007915. PMID: 1785269. Exclusion: 4. [PubMed: 1785269] [CrossRef]
446.
Prager M, Eneroth-Grimfors E, Edlund M, et al. A randomised controlled trial of intravaginal dinoprostone, intravaginal misoprostol and transcervical balloon catheter for labour induction. BJOG. 2008 Oct;115(11):1443–50. doi: 10.1111/j.1471-0528.2008.01843.x. PMID: 18715244. Exclusion: 4. [PubMed: 18715244] [CrossRef]
447.
Prameela, Sharma KD. Comparison between use of oral misoprostol versus vaginal misoprostol for induction of labour at term. J Obstet Gynaecol India. 2018 Apr;68(2):88–92. doi: 10.1007/s13224-017-0978-3. PMID: 29662276. Exclusion: 4. [PMC free article: PMC5895553] [PubMed: 29662276] [CrossRef]
448.
Prasad RN, Adaikan PG, Arulkumaran S, et al. Preinduction cervical priming with PGE2 vaginal film in primigravidae--a randomised, double blind, placebo controlled study. Prostaglandins Leukot Essent Fatty Acids. 1989 Jun;36(3):185–8. doi: 10.1016/0952-3278(89)90060-4. PMID: 2780762. Exclusion: 4. [PubMed: 2780762] [CrossRef]
449.
Prata N, Mbaruku G, Grossman AA, et al. Community-based availability of misoprostol: is it safe? Afr J Reprod Health. 2009 Jun;13(2):117–28. PMID: 20690255. Exclusion: 1. [PubMed: 20690255]
450.
Prosser SJ, Barnett AG, Miller YD. Factors promoting or inhibiting normal birth. BMC Pregnancy Childbirth. 2018 Jun 18;18(1):241. doi: 10.1186/s12884-018-1871-5. PMID: 29914395. Exclusion: 1. [PMC free article: PMC6006773] [PubMed: 29914395] [CrossRef]
451.
Qazi Q, Fatima SS, Wahab S, et al. Efficacy of misoprostol and prostaglandin E2 gel for induction of labor in term pregnancy. Journal of Postgraduate Medical Institute. 2019;33(4):331–6. Exclusion: 1.
452.
Rahman H, Pradhan A, Kharka L, et al. Comparative evaluation of 50 microgram oral misoprostol and 25 microgram intravaginal misoprostol for induction of labour at term: a randomized trial. J Obstet Gynaecol Can. 2013 May;35(5):408–16. doi: 10.1016/S1701-2163(15)30931-2. PMID: 23756271. Exclusion: 4. [PubMed: 23756271] [CrossRef]
453.
Ramsey PS, Harris DY, Ogburn PL, Jr., et al. Comparative efficacy and cost of the prostaglandin analogs dinoprostone and misoprostol as labor preinduction agents. Am J Obstet Gynecol. 2003 Feb;188(2):560–5. doi: 10.1067/mob.2003.150. PMID: 12592272. Exclusion: 4. [PubMed: 12592272] [CrossRef]
454.
Ramsey PS, Meyer L, Walkes BA, et al. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstet Gynecol. 2005 Jan;105(1):85–90. doi: 10.1097/01.AOG.0000146638.51536.09. PMID: 15625147. Exclusion: 4. [PubMed: 15625147] [CrossRef]
455.
Rane SM, Guirgis RR, Higgins B, et al. The value of ultrasound in the prediction of successful induction of labor. Ultrasound Obstet Gynecol. 2004 Oct;24(5):538–49. doi: 10.1002/uog.1100. PMID: 15386612. Exclusion: 2. [PubMed: 15386612] [CrossRef]
456.
Rankin K, Chodankar R, Raymond K, et al. Misoprostol vaginal insert versus dinoprostone vaginal insert: a comparison of labour and delivery outcomes. Eur J Obstet Gynecol Reprod Biol. 2019 Apr;235:93–6. doi: 10.1016/j.ejogrb.2018.07.025. PMID: 30122321. Exclusion: 4. [PubMed: 30122321] [CrossRef]
457.
Rasheed R, Alam AA, Younus S, et al. Oral versus vaginal misoprostol for labour induction. J Pak Med Assoc. 2007 Aug;57(8):404–7. PMID: 17902524. Exclusion: 4. [PubMed: 17902524]
458.
Rath W. A clinical evaluation of controlled-release dinoprostone for cervical ripening--a review of current evidence in hospital and outpatient settings. J Perinat Med. 2005;33(6):491–9. doi: 10.1515/JPM.2005.087. PMID: 16318611. Exclusion: 5. [PubMed: 16318611] [CrossRef]
459.
Rath WH. Outpatient induction -- how safe. J Perinat Med. 2009;37(5):461–7. doi: 10.1515/JPM.2009.086. PMID: 19492924. Exclusion: 9. [PubMed: 19492924] [CrossRef]
460.
Rauf Z, Alfirevic Z. Outpatient approaches to elective induction of labor: past, present, and future. Clin Obstet Gynecol. 2014 Jun;57(2):391–400. doi: 10.1097/GRF.0000000000000028. PMID: 24662772. Exclusion: 9. [PubMed: 24662772] [CrossRef]
461.
Rauf Z, O’Brien E, Stampalija T, et al. Home labour induction with retrievable prostaglandin pessary and continuous telemetric trans-abdominal fetal ECG monitoring. PLoS ONE. 2011;6(11):e28129. doi: 10.1371/journal.pone.0028129. PMID: 22140522. Exclusion: 5. [PMC free article: PMC3225384] [PubMed: 22140522] [CrossRef]
462.
Rayburn W, Gosen R, Ramadei C, et al. Outpatient cervical ripening with prostaglandin E2 gel in uncomplicated postdate pregnancies. Am J Obstet Gynecol. 1988 Jun;158(6 Pt 1):1417–23. doi: 10.1016/0002-9378(88)90376-6. PMID: 3289398. Exclusion: 4. [PubMed: 3289398] [CrossRef]
463.
Rayburn W, Woods R, Ramadei C. Intravaginal prostaglandin E2 gel and cardiovascular changes in hypertensive pregnancies. Am J Perinatol. 1991 Jul;8(4):233–5. doi: 10.1055/s-2007-999385. PMID: 1741863. Exclusion: 4. [PubMed: 1741863] [CrossRef]
464.
Rhoades JS, Stout MJ, Macones GA, et al. Effect of oligohydramnios on fetal heart rate patterns during term labor induction. Am J Perinatol. 2019 Jun;36(7):715–22. doi: 10.1055/s-0038-1675152. PMID: 30372774. Exclusion: 5. [PubMed: 30372774] [CrossRef]
465.
Rindfuss RR, Gortmaker SL, Ladinsky JL. Elective induction and stimulation of labor and the health of the infant. Am J Public Health. 1978 Sep;68(9):872–8. doi: 10.2105/ajph.68.9.872. PMID: 686212. Exclusion: 2. [PMC free article: PMC1654048] [PubMed: 686212] [CrossRef]
466.
Rix P, Ladehoff P, Moller AM, et al. Cervical ripening and induction of delivery by local administration of prostaglandin E2 gel or vaginal tablets is equally effective. Acta Obstet Gynecol Scand. 1996 Jan;75(1):45–7. doi: 10.3109/00016349609033282. PMID: 8560996. Exclusion: 2. [PubMed: 8560996] [CrossRef]
467.
Roberts G. Induction of labour using prostaglandins. J Reprod Fertil. 1970 Nov;23(2):370–1. doi: 10.1530/jrf.0.0230370. PMID: 4921306. Exclusion: 4. [PubMed: 4921306] [CrossRef]
468.
Roberts WE, Martin RW, Roach HH, et al. Are obstetric interventions such as cervical ripening, induction of labor, amnioinfusion, or amniotomy associated with umbilical cord prolapse? Am J Obstet Gynecol. 1997 Jun;176(6):1181–3; discussion 3–5. doi: 10.1016/s0002-9378(97)70332-6. PMID: 9215171. Exclusion: 4. [PubMed: 9215171] [CrossRef]
469.
Rosenbloom JI, Tuuli MG, Stout MJ, et al. A prediction model for severe maternal morbidity in laboring patients at term. Am J Perinatol. 2019;36(1):8–14. doi: 10.1055/s-0038-1626716. PMID: 134051871. Exclusion: 5. [PubMed: 29528468] [CrossRef]
470.
Rouben D, Arias F. A randomized trial of extra-amniotic saline infusion plus intracervical foley catheter balloon versus prostaglandin E2 vaginal gel for ripening the cervix and inducing labor in patients with unfavorable cervices. Obstet Gynecol. 1993 Aug;82(2):290–4. PMID: 8336880. Exclusion: 4. [PubMed: 8336880]
471.
Rouzi AA, Alsahly N, Alamoudi R, et al. Randomized clinical trial between hourly titrated and 2 hourly static oral misoprostol solution for induction of labor. Am J Obstet Gynecol. 2017 Apr;216(4):405.e1–.e6. doi: 10.1016/j.ajog.2016.11.1054. PMID: 27986461. Exclusion: 4. [PubMed: 27986461] [CrossRef]
472.
Rouzi AA, Alsibiani S, Mansouri N, et al. Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor. Am J Obstet Gynecol. 2014 Jan;210(1):56.e1–6. doi: 10.1016/j.ajog.2013.08.033. PMID: 23999422. Exclusion: 4. [PubMed: 23999422] [CrossRef]
473.
Rowlands S, Bell R, Donath S, et al. Misoprostol versus dinoprostone for cervical priming prior to induction of labour in term pregnancy: a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2001 May;41(2):145–52. doi: 10.1111/j.1479-828x.2001.tb01199.x. PMID: 11453262. Exclusion: 3. [PubMed: 11453262] [CrossRef]
474.
Roztocil A, Pilka L, Jelinek J, et al. A comparison of three preinduction cervical priming methods: prostaglandin E2 gel, dilapan S rods and estradiol gel. Ceska Gynekol. 1998 Feb;63(1):3–9. PMID: 9650373. Exclusion: 7. [PubMed: 9650373]
475.
Rugarn O, Tipping D, Powers B, et al. Induction of labour with retrievable prostaglandin vaginal inserts: outcomes following retrieval due to an intrapartum adverse event. BJOG. 2017 Apr;124(5):796–803. doi: 10.1111/1471-0528.14147. PMID: 27307397. Exclusion: 4. [PMC free article: PMC5396314] [PubMed: 27307397] [CrossRef]
476.
Runsewe-Abiodun IT, Ogunfowora OB, Fetuga BM. Neonatal malaria in Nigeria--a 2 year review. BMC Pediatr. 2006 Jun 12;6:19. doi: 10.1186/1471-2431-6-19. PMID: 16768801. Exclusion: 1. [PMC free article: PMC1523330] [PubMed: 16768801] [CrossRef]
477.
Rust OA, Greybush M, Atlas RO, et al. Preinduction cervical ripening. A randomized trial of intravaginal misoprostol alone vs. a combination of transcervical foley balloon and intravaginal misoprostol. J Reprod Med. 2001 Oct;46(10):899–904. PMID: 11725734. Exclusion: 4. [PubMed: 11725734]
478.
Rydhstrom H, Ingemarsson I. No benefit from conservative management in nulliparous women with premature rupture of the membranes (PROM) at term. A randomized study. Acta Obstet Gynecol Scand. 1991;70(7–8):543–7. PMID: 1785268. Exclusion: 4. [PubMed: 1785268]
479.
Rzepka R, Torbe A, Kwiatkowski S, et al. Clinical outcomes of high-risk labours monitored using fetal electrocardiography. Ann Acad Med Singapore. 2010 Jan;39(1):27–32. PMID: 20126811. Exclusion: 1. [PubMed: 20126811]
480.
Saad AF, Villarreal J, Eid J, et al. A randomized controlled trial of dilapan-S vs foley balloon for preinduction cervical ripening (DILAFOL trial). Am J Obstet Gynecol. 2019 Mar;220(3):275.e1–.e9. doi: 10.1016/j.ajog.2019.01.008. PMID: 30790569. Exclusion: 4. [PubMed: 30790569] [CrossRef]
481.
Saeed GA, Fakhar S, Nisar N, et al. Misoprostol for term labor induction: a randomized controlled trial. Taiwan J Obstet Gynecol. 2011 Mar;50(1):15–9. doi: 10.1016/j.tjog.2009.08.001. PMID: 21482368. Exclusion: 4. [PubMed: 21482368] [CrossRef]
482.
Sahin HG, Sahin HA, Kocer M. Induction of labor in toxemia with misoprostol. Acta Obstet Gynecol Scand. 2002 Mar;81(3):252–7. doi: 10.1034/j.1600-0412.2002.810311.x. PMID: 11966483. Exclusion: 2. [PubMed: 11966483] [CrossRef]
483.
Sajjad N, Ali S, Hassan S, et al. Determine the outcome of labour induction and compare the results between misoprostol and oxytocin in post-date pregnancy. Pakistan Journal of Medical and Health Sciences. 2020;14(1):35–7. Exclusion: 1.
484.
Salamalekis E, Vitoratos N, Loghis C, et al. Evaluation of non-reassuring fetal heart rate patterns with fetal pulse oximetry combined with vibratory acoustic stimulation. J Matern Fetal Neonatal Med. 2003 Feb;13(2):110–4. doi: 10.1080/jmf.13.2.110.114. PMID: 12735411. Exclusion: 1. [PubMed: 12735411] [CrossRef]
485.
Salmon YM, Kee WH, Tan SL, et al. Cervical ripening by breast stimulation. Obstet Gynecol. 1986 Jan;67(1):21–4. PMID: 3940333. Exclusion: 2. [PubMed: 3940333]
486.
Sanchez-Ramos L, Chen AH, Kaunitz AM, et al. Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study. Obstet Gynecol. 1997 Jun;89(6):909–12. doi: 10.1016/s0029-7844(97)00113-0. PMID: 9170463. Exclusion: 2. [PubMed: 9170463] [CrossRef]
487.
Sanchez-Ramos L, Kaunitz AM. Misoprostol for cervical ripening and labor induction: a systematic review of the literature. Clin Obstet Gynecol. 2000 Sep;43(3):475–88. doi: 10.1097/00003081-200009000-00008. PMID: 10949752. Exclusion: 9. [PubMed: 10949752] [CrossRef]
488.
Sanchez-Ramos L, Kaunitz AM, Del Valle GO, et al. Labor induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial. Obstet Gynecol. 1993 Mar;81(3):332–6. PMID: 8437780. Exclusion: 2. [PubMed: 8437780]
489.
Sareen S, Chawla I, Singh P. Labor induction with 50 μg vaginal misoprostol: can we reduce induction-delivery intervals safely? J Obstet Gynaecol India. 2014;64(4):270–3. doi: 10.1007/s13224-014-0521-8. Exclusion: 4. [PMC free article: PMC4126944] [PubMed: 25136173] [CrossRef]
490.
Sarvanan N, Jha N, Dhodapkar SB, et al. Fetomaternal outcome in medically indicated induction of labour at term gestation. J Clin Diagn Res. 2017;11(11):QC21–QC4. doi: 10.7860/JCDR/2017/30431.10872. Exclusion: 4. [CrossRef]
491.
Sasaki K, Nakano R, Kadoya Y, et al. Cervical ripening with dehydroepiandrosterone sulphate. Br J Obstet Gynaecol. 1982 Mar;89(3):195–8. doi: 10.1111/j.1471-0528.1982.tb03612.x. PMID: 6461353. Exclusion: 2. [PubMed: 6461353] [CrossRef]
492.
Sawai SK, O’Brien WF. Outpatient cervical ripening. Clin Obstet Gynecol. 1995 Jun;38(2):301–9. doi: 10.1097/00003081-199506000-00013. PMID: 7554598. Exclusion: 9. [PubMed: 7554598] [CrossRef]
493.
Schaal NK, Fehm T, Albert J, et al. Comparing birth experience and birth outcome of vaginal births between induced and spontaneous onset of labour: a prospective study. Arch Gynecol Obstet. 2019 07;300(1):41–7. doi: 10.1007/s00404-019-05150-8. PMID: 30976970. Exclusion: 1. [PubMed: 30976970] [CrossRef]
494.
Scher J, Davey DA, Baillie P, et al. A comparison of prostaglandin F2 alpha and oxytocin in the induction of labour. S Afr Med J. 1972 Dec 23;46(51):2009–12. PMID: 4651882. Exclusion: 4. [PubMed: 4651882]
495.
Scher J, Dryden P, Davey DA. Induction of labour with buccal prostaglandin E2. Br Med J. 1976 Apr 03;1(6013):812–3. doi: 10.1136/bmj.1.6013.812-a. PMID: 1260346. Exclusion: 6. [PMC free article: PMC1639467] [PubMed: 1260346] [CrossRef]
496.
Schirm E, Tobi H, de Jong-van den Berg LT. Low use of medication in home deliveries in the Netherlands. Int J Gynaecol Obstet. 2002 Oct;79(1):5–9. doi: 10.1016/s0020-7292(02)00173-x. PMID: 12399084. Exclusion: 1. [PubMed: 12399084] [CrossRef]
497.
Schmidt M, Neophytou M, Hars O, et al. Clinical experience with misoprostol vaginal insert for induction of labor: a prospective clinical observational study. Arch Gynecol Obstet. 2019 Jan;299(1):105–12. doi: 10.1007/s00404-018-4942-y. PMID: 30374645. Exclusion: 4. [PMC free article: PMC6328513] [PubMed: 30374645] [CrossRef]
498.
Sciscione A, Larkin M, O’Shea A, et al. Preinduction cervical ripening with the foley catheter and the risk of subsequent preterm birth. Am J Obstet Gynecol. 2004 Mar;190(3):751–4. doi: 10.1016/j.ajog.2003.10.696. PMID: 15042009. Exclusion: 4. [PubMed: 15042009] [CrossRef]
499.
Sciscione AC, Bedder CL, Hoffman MK, et al. The timing of adverse events with foley catheter preinduction cervical ripening; implications for outpatient use. Am J Perinatol. 2014 Oct;31(9):781–6. doi: 10.1055/s-0033-1359718. PMID: 24347259. Exclusion: 4. [PubMed: 24347259] [CrossRef]
500.
Sciscione AC, McCullough H, Manley JS, et al. A prospective, randomized comparison of foley catheter insertion versus intracervical prostaglandin E2 gel for preinduction cervical ripening. Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):55–60. doi: 10.1016/s0002-9378(99)70149-3. PMID: 9914578. Exclusion: 4. [PubMed: 9914578] [CrossRef]
501.
Sciscione AC, Nguyen L, Manley J, et al. A randomized comparison of transcervical foley catheter to intravaginal misoprostol for preinduction cervical ripening. Obstet Gynecol. 2001 Apr;97(4):603–7. doi: 10.1016/s0029-7844(00)01186-8. PMID: 11275035. Exclusion: 4. [PubMed: 11275035] [CrossRef]
502.
Seeras RC. Induction of labor utilizing vaginal vs. intracervical prostaglandin E2. Int J Gynaecol Obstet. 1995 Feb;48(2):163–7. doi: 10.1016/0020-7292(94)02260-6. PMID: 7789590. Exclusion: 4. [PubMed: 7789590] [CrossRef]
503.
Seeras RC, Olatunbosun OA, Pierson RA, et al. Induction of labor using prostaglandin E2 (PGE2) vaginal gel in triacetin base. An efficacy study comparing two dosage regimens. Clin Exp Obstet Gynecol. 1995;22(2):105–10. PMID: 7781174. Exclusion: 4. [PubMed: 7781174]
504.
Sennik BK. Outpatient use of a sustained-release PGE2 vaginal insert - a retrospective study. Today’s Therapeutic Trends. 2001;19(2):77–84. Exclusion: 5.
505.
Shaheen N, Khalil S. Misoprostol versus dinoprostone for induction of labor at term: a randomized controlled trial. Rawal Medical Journal. 2014 Nov 4;39(3):307–10. PMID: 01002078. Exclusion: 4.
506.
Shakya R, Shrestha J, Thapa P. Safety and efficacy of misoprostol and dinoprostone as cervical ripening agents. JNMA J Nepal Med Assoc. 2010 Jan–Mar;49(177):33–7. PMID: 21180218. Exclusion: 4. [PubMed: 21180218]
507.
Sharami SH, Milani F, Faraji R, et al. Comparison of 25 micro g sublingual and 50 micro g intravaginal misoprostol for cervical ripening and labor: a randomized controlled equivalence trial. Arch Iran Med. 2014 Oct;17(10):652–6. doi: 0141710/AIM.003. PMID: 25305762. Exclusion: 4. [PubMed: 25305762]
508.
Sharma C, Soni A, Gupta A, et al. Mifepristone vs balloon catheter for labor induction in previous cesarean: a randomized controlled trial. Arch Gynecol Obstet. 2017 Aug;296(2):241–8. doi: 10.1007/s00404-017-4431-8. PMID: 28624988. Exclusion: 2. [PubMed: 28624988] [CrossRef]
509.
Sharma Y, Kumar S, Mittal S, et al. Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. J Obstet Gynaecol Res. 2005 Jun;31(3):210–5. doi: 10.1111/j.1447-0756.2005.00271.x. PMID: 15916656. Exclusion: 2. [PubMed: 15916656] [CrossRef]
510.
Sharp AN, Stock SJ, Alfirevic Z. Outpatient induction of labour in the UK: a survey of practice. Eur J Obstet Gynecol Reprod Biol. 2016 Sep;204:21–3. doi: 10.1016/j.ejogrb.2016.06.023. PMID: 27513897. Exclusion: 5. [PubMed: 27513897] [CrossRef]
511.
Shechter-Maor G, Haran G, Sadeh-Mestechkin D, et al. Intra-vaginal prostaglandin E2 versus double-balloon catheter for labor induction in term oligohydramnios. J Perinatol. 2015 Feb;35(2):95–8. doi: 10.1038/jp.2014.173. PMID: 25275693. Exclusion: 1. [PubMed: 25275693] [CrossRef]
512.
Sheikher C, Suri N, Kholi U. Comparative evaluation of oral misoprostol, vaginal misoprostol and intracervical folley’s catheter for induction of labour at term. JK Science. 2009;11(2):75–7. Exclusion: 4.
513.
Sheiner E, Levy A, Feinstein U, et al. Risk factors and outcome of failure to progress during the first stage of labor: a population-based study. Acta Obstet Gynecol Scand. 2002 Mar;81(3):222–6. PMID: 11966478. Exclusion: 4. [PubMed: 11966478]
514.
Shetty A, Danielian P, Templeton A. Sublingual misoprostol for the induction of labor at term. Am J Obstet Gynecol. 2002 Jan;186(1):72–6. doi: 10.1067/mob.2002.118917. PMID: 11810088. Exclusion: 4. [PubMed: 11810088] [CrossRef]
515.
Shetty A, Livingston I, Acharya S, et al. Vaginal prostaglandin E2 gel versus tablet in the induction of labour at term--a retrospective analysis. J Obstet Gynaecol. 2004 Apr;24(3):243–6. doi: 10.1080/01443610410001660706. PMID: 15203616. Exclusion: 4. [PubMed: 15203616] [CrossRef]
516.
Shime J, Gare DJ, Andrews J, et al. Prolonged pregnancy: surveillance of the fetus and the neonate and the course of labor and delivery. Am J Obstet Gynecol. 1984 Mar 01;148(5):547–52. doi: 10.1016/0002-9378(84)90745-2. PMID: 6702916. Exclusion: 1. [PubMed: 6702916] [CrossRef]
517.
Sichitiu J, Vial Y, Panchaud A, et al. Tachysystole and risk of cesarean section after labor induction using misoprostol: A cohort study. Eur J Obstet Gynecol Reprod Biol. 2020 Jun;249:54–8. doi: 10.1016/j.ejogrb.2020.04.026. PMID: 32361173. Exclusion: 1. [PubMed: 32361173] [CrossRef]
518.
Sifakis S, Angelakis E, Avgoustinakis E, et al. A randomized comparison between intravaginal misoprostol and prostaglandin E2 for labor induction. Arch Gynecol Obstet. 2007 Apr;275(4):263–7. doi: 10.1007/s00404-006-0258-4. PMID: 17028904. Exclusion: 4. [PubMed: 17028904] [CrossRef]
519.
Silfeler DB, Tandogan B, Ayvaci H, et al. A comparison of misoprostol, controlled-release dinoprostone vaginal insert and oxytocin for cervical ripening. Arch Gynecol Obstet. 2011 Dec;284(6):1331–7. doi: 10.1007/s00404-011-1844-7. PMID: 21290140. Exclusion: 2. [PubMed: 21290140] [CrossRef]
520.
Singh T, Sankaran S, Thilaganathan B, et al. The prediction of intra-partum fetal compromise in prolonged pregnancy. J Obstet Gynaecol. 2008 Nov;28(8):779–82. doi: 10.1080/01443610802431857. PMID: 19085543. Exclusion: 2. [PubMed: 19085543] [CrossRef]
521.
Sinkey RG, Blanchard CT, Szychowski JM, et al. Elective induction of labor in the 39th week of gestation compared with expectant management of low-risk multiparous women. Obstet Gynecol. 2019 08;134(2):282–7. doi: 10.1097/AOG.0000000000003371. PMID: 31306328. Exclusion: 1. [PubMed: 31306328] [CrossRef]
522.
Skinner J, Greene RA, Gardeil F, et al. Does increased resistance on umbilical artery doppler preclude a trial of labour? Eur J Obstet Gynecol Reprod Biol. 1998 Jul;79(1):35–8. doi: 10.1016/s0301-2115(98)00034-7. PMID: 9643400. Exclusion: 1. [PubMed: 9643400] [CrossRef]
523.
Smith CV, Eglinton GS. Cervical ripening. A retrospective experience with prostaglandin E2 “chips”. J Reprod Med. 1990 Apr;35(4):388–90. PMID: 2352231. Exclusion: 4. [PubMed: 2352231]
524.
Smith LK. Outpatient induction of labour with prostaglandins: safety, effectiveness and women’s views. Br J Midwifery. 2017;25(12):774–82. doi: 10.12968/bjom.2017.25.12.774. PMID: 126675004. Exclusion: 9. [CrossRef]
525.
Soilemetzidis M, Pinidis P, Tsagias N, et al. The effectiveness of misoprostol or dinoprostone in neonatal outcome after labour induction in post-term nulliparas. Clin Exp Obstet Gynecol. 2015;42(5):649–52. PMID: 26524816. Exclusion: 1. [PubMed: 26524816]
526.
Solone M, Shaw KA. Induction of labor with an unfavorable cervix. Curr Opin Obstet Gynecol. 2020 Apr;32(2):107–12. doi: 10.1097/GCO.0000000000000608. PMID: 32004172. Exclusion: 5. [PubMed: 32004172] [CrossRef]
527.
Son GH, Kim JH, Kwon JY, et al. Risk factors for cesarean delivery after induction of labor in nulliparous women with an unfavorable cervix at or beyond 41 weeks of gestation. Gynecol Obstet Invest. 2013;76(4):254–9. doi: 10.1159/000350798. PMID: 24192506. Exclusion: 4. [PubMed: 24192506] [CrossRef]
528.
Son SL, Benson AE, Hart Hayes E, et al. Outpatient cervical ripening: a cost-minimization and threshold analysis. Am J Perinatol. 2020 Feb;37(3):245–51. doi: 10.1055/s-0039-1694791. PMID: 31430827. Exclusion: 3. [PubMed: 31430827] [CrossRef]
529.
Soni S, Pappas K, Lesser ML, et al. Is vaginal misoprostol more effective than oral misoprostol for cervical ripening in obese women? J Matern Fetal Neonatal Med. 2019 Feb 10:1–8. doi: 10.1080/14767058.2019.1575684. PMID: 30741048. Exclusion: 4. [PubMed: 30741048] [CrossRef]
530.
Soriano D, Vicus D, Schonman R, et al. Long-term outcome after laparoscopic treatment of heterotopic pregnancy: 19 cases. J Minim Invasive Gynecol. 2010 May–Jun;17(3):321–4. doi: 10.1016/j.jmig.2010.01.016. PMID: 20417422. Exclusion: 2. [PubMed: 20417422] [CrossRef]
531.
Sorokin Y, Hallak M, Klein O, et al. Effects of induction of labor with prostaglandin E2 on fetal breathing and body movements: controlled, randomized, double-blind study. Obstet Gynecol. 1992 Nov;80(5):788–91. PMID: 1407917. Exclusion: 4. [PubMed: 1407917]
532.
Souza AS, Feitosa FE, Costa AA, et al. Titrated oral misoprostol solution versus vaginal misoprostol for labor induction. Int J Gynaecol Obstet. 2013 Dec;123(3):207–12. doi: 10.1016/j.ijgo.2013.06.028. PMID: 24112746. Exclusion: 4. [PubMed: 24112746] [CrossRef]
533.
Spallicci MD, Chiea MA, Singer JM, et al. Use of hyaluronidase for cervical ripening: a randomized trial. Eur J Obstet Gynecol Reprod Biol. 2007 Jan;130(1):46–50. doi: 10.1016/j.ejogrb.2005.10.028. PMID: 16324780. Exclusion: 2. [PubMed: 16324780] [CrossRef]
534.
Sparks TN, Yeaton-Massey A, Granados JM, et al. How do maternal views of delivery outcomes vary by demographics and preferred mode of delivery? Am J Perinatol. 2015 Jul;32(8):741–6. doi: 10.1055/s-0034-1395480. PMID: 25519201. Exclusion: 2. [PubMed: 25519201] [CrossRef]
535.
Srisomboon J, Tongsong T, Tosiri V. Preinduction cervical ripening with intravaginal prostaglandin E1 methyl analogue misoprostol: a randomized controlled trial. J Obstet Gynaecol Res. 1996 Apr;22(2):119–24. PMID: 8697339. Exclusion: 4. [PubMed: 8697339]
536.
St Onge RD, Connors GT. Preinduction cervical ripening: a comparison of intracervical prostaglandin E2 gel versus the foley catheter. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):687–90. doi: 10.1016/0002-9378(95)90594-4. PMID: 7856707. Exclusion: 4. [PubMed: 7856707] [CrossRef]
537.
Stampe Sorensen S, Palmgren Colov N, Andreasson B, et al. Induction of labor by vaginal prostaglandin E2. A randomized study comparing pessaries with vaginal tablets. Acta Obstet Gynecol Scand. 1992 Apr;71(3):201–6. doi: 10.3109/00016349209009919. PMID: 1317643. Exclusion: 4. [PubMed: 1317643] [CrossRef]
538.
Steegers EA, Theunissen RP, Nijdam WS, et al. Obstetrical policy during labor and perinatal results: a comparison between two university clinics. Eur J Obstet Gynecol Reprod Biol. 1986 Nov;23(3–4):225–31. doi: 10.1016/0028-2243(86)90151-6. PMID: 3817264. Exclusion: 1. [PubMed: 3817264] [CrossRef]
539.
Stefos T, Sotiriadis A, Tsirkas P, et al. Evaluation of fetal heart monitoring in the first stage of labor. J Matern Fetal Med. 2001 Feb;10(1):48–51. doi: 10.1080/714052716. PMID: 11332420. Exclusion: 1. [PubMed: 11332420] [CrossRef]
540.
Stephenson E, Borakati A, Simpson I, et al. Foley catheter for induction of labour: a UK observational study. J Obstet Gynaecol. 2019 Dec 03:1–5. doi: 10.1080/01443615.2019.1676213. PMID: 31793372. Exclusion: 2. [PubMed: 31793372] [CrossRef]
541.
Stephenson ML, Powers BL, Wing DA. Fetal heart rate and cardiotocographic abnormalities with varying dose misoprostol vaginal inserts. J Matern Fetal Neonatal Med. 2013 Apr;26(2):127–31. PMID: 00862882. Exclusion: 4. [PubMed: 22712609]
542.
Stephenson ML, Wing DA. A novel misoprostol delivery system for induction of labor: clinical utility and patient considerations. Drug Des Devel Ther. 2015;9:2321–7. doi: 10.2147/DDDT.S64227. PMID: 25960635. Exclusion: 9. [PMC free article: PMC4410824] [PubMed: 25960635] [CrossRef]
543.
Steward R, Melamed A, Kim R, et al. Infection and extramural delivery with use of digoxin as a feticidal agent. Contraception. 2012 Feb;85(2):150–4. doi: 10.1016/j.contraception.2011.01.005. PMID: 22067811. Exclusion: 1. [PubMed: 22067811] [CrossRef]
544.
Stewart JD, Rayburn WF, Farmer KC, et al. Effectiveness of prostaglandin E2 intracervical gel (Prepidil), with immediate oxytocin, versus vaginal insert (Cervidil) for induction of labor. Am J Obstet Gynecol. 1998 Nov;179(5):1175–80. PMID: 9822496. Exclusion: 4. [PubMed: 9822496]
545.
Stewart P, Kennedy JH, Barlow DH, et al. A comparison of oestradiol and prostaglandin E2 for ripening the cervix. Br J Obstet Gynaecol. 1981 Mar;88(3):236–9. doi: 10.1111/j.1471-0528.1981.tb00974.x. PMID: 7470413. Exclusion: 2. [PubMed: 7470413] [CrossRef]
546.
Stewart RD, Bleich AT, Lo JY, et al. Defining uterine tachysystole: how much is too much? Am J Obstet Gynecol. 2012 Oct;207(4):290.e1–6. doi: 10.1016/j.ajog.2012.07.032. PMID: 22901710. Exclusion: 4. [PubMed: 22901710] [CrossRef]
547.
Stirrat GM, Thomas TA. Prescribing for labour. Clin Obstet Gynaecol. 1986 Jun;13(2):215–29. PMID: 2873914. Exclusion: 9. [PubMed: 2873914]
548.
Stone JL, Lockwood CJ, Berkowitz G, et al. Use of cervical prostaglandin E2 gel in patients with previous cesarean section. Am J Perinatol. 1994 Jul;11(4):309–12. doi: 10.1055/s-2007-994600. PMID: 7945629. Exclusion: 4. [PubMed: 7945629] [CrossRef]
549.
Strobelt N, Meregalli V, Ratti M, et al. Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy. Acta Obstet Gynecol Scand. 2006;85(3):302–5. doi: 10.1080/00016340500523685. PMID: 16553177. Exclusion: 4. [PubMed: 16553177] [CrossRef]
550.
Suidan RS, Rondon KC, Apuzzio JJ, et al. Labor outcomes of obese patients undergoing induction of labor with misoprostol compared to dinoprostone. Am J Perinatol. 2015 Feb;30(2):187–92. doi: 10.1055/s-0034-1381721. PMID: 24915563. Exclusion: 4. [PubMed: 24915563] [CrossRef]
551.
Sulkowski C, Schneider F, Tessier V, et al. Interest of cervical ripening using double balloon catheters for labour induction in term nulliparous women. J Gynecol Obstet Hum Reprod. 2019 Oct;48(8):669–72. doi: 10.1016/j.jogoh.2019.05.004. PMID: 31075432. Exclusion: 1. [PubMed: 31075432] [CrossRef]
552.
Surita FG, Cecatti JG, Parpinelli MA, et al. Hyaluronidase versus foley catheter for cervical ripening in high-risk term and post term pregnancies. Int J Gynaecol Obstet. 2005 Mar;88(3):258–64. doi: 10.1016/j.ijgo.2004.12.006. PMID: 15733878. Exclusion: 2. [PubMed: 15733878] [CrossRef]
553.
Szczesny W, Sandvik L. Pre-induction cervical ripening with 25 microg and 50 microg vaginal misoprostol in 181 nulliparous parturients. J Matern Fetal Neonatal Med. 2009 Mar;22(3):265–8. doi: 10.1080/14767050902763142. PMID: 19330712. Exclusion: 4. [PubMed: 19330712] [CrossRef]
554.
Tabasi Z, Mesdaghinia E, Abedzadeh-Kalahroudi M, et al. Comparing the effects of vaginal misoprostol, laminaria, and extra amniotic saline infusion on cervical ripening and induction of labor. Obstet. 2020 May;63(3):261–9. doi: 10.5468/ogs.2020.63.3.261. PMID: 32489970. Exclusion: 1. [PMC free article: PMC7231950] [PubMed: 32489970] [CrossRef]
555.
Taher SE, Inder JW, Soltan SA, et al. Prostaglandin E2 vaginal gel or tablets for the induction of labour at term: a randomised controlled trial. BJOG. 2011 May;118(6):719–25. doi: 10.1111/j.1471-0528.2011.02901.x. PMID: 21429067. Exclusion: 4. [PubMed: 21429067] [CrossRef]
556.
Tan TC, Yan SY, Chua TM, et al. A randomised controlled trial of low-dose misoprostol and dinoprostone vaginal pessaries for cervical priming. BJOG. 2010 Sep;117(10):1270–7. doi: 10.1111/j.1471-0528.2010.02602.x. PMID: 20722643. Exclusion: 4. [PubMed: 20722643] [CrossRef]
557.
Tanir HM, Sener T, Yildiz C, et al. A prospective randomized trial of labor induction with vaginal controlled-release dinoprostone inserts with or without oxytocin and misoprostol+oxytocin. Clin Exp Obstet Gynecol. 2008;35(1):65–8. PMID: 18390085. Exclusion: 2. [PubMed: 18390085]
558.
Tanir HM, Sener T, Yildiz Z. Digital and transvaginal ultrasound cervical assessment for prediction of successful labor induction. Int J Gynaecol Obstet. 2008 Jan;100(1):52–5. doi: 10.1016/j.ijgo.2007.07.014. PMID: 17920604. Exclusion: 2. [PubMed: 17920604] [CrossRef]
559.
Tassone SA, Pearman CR, Rayburn WF. Outpatient cervical ripening using a sustained-release prostaglandin E2 vaginal insert. J Reprod Med. 2001 Jun;46(6):599–600. PMID: 11441687. Exclusion: 2. [PubMed: 11441687]
560.
Ten Eikelder ML, Mast K, van der Velden A, et al. Induction of labor using a foley catheter or misoprostol: a systematic review and meta-analysis. Obstet Gynecol Surv. 2016 Oct;71(10):620–30. doi: 10.1097/OGX.0000000000000361. PMID: 27770132. Exclusion: 9. [PubMed: 27770132] [CrossRef]
561.
Ten Eikelder ML, Neervoort F, Oude Rengerink K, et al. Induction of labour with a foley catheter or oral misoprostol at term: the PROBAAT-II study, a multicentre randomised controlled trial. BMC Pregnancy Childbirth. 2013 Mar 19;13:67. doi: 10.1186/1471-2393-13-67. PMID: 23506128. Exclusion: 5. [PMC free article: PMC3610263] [PubMed: 23506128] [CrossRef]
562.
Ten Eikelder ML, Oude Rengerink K, Jozwiak M, et al. Induction of labour at term with oral misoprostol versus a foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial. Lancet. 2016 Apr 16;387(10028):1619–28. doi: 10.1016/S0140-6736(16)00084-2. PMID: 26850983. Exclusion: 4. [PubMed: 26850983] [CrossRef]
563.
Thaisomboon A, Russameecharoen K, Wanitpongpan P, et al. Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. Int J Gynaecol Obstet. 2012 Jan;116(1):13–6. doi: 10.1016/j.ijgo.2011.07.027. PMID: 21959071. Exclusion: 4. [PubMed: 21959071] [CrossRef]
564.
Thiery M, Benijts G, Derom R, et al. Induction and augmentation of labor in hypertensive patients with intravenous prostaglandin E2. Z Geburtshilfe Perinatol. 1977 Oct;181(5):345–51. PMID: 605644. Exclusion: 4. [PubMed: 605644]
565.
Thiery M, Defoort P, Benijts G, et al. Fetal effects of cervical ripening with extra-amniotic prostaglandin E2 in gel. Prostaglandins. 1978 Jan;15(1):175–86. doi: 10.1016/s0090-6980(78)80016-1. PMID: 625571. Exclusion: 4. [PubMed: 625571] [CrossRef]
566.
Thiery M, Parewyck W, De Gezelle H, et al. Pre-induction ripening of the cervix with extra-amniotic prostaglandin E2 in gel. Z Geburtshilfe Perinatol. 1978 Oct;182(5):352–7. PMID: 735273. Exclusion: 8. [PubMed: 735273]
567.
Thomas IL, Chenoweth JN, Tronc GN, et al. Preparation for induction of labour of the unfavourable cervix with foley catheter compared with vaginal prostaglandin. Aust N Z J Obstet Gynaecol. 1986 Feb;26(1):30–5. doi: 10.1111/j.1479-828x.1986.tb01524.x. PMID: 3524549. Exclusion: 4. [PubMed: 3524549] [CrossRef]
568.
Thorbiornson A, Vladic T, Stjernholm YV. Oral versus vaginal prostaglandin for labor induction. J Matern Fetal Neonatal Med. 2017 Apr;30(7):789–92. doi: 10.1080/14767058.2016.1190823. PMID: 27186795. Exclusion: 4. [PubMed: 27186795] [CrossRef]
569.
Tomlinson AJ, Archer PA, Hobson S. Induction of labour: a comparison of two methods with particular concern to patient acceptability. J Obstet Gynaecol. 2001;21(3):239–41. doi: 10.1080/01443610120046314. Exclusion: 4. [PubMed: 12521850] [CrossRef]
570.
Toohill J, Flenady V, Lewis L, et al. Do models of care affect birthing outcomes for low risk women induced with PGE2 [corrected] [published errata appear in BIRTH ISSUES 2004;13(1):8A]. Birth Issues. 2004;13(1):5–10. PMID: 106593904. Exclusion: 4.
571.
Toohill J, Turkstra E, Gamble J, et al. A non-randomised trial investigating the cost-effectiveness of Midwifery Group Practice compared with standard maternity care arrangements in one Australian hospital. Midwifery. 2012 Dec;28(6):e874–9. doi: 10.1016/j.midw.2011.10.012. PMID: 22172743. Exclusion: 2. [PubMed: 22172743] [CrossRef]
572.
Toppozada MK, Anwar MY, Hassan HA, et al. Oral or vaginal misoprostol for induction of labor. Int J Gynaecol Obstet. 1997 Feb;56(2):135–9. doi: 10.1016/s0020-7292(96)02805-6. PMID: 9061387. Exclusion: 4. [PubMed: 9061387] [CrossRef]
573.
Tournier A, Clouqueur E, Drumez E, et al. Can we induce labor by mechanical methods following preterm premature rupture of membranes? J Gynecol Obstet Hum Reprod. 2020 May 15:101745. doi: 10.1016/j.jogoh.2020.101745. PMID: 32422363. Exclusion: 1. [PubMed: 32422363] [CrossRef]
574.
Tribe RM, Crawshaw SE, Seed P, et al. Pulsatile versus continuous administration of oxytocin for induction and augmentation of labor: two randomized controlled trials. Am J Obstet Gynecol. 2012 Mar;206(3):230.e1–8. doi: 10.1016/j.ajog.2011.11.001. PMID: 22206748. Exclusion: 2. [PubMed: 22206748] [CrossRef]
575.
Triglia MT, Palamara F, Lojacono A, et al. A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score < or = 4. Acta Obstet Gynecol Scand. 2010 May;89(5):651–7. doi: 10.3109/00016340903575998. PMID: 20199360. Exclusion: 4. [PubMed: 20199360] [CrossRef]
576.
Trofatter KF, Jr. Endocervical prostaglandin E2 gel for preinduction cervical ripening. Clinical trial results. J Reprod Med. 1993 Jan;38(1 Suppl):78–82. PMID: 8429531. Exclusion: 9. [PubMed: 8429531]
577.
Trofatter KF, Jr. Effect of preinduction cervical softening with dinoprostone gel on outcome of oxytocin-induced labor. Clin Ther. 1993 Sep–Oct;15(5):838–44. PMID: 8269450. Exclusion: 4. [PubMed: 8269450]
578.
Tromans PM, Beazley J, Shenouda PI. Comparative study of oestradiol and prostaglandin E2 vaginal gel for ripening the unfavourable cervix before induction of labour. Br Med J (Clin Res Ed). 1981 Feb 28;282(6265):679–81. doi: 10.1136/bmj.282.6265.679. PMID: 6781613. Exclusion: 2. [PMC free article: PMC1504503] [PubMed: 6781613] [CrossRef]
579.
Troostwijk AL, van Veen JB, Doesburg WH. Pre-induction intracervical application of a highly viscous prostaglandin E2 gel in pregnant women with an unripe uterine cervix: a double-blind placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol. 1992 Jan 31;43(2):105–11. doi: 10.1016/0028-2243(92)90066-8. PMID: 1563557. Exclusion: 2. [PubMed: 1563557] [CrossRef]
580.
Tsikouras P, Koukouli Z, Manav B, et al. Induction of labor in post-term nulliparous and parous women - potential advantages of misoprostol over dinoprostone. Geburtshilfe Frauenheilkd. 2016 Jul;76(7):785–92. doi: 10.1055/s-0042-105287. PMID: 27582576. Exclusion: 4. [PMC free article: PMC5001574] [PubMed: 27582576] [CrossRef]
581.
Tuffnell DJ, Lilford RJ, Buchan PC, et al. Randomised controlled trial of day care for hypertension in pregnancy. Lancet. 1992 Jan 25;339(8787):224–7. doi: 10.1016/0140-6736(92)90017-w. PMID: 1346182. Exclusion: 1. [PubMed: 1346182] [CrossRef]
582.
Tukur J, Umar NI, Khan N, et al. Comparison of emergency caesarean section to misoprostol induction for the delivery of antepartum eclamptic patients: a pilot study. Niger J Med. 2007 Oct–Dec;16(4):364–7. doi: 10.4314/njm.v16i4.37339. PMID: 18080597. Exclusion: 8. [PubMed: 18080597] [CrossRef]
583.
Tulek F, Gemici A, Soylemez F. Double balloon catheters: A promising tool for induction of labor in multiparous women with unfavorable cervices. J. 2019 11 28;20(4):231–5. doi: 10.4274/jtgga.galenos.2018.2018.0084. PMID: 30222124. Exclusion: 1. [PMC free article: PMC6883752] [PubMed: 30222124] [CrossRef]
584.
Turner JE, Burke MS, Porreco RP, et al. Prostaglandin E2 in tylose gel for cervical ripening before induction of labor. J Reprod Med. 1987 Nov;32(11):815–21. PMID: 3480953. Exclusion: 4. [PubMed: 3480953]
585.
Ugwu EO, Onah HE, Obi SN, et al. Effect of the foley catheter and synchronous low dose misoprostol administration on cervical ripening: a randomised controlled trial. J Obstet Gynaecol. 2013 Aug;33(6):572–7. doi: 10.3109/01443615.2013.786030. PMID: 23919853. Exclusion: 4. [PubMed: 23919853] [CrossRef]
586.
Ulmsten U, Ekman G, Belfrage P, et al. Intracervical versus intravaginal PGE2 for induction of labor at term in patients with an unfavorable cervix. Arch Gynecol. 1985;236(4):243–8. doi: 10.1007/bf02133942. PMID: 3861138. Exclusion: 4. [PubMed: 3861138] [CrossRef]
587.
Ulmsten U, Wingerup L, Belfrage P, et al. Intracervical application of prostaglandin gel for induction of term labor. Obstet Gynecol. 1982 Mar;59(3):336–9. PMID: 7043341. Exclusion: 4. [PubMed: 7043341]
588.
van Baaren GJ, Jozwiak M, Opmeer BC, et al. Cost-effectiveness of induction of labour at term with a foley catheter compared to vaginal prostaglandin E2 gel (PROBAAT trial). BJOG. 2013 Jul;120(8):987–95. doi: 10.1111/1471-0528.12221. PMID: 23530729. Exclusion: 4. [PubMed: 23530729] [CrossRef]
589.
van der Ham DP, van der Heyden JL, Opmeer BC, et al. Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial. Am J Obstet Gynecol. 2012 Oct;207(4):276.e1–10. doi: 10.1016/j.ajog.2012.07.024. PMID: 22901981. Exclusion: 1. [PubMed: 22901981] [CrossRef]
590.
van Haaren-ten Haken TM, Hendrix M, Smits LJ, et al. The influence of preferred place of birth on the course of pregnancy and labor among healthy nulliparous women: a prospective cohort study. BMC Pregnancy Childbirth. 2015 Feb 14;15:33. doi: 10.1186/s12884-015-0455-x. PMID: 25884308. Exclusion: 1. [PMC free article: PMC4342224] [PubMed: 25884308] [CrossRef]
591.
Vannuccini S, Torricelli M, Bocchi C, et al. Fetal middle cerebral artery doppler in late-term pregnancy: a predicting factor for failed induction of labor. J Matern Fetal Neonatal Med. 2018 Oct;31(20):2756–62. doi: 10.1080/14767058.2017.1355900. PMID: 28743210. Exclusion: 2. [PubMed: 28743210] [CrossRef]
592.
Varaklis K, Gumina R, Stubblefield PG. Randomized controlled trial of vaginal misoprostol and intracervical prostaglandin E2 gel for induction of labor at term. Obstet Gynecol. 1995 Oct;86(4 Pt 1):541–4. doi: 10.1016/0029-7844(95)00231-f. PMID: 7675376. Exclusion: 4. [PubMed: 7675376] [CrossRef]
593.
Vardo JH, Thornburg LL, Glantz JC. Maternal and neonatal morbidity among nulliparous women undergoing elective induction of labor. J Reprod Med. 2011 Jan–Feb;56(1–2):25–30. PMID: 21366123. Exclusion: 2. [PubMed: 21366123]
594.
Varma TR, Norman J. A comparison of three dosages of prostaglandin E2 pessaries for ripening the unfavourable cervix prior to induction of labor. Acta Obstet Gynecol Scand. 1984;63(1):17–21. doi: 10.3109/00016348409156268. PMID: 6372360. Exclusion: 4. [PubMed: 6372360] [CrossRef]
595.
Varma TR, Norman J, Cowell L. Induction of labor with vaginal prostaglandin E2 pessaries. Int J Gynaecol Obstet. 1983 Feb;21(1):55–64. doi: 10.1016/0020-7292(83)90071-1. PMID: 6133795. Exclusion: 2. [PubMed: 6133795] [CrossRef]
596.
Veena B, Samal R, Inbaraj LR, et al. Sublingual misoprostol (PGE1) versus intracervical dinoprostone (PGE2) gel for induction of labour: a randomized control trail. J Obstet Gynaecol India. 2016 Oct;66(Suppl 1):122–8. doi: 10.1007/s13224-015-0820-8. PMID: 27651590. Exclusion: 4. [PMC free article: PMC5016429] [PubMed: 27651590] [CrossRef]
597.
Villalain C, Herraiz I, Quezada MS, et al. Labor induction in late-onset fetal growth restriction: foley balloon versus vaginal dinoprostone. Fetal Diagn Ther. 2019;46(1):67–74. doi: 10.1159/000491784. PMID: 30248665. Exclusion: 4. [PubMed: 30248665] [CrossRef]
598.
Villalain C, Quezada MS, Gomez-Arriaga P, et al. Prognostic factors of successful cervical ripening and labor induction in late-onset fetal growth restriction. Fetal Diagn Ther. 2019 Dec 13:1–9. doi: 10.1159/000503390. PMID: 31838473. Exclusion: 5. [PubMed: 31838473] [CrossRef]
599.
Viteri OA, Tabsh KK, Alrais MA, et al. Transcervical foley balloon plus vaginal misoprostol versus vaginal misoprostol alone for cervical ripening in nulliparous obese women: A multicenter, randomized, comparative-effectiveness trial. Am J Perinatol. 2020 04 16;04:16. doi: 10.1055/s-0040-1708805. PMID: 32299108. Exclusion: 1. [PubMed: 32299108] [CrossRef]
600.
Vitner D, Hiersch L, Ashwal E, et al. Induction of labor versus expectant management for gestational diabetes mellitus at term. Arch Gynecol Obstet. 2019 07;300(1):79–86. doi: 10.1007/s00404-019-05171-3. PMID: 31065804. Exclusion: 1. [PubMed: 31065804] [CrossRef]
601.
Vollebregt A, van’t Hof DB, Exalto N. Prepidil compared to propess for cervical ripening. Eur J Obstet Gynecol Reprod Biol. 2002 Sep 10;104(2):116–9. doi: 10.1016/s0301-2115(02)00069-6. PMID: 12206922. Exclusion: 4. [PubMed: 12206922] [CrossRef]
602.
Voss DH, Cumminsky KC, Cook VD, et al. Effect of three concentrations of intracervical prostaglandin E2 gel for cervical ripening. J Matern Fetal Med. 1996 Jul–Aug;5(4):186–93. doi: 10.1002/(SICI)1520-6661(199607/08)5:4<186::AID-MFM5>3.0.CO;2-G. PMID: 8796792. Exclusion: 4. [PubMed: 8796792] [CrossRef]
603.
Walfisch A, Mei-Dan E, Hallak M. Trans-cervical double balloon catheter with and without extra-amniotic saline infusion for cervical ripening: a prospective quasi-randomized trial. J Matern Fetal Neonatal Med. 2015 May;28(7):848–53. doi: 10.3109/14767058.2014.935328. PMID: 24939630. Exclusion: 4. [PubMed: 24939630] [CrossRef]
604.
Wallstrom T, Jarnbert-Pettersson H, Stenson D, et al. Labor induction with orally administrated misoprostol: a retrospective cohort study. Biomed Res Int. 2017;2017:6840592. doi: 10.1155/2017/6840592. PMID: 29124067. Exclusion: 4. [PMC free article: PMC5624161] [PubMed: 29124067] [CrossRef]
605.
Wallstrom T, Strandberg M, Gemzell-Danielsson K, et al. Slow-release vaginal insert of misoprostol versus orally administrated solution of misoprostol for the induction of labour in primiparous term pregnant women: a randomised controlled trial. BJOG. 2019 Aug;126(9):1148–55. doi: 10.1111/1471-0528.15796. PMID: 30989788. Exclusion: 4. [PubMed: 30989788] [CrossRef]
606.
Wang H, Hong S, Liu Y, et al. Controlled-release dinoprostone insert versus foley catheter for labor induction: a meta-analysis. J Matern Fetal Neonatal Med. 2016;29(14):2382–8. doi: 10.3109/14767058.2015.1086331. PMID: 26427519. Exclusion: 9. [PubMed: 26427519] [CrossRef]
607.
Wang L, Zheng J, Wang W, et al. Efficacy and safety of misoprostol compared with the dinoprostone for labor induction at term: a meta-analysis. J Matern Fetal Neonatal Med. 2016;29(8):1297–307. doi: 10.3109/14767058.2015.1046828. PMID: 26067262. Exclusion: 9. [PubMed: 26067262] [CrossRef]
608.
Wang MJ, Jauk VC, George DM, et al. Patient satisfaction with outpatient cervical ripening in parous women. Am J Perinatol. 2020 Mar 03;03:03. doi: 10.1055/s-0040-1705170. PMID: 32126581. Exclusion: 3. [PubMed: 32126581] [CrossRef]
609.
Wang W, Zheng J, Fu J, et al. Which is the safer method of labor induction for oligohydramnios women? Transcervical double balloon catheter or dinoprostone vaginal insert. J Matern Fetal Neonatal Med. 2014 Nov;27(17):1805–8. doi: 10.3109/14767058.2014.880880. PMID: 24397441. Exclusion: 1. [PubMed: 24397441] [CrossRef]
610.
Wang X, Yang A, Ma Q, et al. Comparative study of titrated oral misoprostol solution and vaginal dinoprostone for labor induction at term pregnancy. Arch Gynecol Obstet. 2016 Sep;294(3):495–503. doi: 10.1007/s00404-015-4000-y. PMID: 26746850. Exclusion: 4. [PMC free article: PMC4981622] [PubMed: 26746850] [CrossRef]
611.
Wang Y, Boyd P, Hunter A, et al. Intravaginal rings for continuous low-dose administration of cervical ripening agents. Int J Pharm. 2018 Oct 05;549(1–2):124–32. doi: 10.1016/j.ijpharm.2018.07.053. PMID: 30053490. Exclusion: 5. [PubMed: 30053490] [CrossRef]
612.
Wang Z, Li W, Ouyang W, et al. Cervical ripening in the third trimester of pregnancy with intravaginal misoprostol: a double-blind, randomized, placebo-controlled study. J Tongji Med Univ. 1998;18(3):183–6. doi: 10.1007/bf02888533. PMID: 10806822. Exclusion: 4. [PubMed: 10806822] [CrossRef]
613.
Watanakunakorn C, Perni SC. Proteus mirabilis bacteremia: a review of 176 cases during 1980–1992. Scand J Infect Dis. 1994;26(4):361–7. doi: 10.3109/00365549409008605. PMID: 7984964. Exclusion: 1. [PubMed: 7984964] [CrossRef]
614.
Weeks A, Alfirevic Z. Oral misoprostol administration for labor induction. Clin Obstet Gynecol. 2006 Sep;49(3):658–71. doi: 10.1097/00003081-200609000-00023. PMID: 16885670. Exclusion: 9. [PubMed: 16885670] [CrossRef]
615.
Wegener S, Koenigbauer JT, Laesser C, et al. Do we need a 200 mug misoprostol vaginal insert? A retrospective cohort study comparing the misoprostol vaginal insert to oral misoprostol. J Obstet Gynaecol Res. 2020 Jun;46(6):851–7. doi: 10.1111/jog.14230. PMID: 32363787. Exclusion: 1. [PubMed: 32363787] [CrossRef]
616.
Weinberg D, Blue N, Holbrook B, et al. Outpatient preinduction cervical ripening using a balloon catheter: A meta-analysis. J Reprod Med. 2017;62(5):486–92. Exclusion: 9.
617.
Wickramasinghe R, Senanayake H, De Silva C. Intrauterine Foley catheter for 48 versus 24 hours for cervical ripening: A randomized controlled trial. Int J Gynaecol Obstet. 2020 May;149(2):225–30. doi: 10.1002/ijgo.13109. PMID: 32010972. Exclusion: 1. [PubMed: 32010972] [CrossRef]
618.
Wieland D, Friedman F, Jr. Comparing two dinoprostone agents for preinduction cervical ripening at term. A randomized trial. J Reprod Med. 1999 Aug;44(8):724–8. PMID: 10483544. Exclusion: 4. [PubMed: 10483544]
619.
Williams MA, Luthy DA, Zingheim RW, et al. Preinduction prostaglandin E2 gel prior to induction of labor in women with a previous cesarean section. Gynecol Obstet Invest. 1995;40(2):89–93. doi: 10.1159/000292312. PMID: 8575698. Exclusion: 4. [PubMed: 8575698] [CrossRef]
620.
Wilson PD. A comparison of four methods of ripening the unfavourable cervix. Br J Obstet Gynaecol. 1978 Dec;85(12):941–4. doi: 10.1111/j.1471-0528.1978.tb15858.x. PMID: 367426. Exclusion: 4. [PubMed: 367426] [CrossRef]
621.
Wing DA, Brown R, Plante LA, et al. Misoprostol vaginal insert and time to vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2013 Aug;122(2 Pt 1):201–9. doi: 10.1097/AOG.0b013e31829a2dd6. PMID: 23857539. Exclusion: 4. [PubMed: 23857539] [CrossRef]
622.
Wing DA, Jones MM, Rahall A, et al. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1995 Jun;172(6):1804–10. doi: 10.1016/0002-9378(95)91415-3. PMID: 7778636. Exclusion: 4. [PubMed: 7778636] [CrossRef]
623.
Wing DA, Misoprostol Vaginal Insert C. Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial. Obstet Gynecol. 2008 Oct;112(4):801–12. doi: 10.1097/AOG.0b013e318187042e. PMID: 18827122. Exclusion: 4. [PubMed: 18827122] [CrossRef]
624.
Wing DA, Ortiz-Omphroy G, Paul RH. A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol. 1997 Sep;177(3):612–8. doi: 10.1016/s0002-9378(97)70154-6. PMID: 9322632. Exclusion: 4. [PubMed: 9322632] [CrossRef]
625.
Wing DA, Park MR, Paul RH. A randomized comparison of oral and intravaginal misoprostol for labor induction. Obstet Gynecol. 2000 Jun;95(6 Pt 1):905–8. doi: 10.1016/s0029-7844(00)00815-2. PMID: 10831989. Exclusion: 4. [PubMed: 10831989] [CrossRef]
626.
Wing DA, Paul RH. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1996 Jul;175(1):158–64. doi: 10.1016/s0002-9378(96)70267-3. PMID: 8694043. Exclusion: 4. [PubMed: 8694043] [CrossRef]
627.
Wing DA, Rahall A, Jones MM, et al. Misoprostol: an effective agent for cervical ripening and labor induction. Am J Obstet Gynecol. 1995 Jun;172(6):1811–6. doi: 10.1016/0002-9378(95)91416-1. PMID: 7778637. Exclusion: 4. [PubMed: 7778637] [CrossRef]
628.
Wingerup L, Andersson KE, Ulmsten U. Ripening of the uterine cervix and induction of labour at term with prostaglandin E2 in viscous gel. Acta Obstet Gynecol Scand. 1978;57(5):403–6. doi: 10.3109/00016347809156519. PMID: 364917. Exclusion: 4. [PubMed: 364917] [CrossRef]
629.
Wise MR, Marriott J, Battin M, et al. Outpatient balloon catheter vs inpatient prostaglandin for induction of labour (OBLIGE): a randomised controlled trial. Trials. 2020 Feb 17;21(1):190. doi: 10.1186/s13063-020-4061-5. PMID: 32066505. Exclusion: 3. [PMC free article: PMC7027046] [PubMed: 32066505] [CrossRef]
630.
Witter FR, Mercer BM. Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term. The Prostaglandin E2 insert Study Group. J Matern Fetal Med. 1996 Mar–Apr;5(2):64–9. doi: 10.1002/(SICI)1520-6661(199603/04)5:2<64::AID-MFM3>3.0.CO;2-O. PMID: 8796770. Exclusion: 2. [PubMed: 8796770] [CrossRef]
631.
Worda K, Bancher-Todesca D, Husslein P, et al. Randomized controlled trial of induction at 38 weeks versus 40 weeks gestation on maternal and infant outcomes in women with insulin-controlled gestational diabetes. Wien Klin Wochenschr 2017 Sep;129(17–18):618–24. doi: 10.1007/s00508-017-1172-4. PMID: 28168363. Exclusion: 2. [PubMed: 28168363] [CrossRef]
632.
Xing Y, Li N, Ji Q, et al. Double-balloon catheter compared with single-balloon catheter for induction of labor with a scarred uterus. Eur J Obstet Gynecol Reprod Biol. 2019 Dec;243:139–43. doi: 10.1016/j.ejogrb.2019.10.041. PMID: 31704530. Exclusion: 1. [PubMed: 31704530] [CrossRef]
633.
Yacoob T, Lloyd M, Unwin A, et al. Intracervical prostaglandin E2, 0.5 mg; gel or tablet for cervical ripening and induction of labour with an unfavourable cervix? J Obstet Gynaecol. 1993;13(3):167–70. Exclusion: 4.
634.
Yazdizadeh H, Abedi P, Najar S, et al. The impact of isosorbide mononitrate on cervical ripening and labor induction in primiparous women with term pregnancy: a double-blind, randomized, controlled trial. Iran J Nurs Midwifery Res. 2013 May;18(3):246–50. PMID: 23983763. Exclusion: 2. [PMC free article: PMC3748546] [PubMed: 23983763]
635.
Yefet E, Kuzmin O, Schwartz N, et al. Labor induction versus expectant management at early term in pregnancies with second trimester elevated human chorionic gonadotropin or alpha fetoprotein. J Obstet Gynaecol Res. 2018;44(6):1049–56. doi: 10.1111/jog.13618. PMID: 130267944. Exclusion: 1. [PubMed: 29516643] [CrossRef]
636.
Yenuberi H, Abraham A, Sebastian A, et al. A randomised double-blind placebo-controlled trial comparing stepwise oral misoprostol with vaginal misoprostol for induction of labour. Trop Doct. 2016 Oct;46(4):198–205. doi: 10.1177/0049475515624856. PMID: 26787644. Exclusion: 4. [PubMed: 26787644] [CrossRef]
637.
Yogev Y, Ben-Haroush A, Lahav E, et al. Induction of labor with prostaglandin E2 in women with previous cesarean section and unfavorable cervix. Eur J Obstet Gynecol Reprod Biol. 2004 Oct 15;116(2):173–6. doi: 10.1016/j.ejogrb.2004.02.019. PMID: 15358459. Exclusion: 4. [PubMed: 15358459] [CrossRef]
638.
Yolande H, Namory K, Delphine F, et al. Misoprostol use for labor induction in developing countries: a prospective study in Guinea. Eur J Obstet Gynecol Reprod Biol. 2005 Sep 01;122(1):40–4. doi: 10.1016/j.ejogrb.2004.11.013. PMID: 16154037. Exclusion: 4. [PubMed: 16154037] [CrossRef]
639.
Yonekura ML, Songster G, Smith-Wallace T. Preinduction cervical priming with PGE2 intracervical gel. Am J Perinatol. 1985 Oct;2(4):305–10. doi: 10.1055/s-2007-999976. PMID: 3863624. Exclusion: 4. [PubMed: 3863624] [CrossRef]
640.
Young DC, Delaney T, Armson BA, et al. Oral misoprostol, low dose vaginal misoprostol, and vaginal dinoprostone for labor induction: randomized controlled trial. PLoS ONE. 2020;15(1):e0227245. doi: 10.1371/journal.pone.0227245. PMID: 31923193. Exclusion: 4. [PMC free article: PMC6953875] [PubMed: 31923193] [CrossRef]
641.
Yuen PM, Pang HY, Chung T, et al. Cervical ripening before induction of labour in patients with an unfavourable cervix: a comparative randomized study of the Atad Ripener Device, prostaglandin E2 vaginal pessary, and prostaglandin E2 intracervical gel. Aust N Z J Obstet Gynaecol. 1996 Aug;36(3):291–5. doi: 10.1111/j.1479-828x.1996.tb02713.x. PMID: 8883753. Exclusion: 4. [PubMed: 8883753] [CrossRef]
642.
Zanconato G, Bergamini V, Mantovani E, et al. Induction of labor and pain: a randomized trial between two vaginal preparations of dinoprostone in nulliparous women with an unfavorable cervix. J Matern Fetal Neonatal Med. 2011 May;24(5):728–31. doi: 10.3109/14767058.2011.557108. PMID: 21351838. Exclusion: 4. [PubMed: 21351838] [CrossRef]
643.
Zargar M, Nazari MA, Hormozy L, et al. Efficacy of transcervical foley catheter and laminaria on induction of labor in post-term pregnancy: a clinical study. Tehran University Medical Journal. 2014;72(3):161–6. Exclusion: 7.
644.
Zhang L, Zhang H, Zhang J, et al. Preventive induction of labor for non-urgent indications at term and maternal and neonatal outcomes. Reprod Health. 2016 Apr 21;13:46. doi: 10.1186/s12978-016-0165-5. PMID: 27103111. Exclusion: 4. [PMC free article: PMC4839063] [PubMed: 27103111] [CrossRef]
645.
Zhao L, Lin Y, Jiang TT, et al. Vaginal delivery among women who underwent labor induction with vaginal dinoprostone (PGE2) insert: a retrospective study of 1656 women in China. J Matern Fetal Neonatal Med. 2019 May;32(10):1721–7. doi: 10.1080/14767058.2017.1416351. PMID: 29268652. Exclusion: 4. [PubMed: 29268652] [CrossRef]
646.
Zvandasara P, Saungweme G, Mlambo J, et al. Induction of labour with titrated oral misoprostol suspension. A comparative study with vaginal misoprostol. Cent Afr J Med. 2008 Sep–Dec;54(9–12):43–9. doi: 10.4314/cajm.v54i9-12.62626. PMID: 21644418. Exclusion: 4. [PubMed: 21644418] [CrossRef]
647.
Zwertbroek EF, Franssen MTM, Broekhuijsen K, et al. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial. Am J Obstet Gynecol. 2019 08;221(2):154.e1–.e11. doi: 10.1016/j.ajog.2019.03.024. PMID: 30940558. Exclusion: 1. [PubMed: 30940558] [CrossRef]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (4.7M)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...